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Welcoming Remarks
Greetings of Peace to All,
I am delighted and honoured to welcome you to the 2nd International Conference on Molecular 
Diagnostics and Biomarker Discovery (MDBD). The mission of our institute is “to strive to attain 
research and academic excellence via knowledge creation through training, research and innovation 
in molecular medicine”. One of the ways to achieve this is through scientific discoveries that are 
translated into better diagnostics, leading to better treatment for patients and improve health. 
Since its inception, the core strength of INFORMM has been in the area of Diagnostics, especially 
those that provides solutions for infectious diseases and cater for the needs of populations in low 
resource settings. We have received national recognition from the Ministry of Higher Education 
Malaysia, under the HICoE program, as a centre of excellence in the niche area of Diagnostics 
Platform, with antibody engineering being the principal technology. We also have groups at 
INFORMM that delve into investigating new infection makers, and develop and evaluate nucleic 
acid and protein-based tests, some of which have been commercialised. Each of these phases of 
diagnostics research requires continuous updates in technology, methodology and approaches. 
Thus it is important that we bring together experts, scientists, postgraduate students and scientific 
companies to an event, such as MDBD, that is of mutual interest and benefit to all participants. 
Thus it is apt that the conference is themed “Advances in Biomarker Discovery and Technologies 
for Better Diagnostics”
This MDBD 2017 conference promises to be an exciting event with thirteen invited speakers from 
various parts of the world - Spain, Iran, USA, Saudi Arabia, Singapore, Australia, Brazil, Germany 
and Malaysia. Thus I hope everyone will take this golden opportunity to interact with these experts 
and get their insights into the research questions that you are tackling. Our participants are also 
from diverse backgrounds and countries, thus the opportunity for establishing new collaborations 
and networking, and strengthening existing ones are tremendous. The latest scientific supplies 
and services that can facilitate your research are also on display by our sponsors.
For those from outside Penang, we hope you will also take this opportunity to visit and sample the 
many tourist attractions that the ‘Pearl of the Orient’ has to offer. Again, I welcome all of you and 
hope that this conference will be a scientifically rewarding experience. Thank you.
Sincerely,
       Rahmah Noordin, Ph.D., F.A.Sc.
       Conference Chair
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Conference Programme
Day 1  3 May 2017
0800 - 0845 Registration
0845 - 0900 Opening Remarks
 Director & Conference Chairperson 
0900 - 0935 Plenary 1
 Diagnostic Technologies I
 Approaches to development and commercialisation of POC Tests – Burnet Institute experience
 David Anderson
 Chairperson: Norsyahida Arifin
0935 - 1000 Technology Session 1
 Biomarker discovery: Multiplexing with Luminex xMAP technology
1000 - 1035 Tea Break, Poster Viewing, Exhibition and Networking Session
1035 - 1100 Technology Session 2
 Going digital: In molecular dagnostics
1100 - 1200 Symposium 1
 Diagnostic Technologies II 
 ASSURED Molecular diagnostics: Drivers, barriers and reality
 Ionis Katakis 
 Rapid and low-cost assays for pathogens detection
 Mohammed Zourob
 Chairperson: Gurjeet Kaur 
1200 - 1300 Symposium 2 
 Biomarker Discovery & Assay Development Using Proteomics Approach I 
 A genomic and immunoproteomic approach to identify diagnostic antigens for human   
 paragonimiasis  
 Peter U. Fischer
 Rational design and evaluation of a multi-epitope chimeric fusion protein for detection of  
 Toxoplasma IgM antibodies
 Majid Golkar 
 Chairperson: Prof Rahmah Noordin
1300 - 1400 Lunch, Poster Viewing & Exhibition
1400 - 1430 Symposium 3
 Infectious Disease Diagnosis Using Genomics Approach
 Molecular biology and the environmental monitoring of enteric viruses
 Fernando Spilki 
 Chairperson: Aziah Ismail
1430 - 1500 Opening Ceremony
 Vice Chancellor’s Address
 Prof Datuk Dr Asma Ismail
1500 - 1515 MOU Exchange
1515 - 1615 Keynote Address 1
 Cost-effective point-of-need diagnostics – combining aptamers and advanced lateral flow devices’ 
 Ciara O’Sullivan
 Chairperson: Aziah Ismail
1615 - 1630 Tea, Poster Viewing & Exhibition
1630 - 1815 Oral Presentation Oral Presentation Oral Presentation
 Session 1A Session 1B Session 1C
1815 End of Day
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Conference Programme
Day 2  4 May 2017
0900 - 1000 Keynote Address 2 
 Advanced Nanosystems for Diagnostic Applications
 Jackie Ying Yi-Ru
 Chairperson: Prof Rahmah Noordin
1000 - 1030  Symposium 4
 Diagnostic Test Development & Translational Research
 From bench to market: Challenges in the development and commercialization of diagnostic  
 tools.”
 Andreas Latz
 Chairperson: Norsyahida Arifin
1030 - 1100 Tea Break 
1100 - 1130 Symposium 5
 Diagnostic Technologies III 
 Use of lateral flow membranes for diagnostic rapid tests in the future
 Klaus Hochleitner
 Chairperson: Tye Gee Jun
1130 - 1200 Symposium 6
 Biomarker Discovery & Assay Development Using Proteomics Approach II 
 Proteomics and cancer diagnosis
 Discovery and validation of biomarkers for the early detection of ovarian cancer
 Peter Hoffmann
 Chairperson: Gurjeet Kaur
1200 - 1300 Symposium 7
 Cancer Diagnosis
 Circulatory miRNA biomarkers as “liquid biopsy” in diseases 
 Too Heng-Phon
 Identification and utilization of biomarkers of drug response for precision medicine
 Cheong Sok Ching
 Chairperson: Noor Fatmawati Mokhtar
1300 - 1400 Lunch, Poster Viewing & Exhibition
1400 - 1530 Oral Presentation Oral Presentation Oral Presentation
 Session 2A Session 2B Session 2C
1530 - 1550 Tea, Poster Viewing & Exhibition
1550 - 1700 Oral Presentation Oral Presentation Oral Presentation
 Session 3A Session 3B Session 3C
1700 - 1730 Closing Ceremony
 Presentation of prizes to best poster and oral presenters 
 Closing remarks by Chairperson 
1730 END
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List of speakers 
Code Title Speaker Page 
IL01 Approaches to development and commercialisation of POC 
tests – Burnet Institute experience 
 
Anderson  
IL02 ASSURED Molecular diagnostics: Drivers, barriers and 
reality 
 
Ionis Katakis  
IL03 Rapid and low-cost assays for pathogens detection 
 
Mohammed 
Zourob 
 
IL04 A genomic and immunoproteomic approach to 
identify diagnostic antigens for human 
paragonimiasis   
 
Peter U. Fischer  
IL05 Rational design and evaluation of a multi-epitope chimeric 
fusion protein for detection of Toxoplasma IgM antibodies 
 
Majid Golkar  
IL06 Molecular biology and the environmental 
monitoring of enteric viruses 
 
Fernando Spilki  
IL07 Cost-effective point-of-need diagnostics – combining 
aptamers and advanced lateral flow devices  
 
Ciara O'Sullivan  
IL08 Advanced nanosystems for diagnostic applications 
 
Jackie Ying Yi-Ru  
IL09 From bench to market: Challenges in the development and 
commercialization of diagnostic tools.” 
 
Andreas Latz  
IL10 Use of lateral flow membranes for diagnostic rapid tests in 
the future 
 
Klaus Hochleitner  
IL 11 Proteomics and cancer diagnosis 
Discovery and validation of biomarkers for the early 
detection of ovarian cancer 
 
Peter Hoffmann  
IL12 Circulatory miRNA biomarkers as “liquid biopsy” in 
diseases  
 
Too Heng-Phon  
IL13 Identification and utilization of biomarkers of drug response 
for precision medicine 
 
Cheong Sok Ching  
TS01 Biomarker discovery: Multiplexing with Luminex xMAP 
technology  
 
Chong Mun Keat  
TS02 Going digital: In molecular diagnostics 
 
Hoe Li Nah  
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TABLE OF ORAL PRESENTATIONS 
 
Code 
 
Title Speaker Page 
OP01 Identifying a diagnostic target for Group B Streptococcus Hannah Swinburne  
OP02 Reverse flow immunochromatography assay for early 
detecting autoimmune marker (autoantibody to GAD65) 
on autoimmune diabetic patients 
Aulanni’am 
Aulanni’am 
 
 
OP03 Isolation and characterization of an anti-salbutamol scFv 
antibody from a chicken phage display library for 
immunodiagnostics 
 
Warren Lee Xian 
Liang 
 
OP04 Innovation challenge: the feasibility from lab scale to 
mass production. Can we bring good medical device for 
more people? Ex: Blood Glucose Monitoring System 
Industry 
 
Sue, Jun Wei 
 
OP05 Influence of human immunodeficiency virus (HIV) and 
smear status, and host characteristics on 
seroimmunological biomarkers of pulmonary tuberculosis 
 
Siti Khayriyyah 
Mohd Hanafiah 
 
OP06 Association of Interleukin-13 gene (IL13) rs20541 single 
nucleotide polymorphism with obesity-related traits and 
allergies among UTAR Kampar students 
 
Say Yee How 
 
OP07 QTc interval prolongations in opioid dependent patients 
on methadone maintenance therapy (MMT) 
 
Muslih Abdulkarim 
Ibrahim 
 
OP08 In silico structure based functional annotation of putative 
conserved hypothetical proteins from Streptococcus 
pneumoniae R6 strain 
 
Tinna Devi 
Armasamy 
 
OP09 COMT methylation as a potential peripheral biomarker of 
schizophrenia 
Nour El Huda binti 
Abd Rahim 
 
OP10 Upregulation of metastatic markers MMP2 and N-
cadherin in MCF-7 cells by TSA 
 
Nur Sabrina 
Kamarulzaman 
 
OP11 Effects of gold nanoparticles on dendritic cells in PBMC 
of asthmatic and healthy individual Suhana Ahmad 
 
OP12 miR-21, miR-27b and ABCB1 expression implies new 
markers of chemoresistance in triple negative breast 
cancer 
 
Ahmad Aizat bin 
Abdul Aziz 
 
OP13 Identification of ibmr3 antigen in cancer cell lines using 
two dimensional gel electrophoresis coupled liquid 
chromatography-tandem mass spectrometry technique 
 
Mohd Nazri Ismail 
 
OP14 Investigating the growth and invasion phenotypes of the 
three-dimensional (3D) spheroids generated from 
cervical cancer cell lines 
Kalaivani Muniandy  
 
OP15 in vitro selection of RNA aptamer against CD36 protein 
by Systematic Evolution of Ligand by Exponential 
Enrichment (SELEX) 
 
Nik Abdul Aziz Nik 
Kamarudin  
 
OP16 Construction of shark semi-synthetic VNAR library for 
malaria RDTs improvement 
 
Cheong Wei Shien 
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OP17 Screening for cystic echinococcosis in migrant workers 
revealed significant discordant results among three 
immunoassays 
 
Sam Khanbabaie 
 
OP18 Construction of semi-synthetic phage display library by 
randomization of CDR3 region of human single chain Fv 
for antibody generation targeted against Japanese 
Encephalitis Virus NS1 
 
Chong Hui Ying 
 
OP19 Lateral flow dipstick test using recombinant antigens TES-
26, TES-30 and TES-120 for rapid detection of human 
toxocariasis 
 
Muhammad 
Hafiznur Yunus 
 
OP20 
The value of a panel of autoantibodies and complement 
as biomarkers in Lupus Nephritis patients in HUSM 
Siti Khadijah binti 
Syed Mohammed 
Nazri 
 
OP21 Detection and identification of microsporidia antigens in 
HIV/AIDS patients via serum proteomic approach 
 
Nurul Shazalina 
Zainudin 
 
OP22 Role of TolC in the invasiveness of Salmonella enterica 
serovar Typhi 
 
Ashraf Hussain 
 
OP23 Detection of proteins as potential biomarkers in 
Acanthamoeba exposed to lead and zinc: in vitro study 
 
Nakisah bt Mat 
Amin 
 
OP24 Identification of novel immunogenic proteins of 
Leptospira spp. using ORFeome phage display 
 
Siti Roszilawati 
Ramli 
 
OP25 Simultaneous identification of Salmonella serovars 
causing enteric fever using a Multiplex PCR-Line Probe 
Assay (mPCR-LiPA) 
 
Carlos Silvester 
 
OP26 Identification of potential biomarkers in synovial fluid in 
monoiodoacetate induced osteoarthritis in rabbit model 
 
Tan Wei Miao 
 
OP27 Paternal lineage affinity of the earliest inhabitants in 
Peninsular Malaysia: evidence from Y-STRs analysis 
Sharifah Nany 
Rahayu Karmilla 
binti Syed Hassan 
 
OP28 Protumourigenic CTAG1B is a potential bladder cancer 
biomarker 
 
Siti Farizan Mansor 
 
OP29 Expression profile of E2F genes in cervical 
carcinogenesis using human transcriptome array gene 
expression 
 
Shandra Devi 
Balasubramaniam 
 
OP30 Evaluating the efficacy of polysaccharide extract of 
basidiomycetes on MMP-1 mechanism: A skin 
rejuvenation approach 
 
Nur Amira Syairah 
binti Abdul Halim 
 
OP31 Targeting HIF-1α /CBP to combat Nav1.5-mediated 
breast cancer metastasis: Potential therapeutic 
biomarker 
 
Hemaniswarri Dewi 
A/P Dewadas 
 
OP32 Development of a prototype rapid antigen detection test 
for acute leptospirosis in human 
 
Chang Chiat Han 
 
OP33 Development of carbon nanotube-based aptasensor for 
detection of Salmonella spp. 
 
Thong Kwai Lin 
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OP34 Species specific recognition of bacterial pathogens using 
targeted antibody design 
Christopher 
Johnson 
 
OP35 Lateral flow rapid dipstick test for detection of Entamoeba 
histolytica antigen in stool 
 
Syazwan Saidin 
 
OP36 Production of recombinant monoclonal antibody against 
BmSXP filarial antigen 
 
Anizah bt 
Rahumatullah 
 
OP37 Optimisation of dAbs against HSP16.3 from 
Mycobacterium tuberculosis: in silico approach 
 
Soong Jia Xin 
 
OP38 Optimisation of domain antibody against ac2sgl from 
Mycobacterium tuberculosis in complex with CD1b, from 
the perspective of molecular modelling 
 
Law Cheh Tat 
 
OP39 Membrane proteome analysis of Entamoeba histolytica 
 Jorim Ujang 
 
OP40 Elucidation of antigenic membrane proteins of virulent 
and avirulent variants of Entamoeba histolytica 
HM1:IMSS strain 
 
Gaayathri d/o 
Kumarasamy 
 
OP41 An investigation of differential protein expression of the 
membrane of virulent and avirulent variants of 
Entamoeba histolytica HM1:IMSS 
 
Ng Yee Ling 
 
OP42 In-depth investigation on DNA-AgNCs designs for 
adenosine detection 
 
Lee Shi Ting 
 
OP43 Application of human neonatal Fc receptor in antibody 
immobilization 
 
Ng Woei Kean 
 
OP44 Functional role of Fringe in tumor angiogenesis Cheng Wei Kang  
OP45 Endogenous bioactive dynorphin 3-14 as a biomarker in 
chronic rhinosinusitis and its immunomodulatory effects 
 
Siti Sarah Fazalul 
Rahiman 
 
OP46 Nepenthes gracilis pitcher pot fluid fractions anti-
proliferation effects on MDA-MB231 cell line via ER-α36 
signalling pathway 
 
Geethaa Sahgal 
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TABLE OF POSTER PRESENTATIONS 
Code Title Speaker Page 
PPO1 The anti-proliferative effect of crude protein extract from 
Ximenia americana roots on human breast cancer cell lines 
Nagla Mustafa 
Eltayeb 
 
PPO2 Profiling of microRNA expression in obese and diabetic-
induced mice for biomarker discovery 
Janan Nima Hadi  
PPO3 A pilot acute toxicity study on the effect of Orthosiphon 
stamineus and gemcitabine combination treatment in 
athymic nude mice 
Ashwaq Hamid 
Salem Yehya, 
 
PPO4 Circulating microRNA expression profiling in 
nasopharyngeal carcinoma: A preliminary result 
Azmir Ahmad  
PPO5 Ultrasensitive, rapid and inexpensive detection of DNA 
using paper based lateral flow assay 
Abdulaziz S. 
Bashammakh 
 
PPO6 Rapid identification of clinical and environmental isolates of 
Aeromonas species by lab-on-chip based PCR-RFLP 
Khor Wei Ching   
PPO7 Evaluating the Potential of Autophagy as Biomarker for 
Colorectal Cancer (CRC) 
Teow Sin-Yeang  
PPO8 Application of copper-chitosan nanoparticles in treatment of 
pathogenic local isolates bacteria 
Sohier M.Syame  
PPO9 Human antibody phage display library generated T cell 
receptor (TCR)-like antibody for diagnostics and 
therapeutics 
Sylvia Annabel  
Dass 
 
PP10 Multiplex PCR for rapid and accurate diagnosis of acute 
leptospirosis 
Habib Abdul Hakim 
Esa 
 
PP11 A randomized study on isolation of Salmonella enterica 
serovar Typhi from gallbladder patients with hepatobiliary 
diseases in HUSM 
Asmak Ghazali  
PP12 Nanoparticles-based Colorimetric Aptasensor for 
Biomarker Detection 
Wai Jing Luen  
PP13 Profiling of cytokines, chemokines and other soluble 
proteins as a potential biomarker in colorectal cancer and 
polyps 
Nor Adzimah Johdi  
PP14 Detection of invasive fungal pathogens utilizing Late-PCR  Dhayaalini Bala 
Gopal 
 
PP15 Potential impact of BRCA1-3’UTR- TG or TT variant 
(rs8176318G/T) in the Breast cancer populations of Saudi 
Arabia 
Rashid Mir 
 
 
PP16 Identification of Salmonella enterica serovar Typhi 
virulence factors through bioinformatics analysis and yeast 
morphology assay 
Pong Sze Yen   
PP17 Identification of Salmonella enterica serovar Typhi 
virulence factors using a yeast growth inhibition screen 
Koay Ley Teng   
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PP18 A preliminary report on proteomic-mediated response in 
mud crabs taken from Setiu Wetland lagoon, Terengganu. 
Nur Syafinaz, Mohd 
Razali 
 
 
PP19 The identification of Leptospira interrogans virulent factors 
with a yeast growth inhibition screen 
Lai Weng Yu  
PP20 Establishment of a novel sirtuin inhibitor as an adjuvant 
therapeutic agent in colorectal cancer 
Fong Kwong Soon  
PP21 Development of rapid dot-blot flow through assay for HIV 
antibody detection with novel synthetic multiepitope peptide  
Ragul 
Paramasivam  
 
PP22 Triple negative breast cancer: A review of molecular 
classification and potential target therapies 
Siti Aisyah Osman  
PP23 Review: Recent Molecular Mechanism of Apoptotic 
Pathways in Cancer Cell Lines with Additional Apoptosis-
Inducing Compounds in Natural Plants 
Nasibah Razali  
PP24 Functional annotation and classification of the hypothetical 
proteins of Acinetobacter baumannii 
Prianeesha 
Ganesan 
 
PP25 Functional annotation of conserved hypothetical proteins 
from Salmonella typhi 
Asheelah 
Rajeendran 
 
PP26 Computational functional annotation of putative conserved 
hypothetical proteins from Klebsiella pneumoniae HS11286 
Tamil Arasi a/p 
Tamil Kalanathan 
 
PP27 The Effect of Glucose Oxidase Concentration on the 
Performance of Indium Tin Oxide Glass Electrode for 
Glucose Detection 
Khairunisak Abdul 
Razak 
 
PP28 Comparison of carotenoid biosynthesis gene sequences 
and expression in wild type and a novel hyperproducing 
strain of Xanthopyllomyces dendrorhous 
Ang Fong Sim 
 
 
 
PP29 Optimization of LipL32-Loop-mediated Isothermal 
Amplification (LipL32-LAMP) for faster detection of 
Leptospirosis interrogans  
Dzulaikha 
Khairuddin 
 
PP30 Melioidosis: diagnostic value of IFAT IgM and IFAT IgG in 
comparison with qPCR 
M. Imad. A. 
Mustafa Mahmud 
 
PP31 Synthesis and characterization of gold nanoflowers as label 
in lateral flow dipstick 
Mohammad 
Lukman Yahaya 
 
PP32 Optimization of indirect competitive ELISA for the 
development of immunosensor to detect Aflatoxin B1 in 
peanut sample 
Rashidah Sukor  
PP33 In-vitro cytotoxicity effect of Bismuth Oxide Nanoparticles 
(Bi2O3 Nps) synthesized at different temperature  
Nur Amirah Mohd 
Nor 
 
PP34 Development of immunochromatography based on Thyroid 
Peroxidase (TPO) as autoimmune marker for early 
detection of autoimmune thyroid diseases 
Dyah Kinasih 
Wuragil 
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PP35 Combination of A-1210477 and ABT-263 exhibit synergistic 
effect on  
cervical cancer cell lines – A preliminary study 
Siti Fairus Abdul 
Rahman 
 
 
 
PP36 Serotyping dengue virus with silver nanocluster DNA 
switch 
Chan Soo Khim  
PP37 Cassettes hybridization for vector assembly (CHyVAs): An 
alternative approach towards in vitro antibody affinity 
maturation 
Lai Jing Yi 
 
 
PP38 Identification of potential clones recognized anti-
Strongyloides antibodies by cDNA library immunoscreening 
Norsyahida Arifin  
PP39 Multiplex real-time polymerase chain reaction assay for 
detection of helminthes and protozoan parasites in stools 
of eight aborigine communities in Malaysian Peninsular 
Noorizan Miswan  
PP40 Biopanning of antibody phage clones using ‘Ping Pong’ 
panning 
Lim Chia Chiu  
PP41 Optimization of Protein Expression and Extraction of Zika 
(ZIKV) Non-Structural Protein for Antibody Selection  
Angela Ch’ng, 
Chiew Wen 
 
PP42 Making sense of the mess; pre-panning process for 
improved antibody enrichment in phage display 
Azimah Ahmad  
PP43 Preparation of stable conjugation gold nanoparticles to 
antibody for immunochromatographic strip assay for the 
rapid detection 
Nor Dyana Zakaria  
PP44 Contamination of Leptospira spp. in flood affected areas in 
Kelantan 
Nur Haizum Abdul 
Muony 
 
PP45 A Nanocluster Beacon to detect FOXP3 sequence Lee, Shin Yong  
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FREE PAPERS SESSION 1A 
3 May 2017 
Time: 4.15pm – 5.30pm 
 
Chairperson: Assoc. Prof. Dr. Aziah Ismail 
 
 
Presentation time: 12 mins presentation + 3 mins Q&A 
 
 
Code Title Speaker Time 
OP1 Identifying a diagnostic target for Group B 
Streptococcus Hannah Swinburne 4.15 – 4.30pm 
OP2 Reverse flow immunochromatography assay for 
early detecting autoimmune marker 
(autoantibody to GAD65) on autoimmune diabetic 
patients 
Aulanni’am 
Aulanni’am 4.30 – 4.45pm 
OP3 Isolation and characterization of an anti-
salbutamol scFv antibody from a chicken phage 
display library for immunodiagnostics 
Warren Lee 
Xian Liang 4.45 – 5.00pm 
OP4 Innovation challenge: the feasibility from lab 
scale to mass production. Can we bring good 
medical device for more people? Ex: Blood 
Glucose Monitoring System Industry 
Sue, Jun Wei 5.00 – 5.30pm 
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FREE PAPERS SESSION 1B 
3 May 2017 
Time: 4.15pm – 5.30pm 
 
Chairperson: Assoc. Prof. Dr. Venugopal Balakrishnan 
 
 
Presentation time: 12 mins presentation + 3 mins Q&A 
 
 
Code Title Speaker Time 
OP5 Influence of human immunodeficiency virus (HIV) 
and smear status, and host characteristics on 
seroimmunological biomarkers of pulmonary 
tuberculosis 
Siti Khayriyyah 
Mohd Hanafiah 4.15 – 4.30pm 
OP6 Association of Interleukin-13 gene (IL13) rs20541 
single nucleotide polymorphism with obesity-
related traits and allergies among UTAR Kampar 
students 
Say Yee How 4.30 – 4.45pm 
OP7 QTc interval prolongations in opioid dependent 
patients on methadone maintenance therapy 
(MMT) 
Muslih 
Abdulkarim 
Ibrahim 
4.45 – 5.00pm 
OP8 In silico structure based functional annotation of 
putative conserved hypothetical proteins from 
Streptococcus pneumoniae R6 strain 
Tinna Devi 
Armasamy 5.00 – 5.15pm 
OP9 COMT methylation as a potential peripheral 
biomarker of schizophrenia Nour El Huda binti Abd Rahim 5.15 – 5.30pm 
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FREE PAPERS SESSION 1C 
3 May 2017 
Time: 4.15pm – 5.30pm 
 
Chairperson: Prof. Dr. Gurjeet Kaur 
 
 
Presentation time: 12 mins presentation + 3 mins Q&A 
 
 
Code Title Speaker Time 
OP10 Upregulation of metastatic markers MMP2 and 
N-cadherin in MCF-7 cells by TSA 
Nur Sabrina 
Kamarulzaman 4.15 – 4.30pm 
OP11 Effects of gold nanoparticles on dendritic cells in 
PBMC of asthmatic and healthy individual Suhana Ahmad 4.30 – 4.45pm 
OP12 miR-21, miR-27b and ABCB1 expression implies 
new markers of chemoresistance in triple 
negative breast cancer 
Ahmad Aizat bin 
Abdul Aziz 4.45 – 5.00pm 
OP13 Identification of ibmr3 antigen in cancer cell lines 
using two dimensional gel electrophoresis 
coupled liquid chromatography-tandem mass 
spectrometry technique 
Mohd Nazri 
Ismail 5.00 – 5.15pm 
OP14 Investigating the growth and invasion 
phenotypes of the three-dimensional (3D) 
spheroids generated from cervical cancer cell 
lines 
Kalaivani 
Muniandy 5.15 – 5.30pm 
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FREE PAPERS SESSION 2A 
4 May 2017 
Time: 2.00pm – 3.30pm 
 
Chairperson: Dr. Lim Theam Soon 
 
 
Presentation time: 12 mins presentation + 3 mins Q&A 
 
 
Code Title Speaker Time 
OP15 in vitro selection of RNA aptamer against CD36 
protein by Systematic Evolution of Ligand by 
Exponential Enrichment (SELEX) 
Nik Abdul Aziz 
Nik Kamarudin 2.00 – 2.15pm 
OP16 Construction of shark semi-synthetic VNAR 
library for malaria RDTs improvement Cheong Wei Shien 2.15 – 2.30pm 
OP17 Screening for cystic echinococcosis in migrant 
workers revealed significant discordant results 
among three immunoassays 
Sam 
Khanbabaie 2.30 – 2.45 pm 
OP18 Construction of semi-synthetic phage display 
library by randomization of CDR3 region of 
human single chain Fv for antibody generation 
targeted against Japanese Encephalitis Virus 
NS1 
Chong Hui Ying 2.45 – 3.00pm 
OP19 Lateral flow dipstick test using recombinant 
antigens TES-26, TES-30 and TES-120 for rapid 
detection of human toxocariasis 
Muhammad 
Hafiznur Yunus 3.00 – 3.15pm 
OP20 The value of a panel of autoantibodies and 
complement as biomarkers in Lupus Nephritis 
patients in HUSM 
Siti Khadijah 
binti Syed 
Mohammed 
Nazri 
3.15 – 3.30pm 
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FREE PAPERS SESSION 2B 
4 May 2017 
Time: 2.00pm – 3.15pm 
 
Chairperson: Dr. Nurulhasanah Othman 
 
 
Presentation time: 12 mins presentation + 3 mins Q&A 
 
 
Code Title Speaker Time 
OP21 Detection and identification of microsporidia 
antigens in HIV/AIDS patients via serum 
proteomic approach 
Nurul Shazalina 
Zainudin 2.00 – 2.15pm 
OP22 Role of TolC in the invasiveness of Salmonella 
enterica serovar Typhi Ashraf Hussain 2.15 – 2.30 pm 
OP23 Detection of proteins as potential biomarkers in 
Acanthamoeba exposed to lead and zinc: in vitro 
study 
Nakisah bt Mat 
Amin 2.30 – 2.45pm 
OP24 Identification of novel immunogenic proteins of 
Leptospira spp. using ORFeome phage display Siti Roszilawati Ramli 2.45 – 3.00pm 
OP25 Simultaneous identification of Salmonella 
serovars causing enteric fever using a Multiplex 
PCR-Line Probe Assay (mPCR-LiPA) 
Carlos Silvester 3.00 – 3.15pm 
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Time: 2.00pm – 3.30pm 
 
Chairperson: Dr. Lai Ngit Shin 
 
 
Presentation time: 12 mins presentation + 3 mins Q&A 
 
 
Code Title Speaker Time 
OP26 Identification of potential biomarkers in synovial 
fluid in monoiodoacetate induced osteoarthritis 
in rabbit model 
Tan Wei Miao 2.00 – 2.15pm 
OP27 Paternal lineage affinity of the earliest 
inhabitants in Peninsular Malaysia: evidence 
from Y-STRs analysis 
Sharifah Nany 
Rahayu Karmilla 
binti Syed Hassan 
2.15 – 2.30pm 
OP28 Protumourigenic CTAG1B is a potential bladder 
cancer biomarker Siti Farizan Mansor 
2.30 – 2.45 
pm 
OP29 Expression profile of E2F genes in cervical 
carcinogenesis using human transcriptome 
array gene expression 
Shandra Devi 
Balasubramaniam 2.45 – 3.00pm 
OP30 Evaluating the efficacy of polysaccharide 
extract of basidiomycetes on MMP-1 
mechanism: A skin rejuvenation approach 
Nur Amira 
Syairah binti 
Abdul Halim 
3.00 – 3.15pm 
OP31 Targeting HIF-1α /CBP to combat Nav1.5-
mediated breast cancer metastasis: Potential 
therapeutic biomarker 
Hemaniswarri 
Dewi A/P 
Dewadas 
3.15 – 3.30pm 
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Presentation time: 12 mins presentation + 3 mins Q&A 
 
 
Code Title Speaker Time 
OP32 Development of a prototype rapid antigen 
detection test for acute leptospirosis in human 
Chang Chiat 
Han 
3.50 – 4.05pm 
OP33 Development of carbon nanotube-based 
aptasensor for detection of Salmonella spp. Thong Kwai Lin 
4.05 – 4.20pm 
OP34 Species specific recognition of bacterial 
pathogens using targeted antibody design Christopher Johnson 
 
4.20 – 4.35pm 
OP35 Lateral flow rapid dipstick test for detection of 
Entamoeba histolytica antigen in stool Syazwan Saidin 
4.35 – 4.50pm 
OP36 Production of recombinant monoclonal antibody 
against BmSXP filarial antigen 
Anizah bt 
Rahumatullah 
4.50 – 5.05pm 
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Presentation time: 12 mins presentation + 3 mins Q&A 
 
 
Code Title Speaker Time 
OP37 Optimisation of dAbs against HSP16.3 from 
Mycobacterium tuberculosis: in silico approach Soong Jia Xin 
 
3.50 – 4.05pm 
OP38 Optimisation of domain antibody against ac2sgl 
from Mycobacterium tuberculosis in complex 
with CD1b, from the perspective of molecular 
modelling 
Law Cheh Tat 
 
4.05 – 4.20pm 
OP39 Membrane proteome analysis of Entamoeba 
histolytica Jorim Ujang 
4.20 – 4.35pm 
OP40 Elucidation of antigenic membrane proteins of 
virulent and avirulent variants of Entamoeba 
histolytica HM1:IMSS strain 
Gaayathri d/o 
Kumarasamy 
 
4.35 – 4.50pm 
OP41 An investigation of differential protein 
expression of the membrane of virulent and 
avirulent variants of Entamoeba histolytica 
HM1:IMSS 
Ng Yee Ling 
 
4.50 – 5.05pm 
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Presentation time: 12 mins presentation + 3 mins Q&A 
 
 
Code Title Speaker Time 
OP42 In-depth investigation on DNA-AgNCs designs 
for adenosine detection Lee Shi Ting 
3.50 – 4.05pm 
OP43 Application of human neonatal Fc receptor in 
antibody immobilization Ng Woei Kean 
4.05 – 4.20pm 
OP44 Functional role of Fringe in tumor angiogenesis Cheng Wei 
Kang 
4.20 – 4.35pm 
OP45 Endogenous bioactive dynorphin 3-14 as a 
biomarker in chronic rhinosinusitis and its 
immunomodulatory effects 
Siti Sarah 
Fazalul 
Rahiman 
 
4.35 – 4.50pm 
OP46 Nepenthes gracilis pitcher pot fluid fractions anti-
proliferation effects on MDA-MB231 cell line via 
ER-α36 signalling pathway 
Geethaa Sahgal 
4.50 – 5.05pm 
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Plenary 1-Diagnostic Technologies I
Title : 
Approaches to development and commercialisation of POC tests – Burnet Institute experience
David A. Anderson, PhD
Head, Diagnostics Development Laboratory
Macfarlane Burnet Institute for Medical Research and Public Health (Burnet Institute)
Adjunct Appointments:
Associate Professor, University of Melbourne
Visiting Associate Professor, Rush University, Chicago; Senior Lecturer, Monash University.
E mil: david.anderson@burnet.edu.au
IL 01
CURRICULUM VITAE
Associate Professor Dr. Anderson completed a PhD in molecular virology in 1988, and has worked at the 
Burnet Institute as a full-time research scientist since that time, with a strong focus on translational research 
in diagnostics and vaccines for more than 25 years. His work in diagnostics has expanded from a focus on 
hepatitis viruses (hepatitis A, hepatitis E and hepatitis B) to include other infectious diseases including HIV, 
syphilis, tuberculosis and malaria.  
Assoc. Prof. Anderson led the development of licensed diagnostic products for hepatitis E (Assure™ HEV IgM 
rapid point of care (RPOC) test, HEV IgM ELISA 3.0 and 4.0; MP Biomedicals, Singapore) and led the design 
and development of the Visitect CD4 T-cell test, now manufactured under license by Omega Diagnostics, 
UK, and co-inventor of new syphilis point of care test technology also licensed to Omega Diagnostics, with 
ongoing grant support from Saving Lives at Birth (Gates Foundation, USAID, Grand Challenges Canada, DFID) 
and the Thrasher Foundation for validation of this important tool for improved prevention of congenital 
syphilis. 
Assoc. Prof. Anderson was Founder and serves as President and CEO for the Burnet Institute spinoff 
company, Nanjing BioPoint Diagnostics, established to facilitate accelerated translation, commercialisation, 
manufacture and impact of Burnet’s diagnostic innovations, including the VL-Plasma device to support 
expanded access to HIV viral load testing, and the BioPoint liver disease (ALT) test to support expanded 
access to therapies for hepatitis C, hepatitis B and other forms of liver disease worldwide.
In the area of vaccine development, Assoc. Prof. Anderson was co-inventor and project leader for new 
technology platforms in vaccine development, including the Metavax™ VLP system (licensed by Burnet 
Institute to Artes Biotechnology, Germany, and sublicensed to Crucell and other companies).
RESEARCH INTEREST
i. Point of care tests for diagnosis of infectious diseases (HIV, viral hepatitis, syphilis, TB etc), with the aim 
 of bringing validated and affordable diagnostics to populations of resource-poor countries worldwide
ii. Point of care tests in management of liver disease and other chronic conditions, as above.
iii. Vaccine development based on a virus-like particle (VLP) technology from my lab, now known as Metavax 
 (Artes Biotechnology, Germany) with whom we are collaborating in malaria and HCV vaccine  
 development.
iv. Commercialisation of academic biotechnology, especially in the areas of diagnostics including the 
 establishment of Burnet spinoff company, Nanjing BioPoint Diagnostics (PR China).
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RECENT KEY PUBLICATIONS AND PATENTS
• Anderson, D. A., Li, F., Riddell, M. A., Howard, T., Seow, H.-F., Torresi, J., Perry, G., Sumarsidi, D., Shrestha, S. M., and 
 Shrestha, I. L. (1999). ELISA for IgG-class antibody to hepatitis E virus based on a highly conserved, conformational 
 epitope expressed in Eschericia coli. Journal of Virological Methods 81:131-142. 
• Chen H. Y., Lu Y., Howard T., Anderson D., Fong P. Y., Hu W., Chia C. P., and Guan M. 2005. An immunochromatographic 
 test and its comparison to enzyme-linked immunosorbent assay for rapid detection of immunoglobulin M antibodies 
 to  hepatitis E virus in human sera. Clinical and Diagnostic Laboratory Immunology 12:593-598. 
• International Patent Application PCT/AU2007/001449, granted S. African patent, “A method of diagnosis and kit 
 therefor”: D. Anderson, S. Crowe, A. Landay, R. Lloyd, M. Garcia. Burnet Institute. (CD4 diagnostic test)
• PCT/AU2015/050715 Biological sample collection and storage assembly: D. Anderson, B. Haile, W. Hopper (Plasma 
 separation device).
• Chinese Patent Application, “Point of Care Test” (liver disease test device): D. Anderson, M. Garcia, H. Van, Z. Zhang.
ABSTRACT
Diagnostic tests are essential for the management and control of both infectious and chronic, non-infectious 
diseases, but the vast majority of R&D expenditure worldwide is directed to expensive, complex tests 
for diseases prevalent in wealthy countries. The Burnet Institute’s mission is to achieve better health for 
vulnerable communities by accelerating the translation of research, discovery and evidence into sustainable 
health solutions, and the development of improved diagnostic tools is one of our areas of focus. Over the 
past 15 years we have developed a number of point-of-care (POC) tests for infectious diseases including 
hepatitis E, HIV (CD4 T-cells), syphilis, liver disease etc. This presentation will provide a summary of the 
technologies that we have used in diagnostic test development, and will examine the different approaches 
that we have used in commercialization of tests in order for them to reach target populations worldwide, 
including the important role of academic institutions in validation of new diagnostics to be of benefit in 
global health.
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Symposium 1-Diagnostic Technologies II
Title : 
ASSURED Molecular Diagnostics: Drivers, Barriers and Reality 
Ioanis Katakis, PhD 
Associate Professor, Departament d’Enginyeria Química
Universitat Rovira i Virgili
E mail: ioanis.katakis@urv.cat
IL 02
CURRICULUM VITAE
Ioanis Katakis (B.Eng. Aristotelion University of Thessaloniki 1988, PhD The University of Texas at Austin, 
1994) is associate professor of Chemical Engineering at the Universitat Rovira i Virgili in Tarragona, Spain 
since 1997. His research interests centre in the fields of Bioelectrochemistry and Bioengineering, with 
applications in biosensors, bioelectronics, and biorefineries. Innovation outcomes of his research target 
the human diagnostics, and food industries. He has co-authored more than 70 peer reviewed papers and 
is co-inventor of six patents in these fields. He has led the creation of two technological companies and 
has received awards for his innovation activities. He is teaching Chemical Process and Product Design and 
Bioprocess Engineering and Environmental Technologies. He has directed 13 doctoral theses. He has served 
as director of the Department of Chemical Engineering from 2005 to 2013.
RESEARCH INTEREST
i.  Bio/electrochemical approaches for the development of field diagnostics
ii.  Biofuel cells for algal biorefinery processes
iii. Nano/biotechnology for the development of the cell/electrode interface
RECENT KEY PUBLICATIONS AND PATENTS
• Mayboroda, O; Benito, AG; del Rio, JS; Svobodova, M; Julich, S; Tomaso, H; O’Sullivan, CK; Katakis, I, Isothermal solid-
 phase amplification system for detection of Yersinia pestis, Analytical and Bioanalytical Chemistry, 408(3): 671-676, 
 (2016)
• Joda, H; Beni, V; Willems, A; Frank, R; Hoth, J; Lind, K; Strombom, I; Katakis, I; O’Sullivan, CK, Modified primers for 
 rapid and direct electrochemical analysis of coeliac disease associated HLA alleles, Biosensors & Bioelectronics, 
 73:64-70 (2015)
• Washe, AP; Lozano, P; Bejarano, D; Katakis, I, Eletrochemically Actuated Stop-Go Valves for Capillary Force-Operated 
 Diagnostic Microsystems, ChemPhysChem, 14(10):2164-2173, (2013)
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ABSTRACT
ASSURED (Affordable, Sensitive, Specific, User-friendly, Rapid and robust, Equipment-free and Deliverable to 
end-users) diagnostics is not only a requirement for devices aimed specifically for the detection of infectious 
diseases in developing countries or environments with limited resources. We argue, that, all diagnostics 
ideally should be ASSURED, including the devices aimed to rationalize spending on healthcare in developed 
countries; in fact, development costs for products destined for life-changing detection and prevention in 
resource-limited environments could be met by advanced economies if the need for ASSURED diagnostic 
devices is realized. This is so, because less than 5% of public and private annual spending on health care is 
directed towards prevention, including diagnostics. This pattern is difficult to change since the more than 
80% of the more than $ 5 trillion (1012) worldwide annual health care costs is spent on “last resort” efforts 
to reverse the outcomes of disease. This trend is sure to continue as longevity is increased and more humans 
escape poverty. We argue therefore, that scientists and engineers should adjust their development efforts 
so that diagnostic devices be affordable and disease prevention through early diagnosis can be realized 
within the existing budgetary distribution both for developed and developing economies. 
Our thesis is that the widespread availability of cost effective diagnostic tools assisting prevention reliably is 
an important element that technology can provide for the public good: preventive, personalized medicine 
should not add to the cost of health care, it should provide more at the same cost if it is to be a catalyst of 
change in the current health care system. The ASSURED diagnostic device is already making strides in this 
direction and successful examples can be found in small analyte (e.g. the glucose sensor) and immunological 
target detection (e.g. a plethora of lateral flow devices, including the pregnancy test and numerous rapid 
tests for infectious diseases).
However, as our capacity to correlate molecular markers (such as DNA and RNA) to disease and disease 
progression and management (keys for the implementation of personalised medicine) the question arises if 
we can develop similar simple and low cost platforms for these (molecular) diagnostic targets. What are the 
main barriers to such development?    
In our presentation we discuss others’ and ours (probably Sisyphean) efforts to combine the steps 
(manipulation of sample and clinical operations, that we call “unit operations”) that can be integrated 
to bring to the market ASSURED molecular diagnostics tools for personalized medicine. Our case studies 
include molecular (gene based) detection of biological warfare agents where field-based, real time detection 
has obvious advantages, real time toxic algae detection, and low resolution HLA typing. We show that 
multiplex isothermal amplification of genetic material permits the identification of these targets at relevant 
concentrations in less than one hour (and in some cases in 20 minutes). Isothermal amplification allows the 
independence from the molecular biology lab, and facilitates the field use of molecular diagnostics. Even so, 
reliable and robust detection methods should accompany such advances. We also show several methods for 
the electrochemical quantitative detection of amplicons on-line with the amplification techniques. Finally, 
we show a possible integration platform that can allow operation of the whole diagnostic device at a cost 
calculated (bill of materials) at less than € 1 and at power consumption of less than 100 mW, making it 
operable by power sources used in portable communication devices. We argue that the same concept can be 
applied for management of chronic liver disease and other conditions that require expensive hospitalization 
and medical personnel time, and certainly for the detection and identification of infectious agents. 
Assuming that such efforts lead to solutions for ASSURED field diagnostics/theranostics/personalized 
medicine, we examine examples where they may be used to benefit society.  
This work was made possible partially through support by the Ministry of Economy and Competitiveness of 
Spain (Project SEASENSING: Ref. BIO2014-56024-C2-1-R).
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Symposium 1-Diagnostic Technologies II
Title : 
Rapid and low-cost assays for pathogens detection
Mohammed Zourob, Ph.D.
Professor of Biosensors, Alfaisal University, Riyadh,
KSA
E mail: mzourob@alfaisal.edu 
IL 03
CURRICULUM VITAE
Mohammed Zourob obtained his Ph.D from the Department of Instrumentation and Analytical Science 
(DIAS) at the University of Manchester in 2003. He was a postdoctoral scientist at DIAS, working in 
chemical/biosensors and lab-on-a-chip for biomedical and environmental applications. Then he moved to 
the Department of Materials Science, University of Manchester, to work on developing high-throughput 
screening platforms for “Omics” applications. At the end of 2005, he moved to the Institute of Biotechnology, 
University of Cambridge, where his research focused on optical sensing and biomemetic materials. Dr. Zourob 
headed the biosensors division at Biophage Inc, a biotech company based in Montreal. In 2009 he joined 
GDG Environment Ltd as Director of R&D. In 2010 he joint INRS-University of Quebec as associate professor 
and then he moved to Cranfield University-UK. Now Dr Zourob is holding professor of Biosensors at Alfaisal 
University-KSA. Prof. Zourob is now leading the Biosensors BioMEMS and Bionanotechnology Lab (BBBL). 
The BBBL has more than 20 researchers working in various projects related to food, biomedical, security and 
environmental applications. Dr. Zourob has published many scientific papers in peer-reviewed journals, more 
than thirteen book chapters, and thirteen patents. He edited six books in chemical/biosensors, microarrays 
and lab-on-a-chip.
RESEARCH INTEREST
i.  Novel diagnostic tools
ii.  Highly specific recognition receptors for diagnostic and imaging applications
iii. Lab-on-a-chip systems for sample processing
RECENT KEY PUBLICATIONS AND PATENTS
• Rapid and low-cost biosensor for the detection of Staphylococcus aureus, G. Suaifan, S Alhogail, M Zourob, Biosensors 
 and Bioelectronics 90, 2017, 230-237
• Development of magnetic nanoparticle based calorimetric assay for the detection of bovine mastitis in cow milk, R. 
 Chinnappan, S. Al Attas, W. E. Kaman, F. J. Bikker, M. Zourob, Analytical Biochemistry 523, 2017, 58–64. 
• Paper-based magnetic nanoparticle-peptide probe for rapid and quantitative colorimetric detection of Escherichia 
 coliO157:H7, G. Suaifan, S Alhogail, M Zourob, Biosensors and Bioelectronics 92, 2017, 702–708
• Rapid colorimetric sensing platform for the detection of Listeria monocytogenes foodborne pathogen, S Alhogail, G. 
 Suaifan, M Zourob, Biosensors and Bioelectronics 86, 2016, 1061-1066.
• Emerging Loop-Mediated Isothermal Amplification-Based Microchip and Microdevice Technologies for Nucleic Acid 
 Detection, M Safavieh, MK Kanakasabapathy, F Tarlan, MU Ahmed, M Zourob, W. Asghar, H. Shafiee ACS Biomaterials 
 Science & Engineering 2 (3), 2016, 278-294.
• ‘Method and kit for the detection of microorganisms, US PATENT APPLICATION    NUMBER: 14852526, 2015.
• ‘A novel assay for early detection of a disease using a magnetic nanoparticple biosensor ’ US PATENT APPLICATION 
 NUMBER: 14819195, 2015.
• ‘Biosensor using magnetic particles for pathogen detection’, M. Zourob, US PATENT APPLICATION NUMBER: 14867353, 
 2015.
• “Device for pathogens detection”, M. Safavieh, M. Uddin Ahmed M. Zourob (US patent, application No. 13/987,392) 
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ABSTRACT
The challenges for today’s biosensing platforms are numerous: they have to work with real samples, poor 
detection limit which is far from the infectious dose, suffer from the long analysis time, and use of washing 
steps and liquids which defeat the purpose of field applications. Another challenge is the stability and 
availability of highly specific recognition receptors to be integrated with the sensing platform to have a 
functional device. 
The presentation will highlights our recent developments to overcome such challenges for various biomedical, 
food and security related analytes. We developed various optical, electrochemical, colorimetric sensing 
platforms and integrate it with various natural and synthetic recognition receptors. We integrated a number 
of techniques with the various transducers to concentrate and enrich the analyte onto the immobilized 
recognition receptors on the sensor surface. This technique enhanced and improved the detection limit, 
shortened the analysis time and reduced the non-specific binding, to reduce the false positive results.  
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Symposium 2 -Biomarker Discovery & Assay Development 
Using Proteomics Approach I 
Title : 
A Genomic and Immunoproteomic Approach to Identify Diagnostic Antigens for Human Paragonimiasis 
Peter U. Fischer, PhD, MS
Research Associate Professor,
Division of Infectious Disease,
School of Medicine
Washington University
E mail: pufische@wustl.edu
IL 04
CURRICULUM VITAE
Dr. Fischer got his master’s degree in Biology from the Free University of Berlin, Germany and a PhD in Zoology 
from the University of Hamburg, Germany. He did postdoctoral research at Smith College in Northampton 
MA, USA and was a laboratory leader at the Bernhard Nocht Institute for Tropical Medicine in Hamburg. 
Following his habilitation in parasitology he joined the Infectious Diseases Division at Washington University 
School of Medicine in St. Louis MO, USA, as a Visiting Associate Professor in 2005 and became an Associate 
Professor in 2011. His primary research interest involves medical helminthology, especially filariasis and 
other neglected tropical diseases caused by parasitic worms. He has performed extensive field research on 
the diagnosis, epidemiology and control of filarial parasites in Uganda, Indonesia and many other countries 
and conducted basic laboratory research on filarial nematodes and their Wolbachia endosymbionts. He is 
co-investigator on the Bill and Melinda Gates Foundation funded DOLF project which studies alternative 
filariasis treatment strategies in large scale community trials in Asia and Africa. In addition Dr. Fischer 
studies North American paragonimiasis in Missouri to improve diagnostics for paragonimiasis globally and 
he investigates digenean trematodes as hosts for intracellular Neorickettsia bacteria.
RESEARCH INTEREST
i.  Control and elimination of Neglected Tropical Diseases, especially helminthiasis. 
ii.  Diagnosis of helminth infections.
iii. Interaction of helminth parasites with bacteria (endosymbionts, metagenomics)
RECENT KEY PUBLICATIONS AND PATENTS
• McNulty SN, Rosa BA, Fischer PU, Rumsey JM, Erdman-Gilmore P, Curtis KC, Specht S, Townsend RR, Weil GJ, Mitreva 
 M (2015). An integrated multi-omics approach to identify candidate antigens for serodiagnosis of human 
 onchocerciasis. Molecular and Cellular Proteomics, 14:497-503.
• McNulty SN, Fischer PU, Townsend RR, Curtis KC, Weil GJ, Mitreva M (2014) Systems biology studies of adult 
 Paragonimus lung flukes facilitate the identification of immunodominant parasite antigens. PLoS Neglected Tropical 
 Diseases, 8:e3242.
• Fischer PU, Curtis KC, Folk SM, Wilkins PP, Marcos LA, Weil GJ (2013) Serological diagnosis of North American 
 paragonimiasis by Western blot using Paragonimus kellicotti adult worm antigen. American Journal of Tropical 
 Medicine and Hygiene, 88:1035-1040.
• Supali T, Djuardi Y, Bradley M, Noordin R, Ruckert P, Fischer PU (2013) Impact of six rounds of mass drug administration 
 on brugian filariasis and soil-transmitted helminth infections in eastern Indonesia. PLoS Neglected Tropical Diseases, 
 7:e2586.
• McNulty SN, Foster J, Mitreva M, Hotopp-Dunning JC Martin J, Fischer K, Wu B, Davis PJ, Kumar S, Hotopp-Dunning JC, 
 Brattig NW, Slatko BE, Weil GJ, Fischer PU (2010) Endosymbiont DNA in endobacteria-free filarial nematodes indicates 
 ancient horizontal genetic transfer. PLoS One, 5:e11029.
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ABSTRACT
Paragonimus lung fluke infection affects about 23 million people mainly in South-East Asia, but also in Africa 
and the Americas. Paragonimus kellicotti is the only Paragonimus species in North America and is prevalent 
in its animal reservoirs, but only rarely infects humans. While effective treatment strategies exist, diagnosis 
of paragonimiasis is often difficult, because parasitological or DNA detection of worm eggs in sputum or stool 
is insensitive. Clinically, paragomimiasis is often misdiagnosed as tuberculosis or lung cancer. We identified 
several P. kellicotti adult worm antigens by immunoprecipitation using patients’ sera and proteomics as highly 
immunoreactive antigens with serodiagnostic potential. A full-length cysteine protease (Pkcp-6) of 35 kDa 
was expressed in E. coli, purified and its diagnostic potential was compared to crude total P. kellicotti extract. 
In a Western Blot assay Pkcp-6 was specific for the detection of IgG4 subclass antibodies in 27 subjects 
with either proven P. kellicotti or P. westermani infection. The recombinant antigen did not cross-react with 
sera of 30 subjects with other trematode or with cestode infections or with sera from healthy volunteers. 
Results showed a similar sensitivity of Pkcp-6 as the crude worm extract, but decreased background. The 
assay was also used to screen 157 serum samples from a paragonimiasis focus in western Cameroon, and 
detected 10.8% positive subjects while microscopic detection of eggs in sputum or stool identified fewer 
positive individuals (2.5% and 3.2%, respectively). The novel, specific and sensitive antigen for the detection 
of parasite-specific IgG4 antibodies may greatly improve the serodiagnosis of human paragonimiasis and 
may help to evaluate paragonimiasis control programs globally.
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Symposium 2 -Biomarker Discovery & Assay Development 
Using Proteomics Approach I 
Title : 
Rational Design and Evaluation of a Multi-epitope Chimeric Fusion Protein for Detection of Toxoplasma IgM 
antibodies
Majid Golkar, PhD 
Associate Professor, 
Department of Parasitology, 
Pasteur Institute of Iran, 
Tehran, Iran 
E mail: golkar@pasteur.ac.ir
IL 05
CURRICULUM VITAE
Dr. Majid Golkar received a Pharm.D from Shahid Beheshti University of Medical Science, Tehran, Iran 
(1992-1998). He got his PhD in Medical Biotechnology from Pasteur Institute of Iran (1999-2004) working 
on development of DNA and protein vaccine against Toxoplasma gondii infection. He worked for one year in 
the lab of Dr. Cesbron Delauw, Grenoble, France, to complete his PhD. He continued his career as a faculty 
member in department of Parasitology, Pasteur Institute of Iran. His research has been mainly focused 
on development of recombinant diagnostic tests for parasitic infections, mainly Toxoplasma infection. He 
developed, in collaboration with international collaborators, Toxoplasma IgG, IgM and IgG avidity ELISA 
tests for human use. The IgG test kit was approved by Iranian ministry of health for human use. The IgM 
and IgG avidity tests are to be approved by ministry of health. He has established a spin-off company to 
commercialize the diagnostic tests. Apart from diagnostic field, He is also actively focused on production 
and commercialization of recombinant pharmaceutical proteins i.e. active pharmaceutical ingredients such 
as human Epidermal Growth Factor (hEGF). Dr. Golkar is currently an associate professor in department of 
Parasitology, Pasteur Institute of Iran
RESEARCH INTEREST
i.  Production and Evaluation of Toxoplasma Protein and DNA Vaccines using different adjuvant systems, 
  for prevention against acute and chronic infection
ii.  Assessment of Toxoplasma Recombinant Proteins in serological tests for detection of Toxoplasma   
  infection, 
  and discriminating acute from chronic infection. 
iii. Development of Molecular and Serological Tools for Accurate diagnosis of  T. gondii infection
iv.  Recombinant Production, Process Development and formulation of Recombinant therapeutic proteins
RECENT KEY PUBLICATIONS AND PATENTS
• 2015: Allahyari M, Mohabati R, Babaie J, Amiri S, Siavashani ZJ, Zare M, Sadeghiani G, Golkar M. Production of in-
 vitro refolded and highly antigenic SAG1 for development of a sensitive and specific Toxoplasma IgG ELISA. J Immunol 
 Methods. 416:157-66.
• 2014: Havakhah Y, Esmaeili Rastaghi AR, Amiri S, Babaie J,  Aghighi Z, Golkar M. Prevalence of Toxoplasma gondii in 
 Sheep and Goats in Three Counties of Gilan Province, North of Iran; the More Humid Climate the Higher Prevalence. 
 J Med Microbiol Infec Dis. 2 (2): 80-83
• 2014: Talebzadeh M, Mohabati R, Babaie J,  Amiri S, Allahyari M , Golkar M. Production of MAG1 Antigen of Toxoplasma 
 gondii in Escherichia coli.  J Med Microbiol Infec Dis. 2(1): 40-44.
• 2013: Amerizadeh A, Khoo BY, Teh AY, Golkar M, Abdul Karim IZ, Osman S, Yunus MH, Noordin R. Identification and 
 real-time expression analysis of selected Toxoplasma gondii in-vivo induced antigens recognized by IgG and IgM in 
 sera of acute toxoplasmosis patients. BMC Infect Dis. 24:13-287.
• 2013: Mohabati R, Babaie J, Amiri S, Talebzadeh M, Fard-Esfahani P, Darbouy M, Golkar M. Expression and Purification 
 of Recombinant ROP1 of Toxoplasma gondii in Bacteria. Avicenna J Med Biotechnol. 5(4):227-33.
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ABSTRACT
Recombinant antigens present advantages such as ease of production and higher specificity for development 
of diagnostic tests. Instead of using a combination of antigens, a multi-epitope chimeric antigen can be 
designed by fusing epitopes/antigenic part(s) of several target antigens. In order to develop a chimeric 
antigen for detection of Toxoplasma IgM antibodies, linear  antibody epitopes from protein sequences of 
dense granule protein 6 (GRA6), GRA8 and rhoptry protein 1 (ROP1) were predicted using Bepipred B-cell 
epitope prediction tool. The predicted epitopes/antigenic parts were fused together by triglycyl linkers. 
The recombinant Toxoplasma chimeric protein was expressed in Escherichia coli and purified in a single 
step by immobilized metal ion affinity chromatography. Western blot analysis showed serum from a rabbit 
immunized with the chimeric antigen was capable of recognizing individual antigens, indicating correct folding 
of individual antigenic parts within the chimeric antigen. An enzyme-linked immunosorbent assay (ELISA) 
was developed using the chimeric antigen to detect Toxoplasma IgM antibodies in a seroconversion panel 
of 98 patient sera. The test showed sensitivity and specificity of 77.7 and 95.5 %, respectively, for detection 
of IgM antibodies and performed better than a commercial recombinant IgM ELISA kit. Interestingly, the 
sensitivity for sera collected between 1 to 4 month after infection was higher than for IgM positive sera 
collected between 5 to 11 month after infection. 
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Symposium 3-Infectious disease diagnosis using genomics 
approach
Title : 
Molecular biology and the environmental monitoring of enteric viruses
Fernando Spilki, PhD 
Coordinator of Virology Program
Universidade Feevale,Brazil
E mail: fernandors@feevale.br
IL 06
CURRICULUM VITAE
Holds a Veterinary degree (DVM , 2001) and Master’s in Veterinary Sciences (2004) from the Federal 
University of RioGrande do Sul, Brazil. He earned his PhD in Genetics and Molecular Biology from State 
University of Campinas (2006), Brazil. Dr. Spilki is now Professor at Feevale University, Novo Hamburgo, 
Brazil and his main research focus is on the detection and characterization of enteric viruses from human 
beings and domestic animals in environmental matrices and food samples. Another current research line is 
in the biology and epidemiology of arboviruses.
RESEARCH INTEREST
i.  New methods for detection and monitoring  of viruses in water and food
ii.  Next-generation sequencing and metagenomics use in environmental and veterinary virology
iii. Emerging and re-emerging arboviruses in humans and non-human primates
iv.  Antivirals and vaccines for viral diseases
RECENT KEY PUBLICATIONS AND PATENTS
• Staggemeier R, Heck TM, Demoliner M, Ritzel RG, Röhnelt NM, Girardi V, Venker CA, Spilki FR. Enteric viruses and 
 adenovirus diversity in waters from 2016 Olympic venues. Sci Total Environ. 2017 May 15;586:304-312. doi: 10.1016/j.
 scitotenv.2017.01.223.
• Scheffer CM, Varela AP, Cibulski SP, Schmidt C, Campos FS, Paim WP, Dos Santos RN, Teixeira TF, Loiko MR, Tochetto 
 C, Dos Santos HF, de Lima DA, Cerva C, Mayer FQ, Petzhold SA, Franco AC, George TS, Spilki FR, Roehe PM. Genome 
 sequence of bubaline alphaherpesvirus 1 (BuHV1) isolated in Australia in 1972. Arch Virol. 2017 Jan 6. doi: 10.1007/
 s00705-016-3218-8. 
• Heldt FH, Staggmeier R, Gularte JS, Demoliner M, Henzel A, Spilki FR. Hepatitis E Virus in Surface Water, Sediments, 
 and Pork Products Marketed in Southern Brazil. Food Environ Virol. 2016 Sep;8(3):200-5. doi: 10.1007/s12560-016-
 9243-7.
MOLECULAR DIAGNOSTICS & BIOMARKER DISCOVERY
3 - 4 May 2017 • Equatorial Hotel Penang,  Malaysia
MDBD 2017    -  13  -
ABSTRACT
Enteric viruses are widely recognized as a major threat to human health, being most often transmitted 
by water and/or contaminated food. However, due the lack of cost-effective and trained personnel, the 
monitoring of these pathogens in environmental matrices is neglected in many countries. Adenovirus, 
enterovirus, rotavirus and norovirus infections are associated to diarrhea, and the most susceptible are 
children, elderly and immunosuppressed individuals. People living under poor sanitary conditions are 
heavily impacted, and lack of sewage and/or water treatment is a major risk factor for transmission of  these 
viruses. Despite the burden of water- and foodborne,  the advancement of the molecular based protocols 
which occurred in the last 3 decades, detection of viral contaminants of water and food remains a matter of 
research rather than routine in health surveillance laboratories around the globe, especially in developing 
countries. The presentation will show situation of enteric viruses’ prevalence in environmental samples, 
drinking water, and point-of-sale products, using Brazil and Latin America as an example. After, it will be 
discussed how the development of innovative, cost-effective and robust detection methods could solve the 
problem of adoption of a proper monitoring of these microbial contaminants by public health authorities.
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Keynote Address 1
Title : 
Cost-effective point-of-need diagnostics – combining aptamers and advanced lateral flow devices
Ciara O’ Sullivan, PhD
ICREA Research Professor, 
Engineering Sciences Universitat Rovira i Virgili (URV).
E mail: ciara.osullivan@urv.cat
IL 07
CURRICULUM VITAE
Ciara O’ Sullivan, is an ICREA (Catalan Institute for Research and Advanced Studies) Research Professor. 
She received a BSc in Analytical Chemistry from Dublin City University in 1992, a PhD. in Biotechnology 
from Cranfield University in 1996 and then went on to lead the sensors group at University College Cork 
from 1996-99. She then took up a Marie Curie Candidateship at the Universitat Rovira i Virgili (1999-2001) 
and was then awarded a “Ramon y Cajal Candidateship” which she pursued for 1 year prior to taking up 
her current position as ICREA Research Professor and establishing the Nanobiotechnology and Bioanalysis 
Group at the Universitat Rovira i Virgili. Prof. Ciara K. O’ Sullivan has published/presented over 180 articles in 
diverse areas ranging from biosensors to liposomes to aptamers. Her research interests have focused on the 
development of electrochemical biosensors exploiting advances in tailored biocomponents and integrating 
these sensors with microsystem technology. Presently, her work focuses on reducing to practise ultrasensitive 
immuno- apta- and geno- sensors exploiting isothermal amplification, labelled dNTPs and paper diagnostics 
and she is currently expanding into the area of next generation molecular tools for personalised medicine 
and advanced forensics. She is currently visiting professor at Newcastle University, UK and University of the 
Western Cape, South Africa. She has a H-index of 34.
RESEARCH INTEREST
i.  Aptamers and their application in analytical devices
ii.  Low cost molecular diagnostics
iii. Biosensors and biosensor arrays
iv.  Paper analytical diagnostics
RECENT KEY PUBLICATIONS AND PATENTS
• Jauset Rubio, M., Sabaté del Río, J., Mairal, T.,  Svobodová, M., Saeed, A., Nooredeen Abbas, M., El-Shahawi, M., 
 Bashammakh, A.S.,. Alyoubi, A.O. and O ‘Sullivan, CK, Ultrasensitive, rapid and inexpensive detection of DNA using 
 paper based lateral flow assay, 2016, Scientific Reports, DOI: 10.1038/srep37732
• Jauset Rubio, M., Sabaté del Río, J., Mairal, T.,  Svobodová, M., Keegan, N., McNeil, C., El-Shahawi, M., Bashammakh, 
 A.S.,. Alyoubi, A.O. and O ‘Sullivan, CK,, Aptamer lateral flow assays for ultrasensitive detection of β-conglutin 
 combining recombinase polymerase amplification and tailed primers, 2016, Analytical Chemistry, 88 (21), pp 10701–
 10709
• Sabaté del Rio, J., Conejeras, P., and O’ Sullivan, C.K., Electrochemical detection of Piscirickettsia salmonis genomic 
 DNA from salmon samples using solid-phase recombinase polymerase amplification, 2016, Anal Bioanal Chemistry, 
 DOI: 10.1007/s00216-016-9639-0
• Acero Sanchez, J. L., Henry, O. Y. F., Joda, H., Werne Solnestam, B., Kvastad, L., Johansson, E., Akan, P., Lundeberg, J., 
 Lladach, N., Ramakrishnan, D., Riley, I. and O’Sullivan, C. K., Multiplex PCB-based electrochemical detection of cancer 
 biomarkers using MLPA-barcode approach, 2016, Biosensors & Bioelectronics, 15; 82: 224-32
• Debela, A.M., Beni, V., Thorimbert, S., Hasenknopf, B., O’ Sullivan, C.K.* and Ortiz, M.*, Electrochemical primer 
 extension for detection of single nucleotide polymorphisms in the cardiomyopathy associated MYH7 gene, 2016, 
 Chemical Communications, 252, 757-759
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ABSTRACT
Trichomonas vaginalis infection is the most prevalent non-viral sexually transmitted disease worldwide with 
an estimated prevalence of at least 170 million each year. Despite its widespread threats to public health, 
the available diagnostic methods today remain insufficient because of several limitations.  We report on 
the use of an aptamer against the Ap65 adhesion protein, a cell surface marker for Trichomonas vaginalis. 
Aptamers are oligonucleotides, either single-stranded deoxyribonucleic acids (ssDNAs) or ribonucleic acids 
(RNAs) that can bind to target molecules with high affinity, and, possess several properties that may become 
more desirable than the use of standard antibodies in molecular detection.  The DNA aptamer was selected 
in a process of systematic evolution of ligands by exponential enrichment (SELEX) and demonstrated to have 
a Kd of ca. 1nM.  The specificity of the aptamer has been demonstrated with T. vaginalis cells, and no cross-
reactivity observed with Bacillus subtilis, Escherichia coli, Enterococcus faecalis, Klebsiella pneumoniae, 
Pseudomonas aeruginosa, Proteus vulgaris, Staphylococcus aureus, Salmonella enterica or Candida albicans. 
The aptamer was exploited in a lateral flow easy for the rapid and inexpensive detection of T. vaginalis in 
vaginal swabs. The sensitivity of  competition and sandwich lateral flow assays were compared and a lateral 
flow combining isothermal amplification, tailed primers and the selected aptamer was demonstrated to 
achieve ultrasensitive detection limits, with the assay being completed in less than 15 minutes.  Work is 
ongoing to test and validate the lateral flow device with real samples. The talk will give an overview of this 
generic platform that can be applied to a multiplicity of infectious diseases.
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Keynote Address 2 IL 08
YING Jackie Yi-Ru, PhD
IExecutive Director
Institute of Bioengineering and Nanotechnology, Singapore, 2003-Present
Professor, Department of Chemical Engineering, Massachusetts Institute of Technology 
(USA), 2001-2005
E mail: jyying@ibn.a-star.edu.sg
Title : 
Advanced Nanosystems for Diagnostic Applications
CURRICULUM VITAE
Jackie Y. Ying received her B.E. and Ph.D. from The Cooper Union and Princeton University, respectively. She 
joined the faculty at Massachusetts Institute of Technology in 1992, where she was Professor of Chemical 
Engineering until 2005. She has been the Founding Executive Director of the Institute of Bioengineering 
and Nanotechnology in Singapore since 2003. For her research on nanostructured materials, Prof. Ying 
has been recognized with the American Ceramic Society Ross C. Purdy Award, David and Lucile Packard 
Fellowship, Office of Naval Research Young Investigator Award, National Science Foundation Young 
Investigator Award, Camille Dreyfus Teacher-Scholar Award, American Chemical Society Faculty Fellowship 
Award in Solid-State Chemistry, Technology Review’s Inaugural TR100 Young Innovator Award, American 
Institute of Chemical Engineers (AIChE) Allan P. Colburn Award, Singapore National Institute of Chemistry-
BASF Award in Materials Chemistry, Wall Street Journal Asia’s Asian Innovation Silver Award, International 
Union of Biochemistry and Molecular Biology Jubilee Medal, Materials Research Society Fellowship, Royal 
Society of Chemistry Fellowship, Crown Prince Grand Prize in the Brunei Creative, Innovative Product and 
Technological Advancement (CIPTA) Award, American Institute for Medical and Biological Engineering 
Fellowship, Academy of Sciences of Iran Medal of Honor, American Association for the Advancement of 
Science Fellowship, Islamic World Academy of Sciences-COMSTECH Ibrahim Memorial Award, Singapore 
National Academy of Science Fellowship, and The Cooper Union Alumni Association Gano Dunn Award. 
Prof. Ying was elected a World Economic Forum Young Global Leader, and a member of the German National 
Academy of Sciences, Leopoldina. She was named one of the “One Hundred Engineers of the Modern Era” 
by AIChE in its Centennial Celebration. She was selected by The Muslim 500 in 2012, 2013, 2014, 2015 and 
2016 to be one of the world’s 500 most influential Muslims. She was selected as an Inaugural Inductee 
for the Singapore Women’s Hall of Fame in 2014. She was the inaugural winner of the Mustafa Prize “Top 
Scientific Achievement Award” in 2015 for her research in bio-nanotechnology. The laureate of this science 
and technology award receives a certificate, an engraved medal and US$500,000 in prize money. She is the 
Editor-in-Chief of Nano Today, which has an impact factor of 13.157.
RESEARCH INTEREST
i. Bio-Nanotechnology
ii. Nanosystems for diagnostic applications
iii. Lab-on-a-cartridge
iv. Paper-based-assays
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RECENT KEY PUBLICATIONS AND PATENTS
• G. Xu, T.-M. Hsieh, D. Y. S. Lee, E. Mohamed Ali, H. Xie, X. L. Looi, E. S.-C. Koay, M.-H. Li, and J. Y. Ying, “A Self-Contained 
 All-in-One Cartridge for Sample Preparation and Real-Time PCR in Rapid Influenza Diagnosis,” Lab Chip, 10 (2010) 
 3103-3111. 
• Y. Zu, M.-H. Tan, B. Chowbay, S. C. Lee, H. Yap, M. T. M. Lee, L.-S. Lu, C.-P. Chang, and J. Y. Ying, “Nanoprobe-Based 
 Genetic Testing,” Nano Today, 9 (2014) 166-171.  
• Y. Zhang, J. Bai, and J. Y. Ying, “A Stacking Flow Immunoassay for the Detection of Dengue-Specific Immunoglobulins 
 in Salivary Fluid,” Lab Chip, 15 (2015) 1465-1471.  
• I. Cima, S. L. Kong, I. B. Tan, W. M. Phyo, D. Lee, M. Hu, D. Sengupta, C. Iliescu, J. H. Vo, W. L. Goh, M. Rahmani, N. 
 A. Mohamed Suhaimi, J. A. Tai, J. H. Tan, C. Chua, R. Ten, I. Alexander, R. M. van Dam, W. Y. Lim, S. Prabhakar, B. Lim, 
 P. K. Koh, P. Robson, J. Y. Ying, A. M. Hillmer, and M. H. Tan, “Tumor-Derived Circulating Endothelial Cell Clusters Detect 
 Colorectal Cancer,” Science Translational Medicine, 8 (2016) 345ra89.  
• Y. Zu, M. H. Tan, E. C. Ren and J. Y. Ying, “Facile and Phase-Defined Determination of HLA Alleles with Morpholino-
 Functionalized Nanoparticle Probes,” Nanomedicine, (2016) DOI: 10.1016/j.nano.2016.09. 009.
ABSTRACT
Our laboratory has been developing various nanosystems for diagnostic applications. These include 
designing plasmonic nanocrystals for single nucleotide polymorphism (SNP) genotyping. The platform 
involves polymerase chain reaction (PCR) for target sequence amplification and colorimetric detection for 
pharmacogenomics applications. We have also established polymer-based lab-on-a-cartridge for automated 
sample preparation and PCR detection. The integrated all-in-one system, termed MicroKit, allows for the 
rapid and accurate typing and subtyping of influenza and other viral infections within 2 hours. We have 
created the silicon-based Microsieve system for rapid and selective isolation of circulating tumor cells (CTCs) 
from peripheral blood. This non-invasive, near real-time, inexpensive liquid biopsy approach allows for the 
enumeration and biomarker analysis of CTCs for cancer diagnosis, prognosis and monitoring. Recently, we 
have also developed paper-based assays for the rapid detection of various diseases. For example, we have 
created a novel stacking flow immunoassay platform, and demonstrated successful detection of dengue-
specific IgG in salivary fluid.
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Symposium 4-Diagnostic Test Development & Translational 
Research
Title : 
From bench to market: Challenges in the development and commercialization of diagnostic tools.
Andreas Latz, Dr. rer. nat.
NovaTec Immundiagnostica GmbH, Dietzenbach, Germany. 
Project Leader of the genetic engineering department; 
Principal investigator of antigen development and veterinary ELISA; 
Group leader of human diagnostic development
E mail: a.latz@novatec-id.com
IL 09
CURRICULUM VITAE
Dr. Latz is a Project Leader of the Genetic Engineering Department at NovaTec Immundiagnostica GmbH, 
Dietzenbach, Germany since 2010. He is also the principal investigator of antigen development and veterinary 
ELISA and group leader of human diagnostic development at NovaTec. He received his undergraduate (1996-
2002) and doctoral education (2003-2007) at the Julius Maximilian University Wuerzburg, Germany and 
was a postdoc and group leader at the Department of Microbiology at Eberhard Karls University Tuebingen, 
Germany (2007-2010).
RESEARCH INTEREST
i.  One health: Development of diagnostic tools for the application in the human as well as veterinary field
ii.  Diagnostic tools for Zoonotic diseases
iii. Diagnostics on tropical diseases with an special emphasis on parasites and worms
RECENT KEY PUBLICATIONS AND PATENTS
• Epidemiological and clinical profile of paediatric malaria: A prospective study performed in five epidemiological strata 
 of malaria in Cameroon Tebit Emmanuel Kwenti, MSc; Tayong Dizzle Bita Kwenti, MSc; Andreas Latz, PhD; Longdoh 
 Anna Njunda, PhD; Theresa Nkuo-Akenji, PhD  BMC Infectious Diseases INFD-D-17-00363 (submitted)
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ABSTRACT
Every year, many publications in scientific journals are focusing on the discovery of biomarkers and the 
development and evaluation of diagnostic tools. Only very few of these innovations ever reach the market 
and are accessible to the end users. There is a gap in applying that knowledge into products to reduce the 
burdens of illness and disability. This discrepancy between scientific innovation and commercial product is 
mostly due to the fundamental challenge of applying research and development advances into operations. 
In this talk, I will discuss strategies on how to bridge this valley of death in order to overcome barriers to 
more effectively translate research findings into health care practice. 
It is crucial that a translational cooperation between scientific institutions and the industry is established 
right at the beginning of a new development. This may start with a joint application for funding and has to 
be intensively continued during the development and commercialization process. Even after launching a 
product into market, the continuation of the cooperation will be essential for the commercial success of the 
diagnostic product.
During the initial stages of research and development, many points have to be considered; like the 
assessment that a discovery has commercial value or an important impact on the health care industry. After 
choosing the appropriate platform for a new diagnostic tool, many different points; like product design, 
usability, reproducibility, precision, stability, constant evaluation, quality control, quality management or 
risk assessment have to be addressed.
For the period of the validation/verification process, interferences, cross reactivity, clinical evidence, sample 
material (serum/plasma/liquor/milk/urine etc…), sample population and statistical significance or high dose 
hook effect have to be considered. 
To be able to produce the final product, production flow charts and operation protocols have to be 
established.
Most of the diagnostic tools, for veterinary or human use, have to be registered by local authorities prior of 
use. The requirements differ from parameter to parameter and from country to country. Furthermore, they 
are one of the most crucial and time consuming steps during the commercialization process.
Finally, the product will need marketing and external validation data. OEM businesses and/or dealers’ 
network have to be established. As well as systems for post market surveillance.
These points will be discussed with practical examples from our company.
Globalization, demographic shifts, urbanization, climate change and internet proliferation are the 
macroeconomic megatrends that will shape the 21st century and will have an influence on future 
development in biomarker discovery and development of new diagnostic tools.
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Symposium 5-Diagnostic Technologies III
Title : 
Use of lateral flow membranes for diagnostic rapid tests in the future
Klaus Hochleitner, Dr. rer. nat.
Global Lead Technology 
Product Specialist bei GE Healthcare
E mail: Klaus.Hochleitner@ge.com
IL 10
CURRICULUM VITAE
Dr. Klaus obtained his Dr. rer. nat. (PhD) from the University of Essen Medical School in 1992. He has many 
years of experience in diagnostics, particularly in the development of lateral flow tests. He has previously 
worked at Schleicher & Schuell GmbH as a Laboratory Manager of Life Science (1993-1997), Business 
Development Diagnostic Components (1997-2001) and Application Manager Life Science and Diagnostics 
(2001-2005). After that he led the R&D manager at Whatman GmbH (2005-2011) in design development 
and design control of cellulosic and polymeric membranes in ISO 9001/ISO 13485 QM system. Since 2011, 
he is the Global Lead Technology Product Specialist at GE Healthcare. This role sees him applying his 
vast experience to provide clinical, technical and professional guidance to the global field in developing 
applications in immuno- and molecular diagnostics. He holds several diagnostics-related patents.
RECENT KEY PUBLICATIONS AND PATENTS
• Improvements in and relating to lateral flow testing. United Kingdom WO2015150067. Filed March 31, 2014. 
 A.Schenk, S.Kiel, Klaus Hochleitner, M.Thieme
• Membrane filter including bile acid and method manufacturing same. Europe EP2819772 Filed February 29, 2012. 
 Klaus Hochleitner, , S.Kiel
• Membrane filter including bile acid and method manufacturing same. China CN104379242. Filed February 29, 2012. 
 Klaus Hochleitner, S.Kiel
• Medical diagnostic systems and a matrix therefor United Kingdom WO2014122094. Filed February 8, 2013. Klaus 
 Hochleitner, A.Schenk, S.Kiel, W. Sun
• Method for detecting concentration of antibody or fusion protein. China CN103376327. Filed April 28, 2012. L.Chen, 
 R.Hou, Klaus Hochleitner, L.Lu
• Method and apparatus for isolating nucleic acids. Europe EP2794631. Filed December 22, 2011. L.Chen, Klaus 
 Hochleitner, B.Zhang, R.Hou
• Method and apparatus for isolating nucleic acids. Japan JP2015503324. Filed December 22, 2011. L.Chen, Klaus 
 Hochleitner, B.Zhang, R.Hou
• Method and apparatus for isolating nucleic acids. United States US9441220 B2. Issued September 13, 2016. L. Chen, 
 Klaus Hochleitner, B.Zhang, R.Hou
• Improvements in and relating to polymeric membranes. United Kingdom WO2016156250. Filed March 30, 2015. Dr. 
 Marcel Thieme, Suzana Kiel, Klaus Hochleitner, Dr. Alexander Schenk
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ABSTRACT
Introduction: Since their invention in the middle of the 1980s, lateral flow rapid tests have become a 
widespread and versatile tool for the detection of analytes in sample liquids ranging from water over urine 
and blood to resolubilized solid materials.
A key component of lateral flow tests is the membrane part on which the detection of the analyte is 
performed. Recent developments to improve test sensitivity, permit quantitation of analytes, reduce reagent 
usage, and improve multi-parameter analysis will be discussed.
Methods: Optimization of membrane manufacturing conditions, surface activation, and improved dispensing 
technologies were used to achieve improved test performance.
Results and Discussion: Compared to standard materials, it is possible to achieve an up to 6-fold higher 
sensitivity, and tests CVs far below 10 % for selected test systems with a concomitant reduction of reagent 
use of up to 50 %.
Multiplexing can be achieved by the creation of lateral flow arrays.  
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Symposium 6-Biomarker Discovery and Assay using 
Proteomics Approach II
Title : 
Proteomics and cancer diagnosis
Discovery and validation of biomarkers for the early detection of ovarian cancer.
Prof Peter Hoffmann, PhD 
Strand Leader and Lloyd Sansom Chair 
Biomaterials Engineering and Nanomedicine
Future Industries Institute
University of South Australia
E-mail: peter.hoffmann@unisa.edu.au
IL 11
CURRICULUM VITAE
Prof Hoffmann received his PhD in Analytical Chemistry at University of the Saarland, Germany in 1999. He 
spent four years in Melbourne working with Prof Richard Simpson and Prof Bruce Kemp where he specialised 
in the use of free-flow electrophoresis in proteomics and the detection of protein phosphorylation by mass 
spectrometry. He moved back to Germany in 2003 and played an integral role in establishing a proteomics 
facility at the University Leipzig, Germany. In 2005, he was recruited back to Australia to establish a 
Proteomics Centre at the University of Adelaide and held a Chair in Proteomics and was Director of the 
Adelaide Proteomics Centre at the University of Adelaide. His research is focused on biomarker discovery 
in cancer, detection of protein phosphorylation and Tissue Imaging Mass Spectrometry. The Adelaide 
Proteomics Centre houses the national facility for Tissue Imaging Mass Spectrometry for Australia. Prof 
Hoffmann was also Deputy Director of Institute of Photonics and Advanced Sensing one of the five research 
institutes at the University of Adelaide. Prof Hoffmann is currently the Strand Leader and Lloyd Sansom 
Chair of Biomaterials Engineering and Nanomedicine at Future Industries Institute at the University of 
South Australia. Prof Hoffmann is also an elected member of the HUPO Council and Treasurer of the HUPO 
executive committee.
RESEARCH INTEREST
i.  Imaging Mass Spectrometry using FFPE gynecological cancer tissue
ii.  Discovery of Biomarkers for the early detection of ovarian and gastric cancer
iii. Identification and characterization of beer and food related spoilage and production specific 
  microorganisms
iv.  The use of label free mass spectrometry technology for the quantification of disease specific changes in 
  protein expression
 
RECENT KEY PUBLICATIONS AND PATENTS
• A.V. Everest-Dass, M.T. Briggs, K. Gurjeet, M.K. Oehler, P. Hoffmann*, N.H. Packer*. N-glycan MALDI imaging mass 
 spectrometry on formalin-fixed paraffin-embedded tissues enables the delineation of ovarian cancer tissues. Mol Cell 
 Proteomics, 2016, 15(9): 3003-3016. * equal contribution
• M.T. Briggs, J.S. Kuliwaba, D. Muratovic, A.V. Everest-Dass, N.H. Packer, D.M. Findlay, Peter Hoffmann. MALDI mass 
 spectrometry imaging of N-glycans on tibial cartilage and subchondral bone proteins in knee osteoarthritis. 
 Proteomics, 2016 Jun;16(11-12):1736-41.
• Winderbaum LJ, Koch, I., Mittal, P., Hoffmann, P. Classification of MALDI-MS imaging data of tissue microarrays using 
 canonical correlation analysis based varible selection. Proteomics. 2016 Jun;16(11-12):1731-5.
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ABSTRACT
In this presentation, potential autoantibody biomarkers for ovarian cancer were discovered, verified and 
validated as an early detection test. A new immunoproteomic strategy was developed to identify novel 
autoantibodies that were elevated in serous ovarian cancer patients. Lysate extracted from the ovarian 
tissue of a patient was applied to an immunoaffinity column generated with autologous antibodies and 
a paired control immunoaffinity column. Relative quantification of captured autoantigens was performed 
using isotope coded protein label (ICPL) technology coupled with high resolution LC-MS. At a protein ratio 
cutoff of 1.45-fold, 148 autoantibodies were found to be enriched in ovarian cancer patients compared to 
the corresponding controls. Upon bioinformatic prioritisation 50 autoantibody candidates were selected for 
verification. Protein microarray analysis of 98 samples revealed 9 autoantibody candidates to be significantly 
different in early stage cancer patients compared to healthy and benign controls. Biomarker candidates 
anti-ANXA1, anti-SAHH and anti ARP3 showed the greatest potential where each marker achieved greater 
than 90% specificity at 83.3% sensitivity. As a 4 biomarker panel with the ‘gold standard’ for ovarian cancer 
detection, cancer antigen (CA)125, a sensitivity of 76.5% at 100% specificity was attained. These values 
of sensitivity and specificity for early stage ovarian cancer surpassed the minimum requirements for an 
implementable screening test and showed great promise as a diagnostic tool.
• Gustafsson OJ, Briggs MT, Condina MR, Winderbaum LJ, Pelzing M, McColl SR, Everest-Dass AV, Packer NH, Hoffmann 
 P. MALDI imaging mass spectrometry of N-linked glycans released from formalin-fixed murine kidney. Analytical and 
 Bioanalytical Chemistry, 2015, 407, 2127-2139
• Humphries JM, Penno MA, Weiland F, Klingler-Hoffmann M, Zuber A, Boussioutas A, Ernst M, Hoffmann P. Identification 
 and validation of novel candidate protein biomarkers for the detection of human gastric cancer.  Biochim Biophys 
 Acta. 2014, May;1844(5):1051-8.
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Dr Too Heng Phon received his undergraduate training in Biochemistry, Imperial College of Science & 
Technology, UK. He then continued with his PhD training in a joint research project in Imperial College, 
Institute of Ophthalmology and West Minister Hospital, London. Thereafter, he received further training in 
the Medical Research Council, Cambridge (UK), where he was a Procter & Gamble Fellow. He then moved 
to the Department of Anesthesiology and Department of Biological Chemistry & Molecular Pharmacology, 
Harvard Medical School where he was a recipient of the Merck Sharpe Dohme Academic Development 
Fellowship. Currently, he is a faculty in the Department of Biochemistry, National University Singapore, a 
Principal Scientist in the Bioprocess Technological Institute and was a Fellow of the Singapore Massachusetts 
Institute of Technology Alliance (Molecular Engineering of Biological & Chemical Systems program; Chemical 
& Pharmaceutical Engineering program). Dr Too is a molecular biologist focusing on biotechnology and 
neuroscience. In recent years, Roche Diagnostics (USA & Asia Pacific) and National Institute of Health (USA) 
funded him to develop qPCR assays for infectious diseases. He is an awardee of a number of Commercialization 
of Technology grants from A*STAR and Singapore-Massachusetts Research & Technology (SMART). Dr Too 
has recently been awarded a KHIDI-A*STAR grant with a Korean company to co-develop IVD for prognostic/
diagnostic of breast cancer. He is the founder of MiRXES and the lead principal investigator of the miRNA 
profiling facility (µRSIC), A*STAR. He has intellectual property protections on specific diagnostic platforms 
with various research departments and with Massachusetts Institute of Technology, USA. 
RESEARCH INTEREST
i.  Molecular tools for the detection of microRNAs & replicating viruses.
ii.  Non-viral gene delivery.
iii. in vivo & in vitro Metabolic Engineering of the DXP pathway.
iv.  Glial-derived neurotrophic growth factor (GDNF) and related factors.
 
RECENT KEY PUBLICATIONS AND PATENTS
• Zhang C, Zou R, Chen X, Stephanopoulos G, Too HP. Experimental design-aided systematic pathway optimization 
 of glucose uptake and deoxyxylulose phosphate pathway for improved amorphadiene production. Appl Microbiol 
 Biotechnol. 2015. 99(9):3825-37.
• Low SY, Ho YK, Too HP, Yap CT, Ng WH. MicroRNA as potential modulators in chemoresistant high-grade gliomas. J Clin 
 Neurosci. 2014; (3):395-400.
• Zhou L & HPToo. Mitochondrial localized STAT3 is involved in NGF induced neurite outgrowth. PLoS ONE 6(6): e21680, 
 2011.
• Zhou L, Too, H. P. GDNF family ligand dependent STAT3 activation is mediated by specific alternatively spliced isoforms 
 of GFRα2 and RET. Biochim. Biophys. Acta. 2013;1833(12):2789-802.
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ABSTRACT
MicroRNAs (miRNAs) belong to a class of small noncoding RNAs (ncRNAs). These miRNAs are short single-
stranded RNA (~ 22 nt) in length and the number of publications has escalated exponentially, impacting 
on almost all fields of medical and basic sciences.  miRNA are now known to regulate gene expression 
at the post-transcriptional level and to control protein expression noise in the cell. Considering this wide 
involvement in gene control, aberrant miRNA expression is strongly associated with the presence and 
progression of a disease, hence it is not a surprise that miRNAs may serve as biomarkers for the diagnosis 
and prognosis of human disorders including cancers, cardiovascular and others. The majority of miRNAs are 
intracellular, but recently they have been reported in numerous bodily fluids at low levels. Here we describe 
the use of real time qPCR and the design of discovery workflows with extensive quality control system to 
avoid pre-analytical and analytical variables as well as the quantitative determination of expression levels to 
enable the rapid identification of panels of useful biomarkers. Using these validated sequence-independent 
qPCR platform with unparalleled sensitivity and robustness, we found a large number of circulating miRNA 
that can detect the emergence of diseases at early stages and to stratify patients in many disorders. The 
next step is to adapt the panels of biomarkers onto dPCR platform. This presentation will discuss the value 
of circulating miRNAs as biomarkers.
• Lim QE, Wan G, Ho YK and Too, H. P. Multiplexed, Direct miRNA Quantification from Cell Lysates without RNA Isolation. 
 Nat. Protoc. Exchange (2011) doi:10.1038/protex.2011.202.
• Wan G, Lim QE, Too HP. High-performance quantification of mature microRNAs by real-time RT-PCR using deoxyuridine-
 incorporated oligonucleotides and hemi-nested primers. RNA (2010) 16(7):1436-45.
• Ajikumar PK, Xiao WH, Tyo KE, Wang Y, Simeon F, Leonard E, Mucha O, Too HP, Pfeifer B, Stephanopoulos G. Isoprenoid 
 pathway optimization for Taxol precursor overproduction in Escherichia coli. Science (2010) 330 (6000):70-4.
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Prof. Cheong currently leads the Head and Neck Cancer Research Team at Cancer Research Malaysia. She 
received her first class honors degree in Biochemistry from the National University of Malaysia (UKM). She 
continued to pursue her PhD in UKM under the mentorship of Prof Sheila Nathan (UKM) and Prof Dorothy 
Bennett (St Georges Hospital Medical School, London). Her work focuses on identifying genetic changes 
that drive head and neck cancer development with the goal of using this understanding to improve clinical 
management of cancer patients. Her research has resulted in the development of an immunotherapy that 
is currently in preclinical testing. Further, her team has conducted extensive research into building and 
validating tools to that could accelerate cancer research and drug development. To do this, she works with 
scientists from different areas of expertise to leverage on their experiences and to translate laboratory 
findings into the clinic. Her work has received a number of awards including the Norman-Rowe Educational 
Trust (United Kingdom), L’Oreal for Women in Science Award, American Association for Cancer Research 
(AACR) Scholar-In-Training Award and several UICC fellowships. She has published in international peer-
reviewed journals, delivered keynote and plenary lectures in international and national conferences. 
She is a regular reviewer of many cancer and molecular biology related journals and review grants from 
international bodies including those from the Union for International Cancer Control (UICC), The World 
Academy of Sciences (TWAS) and the African Medical Council amongst others. Professor Dr. Cheong serves 
as an Adjunct Professor at University of Malaya, Kuala Lumpur and Visiting Professor at the University of 
Khon Kaen, Thailand. She is currently the Co-Chair of The World Academy of Sciences (TWAS) Young Affiliate 
Network (TYAN), an Associate of the Malaysian Academy of Sciences (ASM), an honorary member of the 
Young Scientist Network (YSN) of the ASM, and a Fellow of the International Academy of Oral Oncology 
(IAOO) and the UICC.  
RESEARCH INTEREST
i.  Cancer immunotherapy
ii.  Drug repurposing for cancer
iii. Models for cancer research
 RECENT KEY PUBLICATIONS AND PATENTS
• B.K.B. Lee, K.H. Tiong, J.K. Chang, C.S. Liew, Z.A.A. Rahman, A.C. Tan, T.F. Khang & S.C. Cheong. DeSigN: connecting 
 gene expression with therapeutics for drug repurposing and development. BMC Genomics. Accepted- Aug 2016.
• M.Z.H. Fadlullah, I.K-N. Chiang,  K.R. Dionne,  P.S. Yee, C.P. Gan, K.K. Sam, K.H. Tiong, A.K.W. Ng, D. Martin, K.P. Lim, 
 T.G. Kallarakkal, W.M. Wan Mustafa, S.H. Lau, M.T. Abraham,  R.B. Zain, ZA.A. Rahman5, A. Molinolo, V. Patel, J. S. 
 Gutkind, A.C. Tan & S.C. Cheong. Genetically-defined novel oral squamous cell carcinoma cell lines for the development 
 of molecular therapies. Oncotarget. 2016 Apr 1. doi: 10.18632/oncotarget.8533. [PMID: 27050151] 
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• C.P. Gan, V. Patel, C.M. Mikelis, R.B. Zain, A.A. Molinolo, M.T. Abraham, S.-H. Teo, Z.A.A. Rahman, J. S. Gutkind & 
 S.C. Cheong. Heterotrimeric G-protein alpha-12 (Gα12) subunit promotes oral cancer metastasis. Oncotarget 2014 
 Oct 30;5(20):9626-40. [PMID: 25275299]
• K.P. Lim, N.A.L. Chun, C.P. Gan, S.H. Teo, Z. A. Abdul Rahman, M.T. Abraham, R.B. Zain, S. Ponniah & S.C. Cheong. 
 Identification of immunogenic MAGED4B peptides for vaccine development in oral cancer immunotherapy. Hum 
 Vaccin Immunother 2014;10 (11):3214-23. [PMID: 25000177]
• C.E. Chong, K.P. Lim, C.P. Gan, C. A. Marsh, R.B. Zain, M.T. Abraham, S.S. Prime, S-H Teo, J.S. Gutkind, V. Patel  & 
 S.C. Cheong. Over-expression of MAGED4B increases cell migration and growth in oral squamous cell carcinoma and 
 is associated with poor disease outcome. Cancer Letters 321 (2012): 18–26. [PMID: 22459352]
• Ajikumar PK, Xiao WH, Tyo KE, Wang Y, Simeon F, Leonard E, Mucha O, Too HP, Pfeifer B, Stephanopoulos G. Isoprenoid 
 pathway optimization for Taxol precursor overproduction in Escherichia coli. Science (2010) 330 (6000):70-4.
ABSTRACT
Precision medicine is about matching the patient with the right drug to achieve the most desirable outcome 
for the patient. In cancer treatment, several companion diagnostic markers indicative of response are 
currently used clinically such as the V600E in BRAF for the use of Vemurafenib or KRAS mutations for the use 
of EGFR inhibitors. In this lecture, I will be focusing on our work in identification of novel therapies for head 
and neck cancer, and in parallel describe approaches to identify biomarkers of response for these drugs. 
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Title : 
Biomarker Discovery: Multiplexing with Luminex xMAP Technology 
Chong Mun Keat, PhD,
Regional Head of Research Marketing,
Flow Cytometry and Multiplexing,
Merck Emerging Asia
TS01
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Chong Mun Keat is the regional head of research marketing in flow cytometry and multiplexing technologies, 
Merck Emerging Asia. His role is to give presentations, training and marketing materials to the team on 
flow cytometry and multiplexing. He received his B.Sc. and Ph.D. degrees from the National University of 
Singapore, under the supervision of Professor Mary Ng. He has 7 years of research experience in molecular 
virology with vast knowledge on protein expression and purification, cellular analyses, molecular cloning 
and high-throughput screening. He has presented more than 20 conference papers in international and local 
conferences with 2 best oral presentation awards and 1 young investigator award. 
ABSTRACT
Biomarker is becoming an essential evaluative tool in drug discovery and development. Various high-
throughput and high-content platforms have been developed to identify potential biomarkers for cancer, 
infectious diseases, diabetes, neurodegenerative diseases and other diseases. Luminex xMAP technology 
is one of the widely used multiplexing platform to boost biomarker discovery studies. In this seminar, 
the principles of Luminex xMAP technology will be elucidated and the roles of Milliplex biomarker kits in 
infectious diseases and immunology studies will be explored.
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Title : 
Going Digital: In Molecular Diagnostics
Hoe Li Nah, PhD
Technical support manager,
Canvio
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Hoe Li Nah received her PhD for Biochemistry from Universiti Kebangsaan Malaysia. She has over 13 
years of experience in the Life Science industry and have performed various functions including technical 
consultancy, support, marketing, and management. In her line of profession, she has had the opportunity to 
acquaint herself with current and upcoming technologies that provide solutions to the research community. 
During this period of time, she has given numerous seminars and workshops to both local and overseas 
researchers.
ABSTRACT
Quantitative real-time PCR is widely used for several applications across life science research, applied testing 
and molecular diagnostics. This 20-year old technology is facing increasing challenges with today’s demands 
for more data with less samples and the need for higher precision, sensitivity and reproducibility. Therefore 
it is important to look into new technologies that can improve research data and come out with better 
methods for diagnostics and ultimately treatment strategies. One of these exciting new technologies is 
Droplet Digital PCR (ddPCR). We will be highlighting the key applications of ddPCR and how it can address 
some of your research questions.
Oral Presentations
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OP01: Identifying a diagnostic target for Group B Streptococcus 
  
*1Swinburne, Hannah; 1Spoors Julia; 1Robert Bolt; 1Johnson Chris; 2Flanagan Keith; 2Anastasi Elisa; 2Lawry 
Beth; 1McNeil Calum; 2Wipat Anil and 1Keegan Neil. 
1Diagnostic & Therapeutic Technologies, Institute of Cellular Medicine, Newcastle University, Newcastle 
upon Tyne, NE2 4HH, UK 
2Interdisciplinary Computing and Complex Biosystems, School of Computing Science, Newcastle University, 
Newcastle upon Tyne, NE1 7RU, UK 
* h.swinburne1@ncl.ac.uk 
 
Abstract 
One in four pregnant women carry the bacterium Streptococcus agalactiae, which, when passed from mother 
to infant during childbirth, can cause sepsis, pneumonia, meningitis and ultimately death. Current 
microbiological culture diagnosis takes between 36 and 72 hours. Due to inaccurate due dates, mothers are 
tested at 35-37 weeks to ensure results are available prior to labour. Levels of S. agalactiae rapidly fluctuate 
in the body, therefore premature testing results in antibiotic prescribing being informed by outdated information. 
With the rise of antibiotic resistance, accurate diagnosis and appropriate drug prescription becomes 
increasingly important. This project aims to develop a sensitive, specific, point of care diagnostic test able to 
detect the 10 serotypes of S. agalactiae, which could be performed at the onset of labour. A novel computer 
programme has been developed to identify peptide sequences distinctive to a group of bacteria. The 
programme captures the protein sequences from all complete bacterial genomes in the RefSeq database and 
splits them into tokens of 15 amino acids in length. Currently this dataset comprises of 1.77 billion tokens from 
4,791 organisms. Tokens are then assessed for their conservation within, and uniqueness to, a group of 
bacterial strains. Three peptides from a surface exposed protein have been identified bioinformatically as being 
present in all S. agalactiae serotypes, and verified using reverse transcription PCR. Murine monoclonal 
antibodies were generated in house against these peptides. Binding affinity to the peptide, recombinant protein 
and bacterial cells is being determined prior to lateral flow assay development. 
 
 
 
 
Keywords: Antibodies; Biomarkers; S. agalactiae 
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OP02: Reverse flow immunochromatography assay for early detecting autoimmune marker 
(autoantibody to GAD65) on autoimmune diabetic patients  
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1Biosains Institute, Brawijaya University 
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Abstract 
Autoantibody profiles are gaining widespread interest as a way to diagnose, predict, and monitor a variety of 
diseases. Insulin-dependent diabetes mellitus (IDDM is an organ-specific autoimmune disease resulting from 
the destruction of pancreatic islet beta cells and consequent insulin deficiency. Glutamic acid Decarboxylse 
(GAD65)  autoantibodies can be found in human islets and have been detected in recent onset diabetic children, 
so in this long studies we developed reliable clinical screening methods based on biomolecular interactions to 
predict, a patient’s risk of developing an autoimmune disease such as type 1 diabetes. Several autoimmune 
abnormalities are detectable in type 1 diabetic sera at the time of diagnosis, although they are observed in the 
sera of subjects who are at increased risk for progression to the disease.  The aim of this study was to 
constructs a rapid test for early detection of autoimmune marker as an autoantibody to GAD65 on autoimmune 
diabetic patients. Human Recombinant GAD65 that produced in E. coli BL21 as competent cell used as antigen 
for detecting autoantibody GAD65 that release in early phase in beta pancreas cell destruction on autoimmune 
diabetic patients. The design of Rapid Test use material such as membrane of nitrocellulose and polyester, 
adsorbent paper, Human Recombinant GAD65, goat anti-mouse IgG as control line, and signal reagent 
contained Nano gold particle and Protein A. The Rapid test based on reverse flow immunochromatography 
assay has been tested with sera of diabetic patients and have a sensitivity of 100% and specificity up to 96 %.  
 
 
 
 
Keywords: autoantibody-GAD65; Type 1 diabetic patients; reverse flow immunochromatogrpahy assay 
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OP03: Isolation and characterization of an anti-salbutamol scFv antibody from a chicken phage 
display library for immunodiagnostics 
 
*Lee, Warren Xian Liang; Tan, Soo Choon and Leow, Chiuan Herng 
Institute for Research in Molecular Medicine (INFORMM), Universiti Sains Malaysia (USM), 11800, Minden, 
Penang, Malaysia 
* warrenlee08@hotmail.com 
 
Abstract 
To date, salbutamol is a preferred β2-agonist drug of abuse in athletics and as a livestock growth promoter 
due to its inexpensiveness. For the detection and isolation of β2-agonists, antibodies remain as the key 
biomolecules to fulfil such purposes. In this study, the use of the chicken (Gallus gallus domesticus) as an 
immunization host for the generation of a monoclonal anti-salbutamol antibody by phage display is investigated. 
A single chicken immunized against SAL-KLH conjugate was used to construct the phage display library. 
Colony PCR and BstNI fingerprinting revealed ~84% of the library had full-length scFvs and ~80% of distinct 
clones respectively. Biopanning from this library isolated six scFv clones which were reactive to salbutamol. 
Following single-point competitive ELISA, one clone with highest apparent affinity was selected for soluble 
scFv expression in Escherichia coli T7 SHuffle Express B (DE3). The functionality of the expressed scFv was 
tested by multi-point competitive ELISA by inhibition with free salbutamol (IC50 salbutamol = ~0.310 μg/ml 
(scFv). The affinity of the antibody was deemed potentially suitable for use as an immunosorbent for 
immunochromatographic-capture solid phase extraction (SPE) for the isolation of salbutamol and its detection 
by more sensitive methods such as LC-MS or GC-MS. 
 
 
 
 
Keywords: beta-2-agonist; salbutamol; chicken scFv; phage display; ELISA 
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OP04: Innovation challenge: the feasibility from lab scale to mass production.  
Can we bring good medical device for more people? Ex: Blood Glucose Monitoring System Industry 
 
*1Sue, Jun Wei; and 2Chung, Hsieh Hsun 
1&2 Zensor R&D Co.,Ltd, Taichung City 412, Taiwan (R.O.C.) 
* Warrick@zensor.com.tw 
 
Abstract 
The development of biosensor in the IVD industry is always the important topic for each one who want to 
introduce their technical aspect change the patient behaviours. Especially, batch to batch variety, quality 
assurance, regulatory of medical device, quality assurance, & user need in the market are serious points during 
lab scale to mass production if scientist want to improve the patient outcome effectively. Each research topic 
should bring new concept for treatment become more effective & also bring the new niche milestone to the 
team who create this biosensor. It is always popular to have the discussion for chronic disease like diabetes. 
According to the report from international diabetes forum (IDF) & WHO, they mentioned almost 10% of 
prevalence in diabetes. It is not only related the budget of health care but also crowded the budget of the other 
field out because the prevalence of diabetes is still going up now. It really impact the social economic status 
in each territory if the policy of health care want to reduce the cost of hospitalization. And blood glucose 
monitoring system (BGMS) is the necessary key point for diabetes care to control glucose level well & prevent 
too much cost used in the hospital. This presentation wants to share the successful example of diabetes care 
& service. It was started from the electrochemical analysis lab in the national university & bring new unique 
platform of biosensor in IVD industry. The performance was also better than major competitor, reduces the 
cost at the beginning stage and provides affordable product to patient. 
 
 
 
 
Keywords: IVD Industry; Diabetes; Blood Glucose; Biosensor; Electrochemical Analysis 
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OP05: Influence of human immunodeficiency virus (HIV) and smear status, and host characteristics 
on seroimmunological biomarkers of pulmonary tuberculosis 
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Abstract  
Globally, pulmonary tuberculosis (PTB) causes disease and death in millions. Early detection and treatment is 
limited by lack of point-of-care (POC) diagnostics. Efforts to develop accurate seroimmunological POC 
diagnostics is hampered by a heterogeneous patient immune response, which are compounded in 
paucibacillary/smear-negative and human immunodeficiency (HIV)-positive PTB patients. To understand the 
variation of common seroimmunological biomarkers across PTB subpopulations, we screened anti-antigen 60 
(A60) IgG and IgA, and C-reactive protein by ELISA in Vietnamese and South African PTB and non-TB patient 
sera (n=404) (including HIV-positive/negative and smear-positive/negative). Statistical analysis for biomarker 
distribution, diagnostic value and host variables across PTB subpopulations were conducted. Combined 
biomarkers had the highest diagnostic value in smear-positive HIV-negative (AUC:0.830), HIV-negative 
(AUC:0.754), and total population (AUC:0.739). CRP had higher accuracy across subpopulations (AUC: 0.614-
0.828), with lowest accuracy in smear-negative and HIV-positive subpopulations. Anti-A60 IgA combined with 
CRP had highest accuracy in HIV-positive (AUC:0.687) and smear-positive HIV-positive subpopulations 
(0.774). Two-way ANOVA indicates significant HIV-status and diagnostic group interaction for anti-A60 IgA (p 
=0.003) and CRP (p=0.005), but not anti-A60 IgG. Anti-A60 IgG and IgA positively correlates in all subgroups 
except smear-negative HIV-positive patients while CRP is not correlated with either anti-A60 IgG or IgA. In 
non-TB, wasting predicted CRP; in smear-positive, weightloss, disease severity, BCG vaccination, and HIV 
status predicted CRP; while in smear-negative, BCG vaccination and smoking predicted anti-A60 IgA, while 
hemoptysis predicted CRP. In conclusion, diagnostic values of biomarkers vary by PTB subpopulation and 
relate to several host characteristics including clinical symptoms and vaccination status. 
 
 
 
 
Keywords: tuberculosis; biomarkers; serodiagnosis; HIV; host factors 
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OP06: Association of Interleukin-13 gene (IL13) rs20541 single nucleotide polymorphism with 
obesity-related traits and allergies among UTAR Kampar students 
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Abstract 
Obesity and allergies are complex disorders caused by genetic and environmental factors. IL-13 is a Th2 
immunoregulatory cytokine which stimulates B cell secretion of IgE and inhibits pro-inflammatory cytokine 
production. The IL13 rs20541 (R130Q) single nucleotide polymorphism (SNP) has been associated with 
increased risk of allergies such as allergic rhinitis (AR), atopic dermatitis (AD) and asthma, but its association 
with obesity-related traits is still elusive. Therefore, this study investigated the association of rs20541 SNP with 
obesity-related traits and allergies among 440 UTAR Kampar students (M/F: 207/233; Chinese/Indians: 
416/24). Anthropometric measurements were taken, allergy questionnaire and skin-prick test were conducted, 
and genotyping was performed by Taqman® SNP Genotyping Assay using DNA extracted from mouthwash 
samples. The prevalence of obesity, AR, AD and asthma was 19.5%, 24.7%, 13.1% and 14.3%, respectively. 
The rs20541 Q allele frequency for Chinese/Indians was 0.50/0.54. IL13 rs20541 genotypes were significantly 
associated with waist circumference (WC) and total body fat (TBF) classes (both p=0.02). Logistic regression 
analysis further revealed that subjects with QQ genotype had increased risk of having high TBF (OR=2.60; 
95% CI=1.27, 5.32; p=0.01 and OR=2.35; 95% CI=1.14, 4.85; p=0.02 in unadjusted and adjusted for ethnicity 
analysis, respectively). AD was associated with body mass index (BMI) and WC classes (both p=0.01), while 
its co-existence with asthma was associated with BMI class (p<0.001). However, IL13 rs20541 was not 
associated with AR, AD and asthma, or their combinations. In conclusion, IL13 rs20541 is associated with 
adiposity, but not allergies among UTAR Kampar students.  
 
 
 
 
Keywords: Interleukin-13; single nucleotide polymorphism; allergic conditions; anthropometric measurements; 
adiposity 
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OP07: QTc interval prolongations in opioid dependent patients on methadone maintenance therapy 
(MMT) 
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Abstract 
Methadone inhibits the cardiac potassium channel hERG and can be associated with a corrected QT (QTc) 
interval prolongation and torsade de pointes (TdP). We conducted a cross-sectional study to investigate QTc 
interval among opioid dependent patients on methadone maintenance therapy (MMT). The sample comprised 
opioid naive individuals and opioid dependent patients from MMT clinics between March and October 2013. 
All participants underwent 12-lead electrocardiogram (ECG). Of the 145 patients who had satisfactory ECG 
recordings, 29 (20%) had QTc interval prolongation > 450 msec. Four (2.8%) opioid naive individuals had a 
prolonged QTc interval. No participant had QTc interval > 500 msec. Patients had significantly longer QT and 
QTc interval compared to opioid naive individuals (p < 0.001). Number of patients with QTc interval 
prolongation > 450 msec was significantly higher compared to opioid naive individuals (p < 0.001). The results 
demonstrate clinical evidence of significant longer QTc interval in opioid dependent patients on MMT compared 
to opioid naive individuals. QTc interval prolongations also occured in a significant proportion of patients. 
Methadone therapy may cause QTc interval prolongations and appropriate clinical management measures 
should be considered to address this challenge. 
 
 
Keywords: methadone maintenance therapy (MMT); opioid dependence; electrocardiogram; corrected QT 
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Abstract 
Streptococcus pneumoniae (pneumococcus) is a major human respiratory pathogen that causes several 
serious diseases, including pneumonia, otitis media (ear infection), sinusitis, meningitis, and septicaemia. 
Despite the introduction of antimicrobial drugs over the past few decades it remains a significant threat to 
health due to antibiotic resistance developed. Hypothetical proteins are the protein which has been identified 
its existence but the function in vivo remains unpredictable. The aim of the study is to identify novel potential 
drug target by structural and functional annotation of hypothetical proteins. In our study, we analysed 484 
hypothetical proteins available in Streptococcus pneumoniae R6 strain genome using various functional and 
structural annotation bioinformatics tools. We used functional annotation tools like Pfam, CDD, Inteproscan 
and SMART tools. We classified successfully out 484 hypothetical proteins, 138 proteins as enzymes, 39 
proteins as binding proteins, 11 proteins as factor, regulator & hormones, 17 proteins as transporters, 8 
proteins as cell cycle related, 3 protein cellular process regulatory, 2 proteins as ion channels, 1 protein-lipid 
binding protein, 184 proteins related to DUF domain with 100% confidence in which all the four tools were 
consistent with prediction. Through sub-cellular localization prediction, 297 were identified as cytoplasmic 
protein. We structurally characterized proteins which are cytoplasmic, functionally characterized and virulent 
predicted through homology modelling by using the Phyre2 server. Through subtractive genomics approach, 
we identified 14 potential drug targets. This present study will facilitate a better understanding of the 
mechanism of virulence, drug resistance, and pathogenesis and for identification drug targets in Streptococcus 
pneumoniae, which emphasizes future perspective to design rational drugs and vaccines. 
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Abstract 
Schizophrenia is a common debilitating neuropsychiatry disorder. Currently, absolute clinical criteria (DSM-V) 
are used for the diagnosis. Identification of prediction and therapeutic markers of schizophrenia could expedite 
the disease diagnosis and management. Catechol-O-methyltransferase (COMT) which regulates 
catecholamine and cognitive function in the developing neurons has long been considered as one of the 
candidate genes of schizophrenia. Recent studies have discovered hypomethylation of the COMT gene in the 
brain of schizophrenia patients. Our study aims to assess the COMT DNA methylation in the peripheral blood, 
on the premises that there are global epigenetic changes and the changes in the peripheral blood mirrors the 
methylation changes of the brain in the schizophrenia patients and the healthy controls. 138 schizophrenia 
patients from the Psychiatry Clinic, Hospital Kuantan Ampuan Afzan, Kuantan Pahang and 132 matched 
healthy controls from Kuantan district were recruited. Genomic DNA from the peripheral blood was bisulfite 
converted and quantitatively measured for the COMT DNA methylation using the MethyLight Taqman® assay 
and normalized with the ALU reference control to give the percentage methylation ratio. We found a significant 
hypomethylation of COMT in schizophrenia as compared to the control group (p=0.000). The hypomethylation 
was also significant in males (p=0.002) and females (p=0.032). This study suggests that DNA methylation 
analysis of COMT can be a potential peripheral biomarker in schizophrenia.  
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Abstract 
Histone deacetylase inhibitors (HDACis) have now appeared as a new therapeutic agent in cancer 
management. Application of HDACis has been reported to be effective in treating haematological malignancies. 
However, clinical trials on HDACis have shown some disappointment in patients with solid tumours. The 
underlying molecular reasoning for this problem is yet to be determined but previous in vitro studies showed 
that HDACis induced epithelial-to-mesenchymal transition in cancer cells and importantly, evidences revealed 
that HDACis caused cardiac toxicity in patients. We have previously reported that HDACi, Trichostatin A (TSA) 
inhibits the mRNA expression of histone deacetylases, hence promotes motility and migration in the weakly 
metastatic human breast cancer cells, MCF-7. Here, we aimed to evaluate the mRNA expression level of two 
metastatic markers, Matrix Metalloproteinase 2 (MMP2) and N-cadherin in MCF-7 cells after TSA treatment. 
MCF-7 cells were treated with several concentrations of TSA (100-10 000 ng/ml) for 24 hours. The mRNA 
expression of MMP2 and N-cadherin was determined by quantitative real-time PCR. Our findings showed that 
TSA significantly upregulate the mRNA expression of both of MMP2 and N-cadherin in dose-dependent 
manner. Therefore, this study supports our previous data that treatment with TSA enhances metastatic 
behaviour of breast cancer cells via upregulation of metastatic markers MMP2 and N-cadherin. We conclude 
that HDACis such as TSA should be carefully evaluated as a potential therapy for patients with solid tumours 
as application of HDACi could induce metastasis.  
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Abstract 
Asthmatic condition involves the exposure of various environmental stimuli including allergen that resulted in 
an activation of effector T cells by antigen-presenting dendritic cells (DCs), secreting various pro-inflammatory 
cytokines. Nanoparticles (NPs) have been shown to have anti-inflammatory properties and reduce the 
symptoms such as hypersecretion of mucus in asthmatic individuals. However, the precise mechanisms of 
NPs exert these effects on DCs, the sentinels of immune system, are still vague. Gold NPs have been chosen 
as NPs of interest due to its advantageous properties including customizable size and shapes, surface 
functionality, low cytotoxicity and biocompatibility. This study have reported that upon exposure to PBMCs of 
healthy donor and asthmatic, we found that gold NPs were taken up by DCs, which were revealed by SEM 
images. Further analyses with flow cytometry and confocal microscopy showed that gold NPs were 
preferentially internalized by DCs of both study cohorts. The uptake of gold NPs induced low cytoxicity and 
immune response associated with a DCs maturation state. This study suggests the potential manipulation of 
DCs with gold NPs, specifically, as targeted delivery for immunotherapies.  
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Abstract 
Triple negative breast cancer (TNBC), characterized by absence of ER, PR and lack of overexpression of 
HER2, is typically associated with poor prognosis, aggressive tumour phenotype(s), partial response to 
chemotherapy and lack of clinically established therapies. TNBC patients receive standard chemotherapy with 
Taxane/Adriamycin/Cyclophosphamide (TAC) regimen but still early relapse is very common in TNBC patients. 
This highlight the urgent need for identification of novel biomarkers for TNBC subtyping and prediction of 
prognosis. The expression of drug efflux transporter gene ABCB1 is associated with altered treatment 
response. microRNAs (miRNAs) are widely recognized as key player in cancer progression and drug 
resistance. This study investigated the expression profile of ABCB1 and 6 miRNAs (miR-21, miR-27b, miR-
34a, miR-182, miR-200c and miR-451) in FFPE samples of 41 TNBC patients. Total RNA was isolated, 
transcribed and preamplified. The expression of ABCB1 and miRNAs were quantified using quantitative real 
time PCR (qRT-PCR) and normalized by normal adjacent tissues. The disease outcome of the patients was 
evaluated after chemotherapy completion. When analyzed to the risk of recurrence, expression of ABCB1 
mRNA was upregulated (2.833) whereas miR-21 and miR-27b were significantly down regulated (0.354 and 
0.388 respectively) in recurrent group compared to non-recurrent group with p-value 0.041 and 0.036 
respectively. The results suggest that expression levels of ABCB1 together with miR-21 and miR-27b 
signatures may serve as biomarkers for prediction of recurrent risk in TNBC patients. Identification of such 
prognostic biomarkers for TNBC patients would allow an optimized treatment selection of regimens that could 
eventually benefit to the patients. 
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Abstract 
IBMR3 is a monoclonal antibody (MAb) which was raised against synthetic peptides that were based on the 
sequence of human interleukin-4 receptors. IBMR3 has been previously shown to be able to inhibit the 
proliferation of cell lines and thus has the potential in cancer treatment. This study aimed to identify the 
expression of IBMR3 antigen in carcinoma (HEp-2 and HT-29), T-leukemic (Jurkat cell line) and normal 
peripheral blood mononuclear cells (PBMC). Immunostaining revealed that IBMR3 MAb can recognize antigen 
in a variety of cell types, including epithelial and haematopoietic cancers and normal cells. Interestingly, IBMR3 
Ag was found to be expressed in the cytoplasm but was absent on the cell surface except for normal 
lymphocytes. Protein extracts were separated via one dimensional electrophoresis and immunoblotting and 
the results showed 2 bands with molecular weights (MWs) of 45 and 25 kDa in HT-29 and one band with MWs 
of 25 kDa in HEp-2. IBMR3 antigen was then identified by combining techniques consisting of two-dimensional 
gel electrophoresis (2-DE), immunoblotting and liquid chromatography tandem mass spectrometry (LC-
MS/MS). The results revealed eight candidate proteins, seven of which are common molecules associated 
with cancer. The protein with the highest significance score in this study was 14-3-3 zeta. Differently expressed 
14-3-3 proteins have been correlated with the prognosis of several cancers. The findings from this study 
exhibited a significant relationship between IBMR3 antigen expression and different types of cancer cells. 
IBMR3 Ag could be a molecule that participates in tumorigenesis through involvement in cell proliferation. 
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Abstract 
Spheroids are self-assembled mass of cells that produce their own extra cellular matrix encompassing the 
complex cell-matrix and cell-cell interactions that mimics the functional properties of the corresponding tissue 
in vivo. The aim of this study is to establish a three-dimensional (3D) spheroid model using the cervical cancer 
cell lines, HeLa (HPV18), CaSki (HPV16) and C33A (non-HPV) as well as to determine its growth and invasion 
phenotype. The liquid overlay method was employed to generate the spheroids which were then embedded in 
bovine collagen I matrix. The HeLa and CaSki cells formed compact spheroids within 72 hours while C33A 
formed loose aggregates. The data obtained showed a remarkable difference in growth and invasion 
phenotype between the HeLa and CaSki spheroids. HeLa spheroids grew and invaded into the collagen matrix 
gradually. CaSki spheroids however, exhibited aggressive invasion phenotype into the collagen and the 
spheroids disintegrated over 10 days. The aggressive invasion phenotype by CaSki prompted us to compare 
the spheroid phenotype with another HPV 16 cell line (SiHa). Contrary to CaSki, SiHa spheroids grew and 
invaded more steadily into the collagen matrix. We also compared the phenotypes between two non HPV cell 
lines (C33A and HT3). Our results showed that both C33A and HT3 cells only formed loose aggregates. In 
conclusion, this study gave an insight into the different growth and invasion phenotypes between different 
cervical cancer cell lines and would be a stepping stone to test existing drugs or to design new treatment 
options for treating cervical cancer according to their HPV infection. 
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Abstract 
Post-mortem studies on patients died after hospital administration with malaria displayed cytoadherence of 
Plasmodium falciparum infected erythrocytes (IEs) on embedded endothelial cells in vital organs such as lung 
and brain. Cytoadherence of the malaria parasite in the organ is mainly mediated by endothelial surface 
receptor CD36 ligand protein that contributed to blockage microcirculatory blood flow. Therefore, it is needed 
to discover a new adjunct therapy to be used as reversal and blocking agent of parasite cytoadherence. 
Aptamer which is single stranded nucleotide (DNA or RNA) or peptide is a new therapeutic and diagnostic 
platform which also known as rival of mAb. In this study, we firstly reported on isolation and characterisation 
of RNA aptamers that specifically bind to CD36 protein. The in vitro SELEX selection was carried out using 
nitrocellulose membrane filter immobilisation method. After 13 rounds of selection, the final product of bound 
RNA pool to CD36 was cloned and sent for DNA sequencing. The sequencing results were aligned and 
clustered using ClusterW software. The RNA aptamer clusters were then analysed for it structures using Mfold 
program followed by evaluating the binding ability using semi-quantitative reverse transcription polymerase 
chain reaction (RT-PCR). Through the binding ability assay there are six RNA aptamer clusters were identified; 
RAC60, RAC25 and RAC46 (p<0.0002). This potential RNA aptamer candidates will be further investigated 
on its kinetic binding affinity through determination of the dissociation constant (Kd) value. As conclusion, this 
study successfully isolated RNA aptamers that can be served as potential candidates for development of 
malaria adjunct-therapy.   
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Abstract 
Malaria is a mosquito-borne infectious disease caused by 5 species of Plasmodium parasites. Species 
infection with P. falciparum is the most prevalent and lethal, causing significant morbidity and mortality 
worldwide. Early and accurate diagnosis of P. falciparum infection is crucial for providing appropriate treatment 
to patients. For this reason, rapid diagnostic tests (RDTs) are increasingly used for malaria diagnosis by 
detection of parasite biomarkers as they offer result in a short period. However, technical limitations of currently 
available RDTs have limited their use in malaria diagnosis. One possible reason is that the current antibodies 
used in RDTs have the propensity to degrade at high ambient temperatures. Therefore, novel antibodies with 
better thermal stability represent important objectives in enhancing the performance of RDTs. In this study, a 
shark semi-synthetic variable new antigen receptor (VNAR) library was constructed to target the malaria 
PfHRP2 protein. The resulting PCR products were ligated into M13 filamentous phagemid vector, and inserted 
into E. coli TG1 cells for the transformation and phage library construction. The result indicated that the primary 
library had a titre of 1 × 107 CFU/ml. DNA sequence analysis showed that 75% of VNAR fragments contained 
an in-frame sequence. In conclusion, VNAR may represent the novel antibody for malaria RDTs.  
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Abstract 
Cystic echinococcosis (CE) is a neglected zoonotic disease which infects both humans and animals worldwide. The 
disease has a big impact on the economy due to complications in treatment and can lead to disabilities. The objective of 
this study was to screen CE in 136 individuals serum samples from migrant workers in Malaysia from Bangladesh (n = 
50), India (n = 52), Nepal (n = 23) and Myanmar (n = 11) using three different immunoassays. The serum samples were 
screened with two commercial ELISA kits ie. Anti-Echinococcus ELISA IgG (EUROIMMUN, Germany), NovaLisa 
Echinoccocus IgG-ELISA (NovaTec Immundiagnostica, Germany) and an In-house IgG4-lateral flow dipstick test using 
recombinant Ag B (Hyd Rapid).  The results showed that 57, 10 and 69 sera were positive and 67, 116 and 67 sera were 
negative with NovaLisa, EUROIMMUN and Hyd Rapid respectively. Among the three assays, concordant positive results 
were seen in 5 samples, concordant negative results in 33 sample; and non-concordant results in 97 samples. Meanwhile, 
among the two commercial tests, concordant positive results were seen in 10 samples, concordant negative results in 67 
sample; and non-concordant results in 58 samples. This study showed a surprising extent of discordant results among that 
the immunoassays. There may be several reasons for the discordant results such as the kind of antigen used, cut-off values 
in the ELISAs and the antibody detected (IgG vs IgG4). Thus it is recommended that an assay should be evaluated using 
a panel of local serum samples before adopting it as a diagnostic immunoassay.  
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Abstract 
Japanese Encephalitis virus (JEV) is known to be serologically similar with other flavivirus such as Dengue 
virus, Zika virus, Yellow Fever virus and others. Co-existence of these viruses with highly homologous 
antigenic epitopes results in antibody-based serodiagnosis being inefficient at detecting and distinguishing 
JEV efficiently from other flaviviruses. This often causes misdiagnosis and inaccurate treatments of flavivirus 
infection. Co-localization of the JEV NS1 protein with the membrane of JEV-infected cells renders the protein 
a potential target. For this reason, the NS1 viral replication protein that reported to confer specificity against 
JEV is used as antigenic marker in this study to generate human antibody fragment against JEV. To improve 
the JEV diagnostic test, we have constructed a human semi-synthetic library displaying single chain antibody 
fragment. Complementary determining region 3 (CDR3) of heavy chain (VH) and light chain (VL) are 
synthetically randomized using degenerate codons. VH and VL were then linked via glycine-serine linker by 
splice overlap extension PCR strategy in respect to construct a highly diverse scFv phage display antibody 
library. DNA sequencing revealed that the quality of library constructed  was good with approximately 60% of 
in-frame scFv repertoires identified and all the sequenced clones confer distinct and unique sequences at the 
CDR3 region. Presently, this library is ready to be deployed for specific clones selection against our in-house 
synthetic recombinant JEV NS1 protein by undertaking repetitive biopanning.  
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Abstract 
Toxocariasis is an important soil-transmitted and zoonotic infection in humans, especially children. 
Laboratory diagnosis of toxocariasis is still a challenge especially in developing countries with 
polyparasitism. Serodiagnosis of human infection is usually performed with commercial IgG-ELISA coated 
with native Toxocara excretory-secretory antigens (TES), however cross-reaction with antibodies to 
other parasitic nematodes is a limiting factor. Therefore, the use of defined recombinant antigens could 
address this problem. Three purified recombinant proteins to Toxocara canis excretory-secretory proteins 
were produced in this study i.e. rTES-26, rTES-30 and rTES-120. The three recombinant antigens were 
expressed, purified and analyzed by Western blot and MALDI TOF/TOF. A rapid test (TcRapid) using the 
antigens and anti-human IgG4 conjugated to colloidal gold was developed and evaluated for serodiagnosis 
of toxocariasis. Comparison of the diagnostic sensitivity and specificity was performed against Bordier's 
kit (Bordier Affinity Products SA), an IgG ELISA which uses toxocara lysate antigen; and against NovaLisa 
Toxocara canis IgG ELISA (Novatec Immundiagnostica Gmbh) which is an IgG-ELISA that uses a synthetic 
antigen. When compared to the commercial IgG-ELISA, TcRapid showed 93 .1 % sensitivity, and 100% 
specificity. IgG4 detection of tissue nematodes is associated with active infection, thus this can explain 
the lower sensitivity of TcRapid as compared to the IgG-based commercial test, the latter likely detects 
both active and ‘old’ infections. Thus, the laboratory prototype of TcRapid showed good potential for prompt 
and accurate diagnosis of toxocariasis and merits further multicentre validation studies. 
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Abstract 
Lupus nephritis (LN) is characterized by renal deposition of immune complexes and it is a serious complication 
in Systemic Lupus Erythematosus (SLE). Normally, serum levels of antinuclear antibodies (ANA), anti double 
stranded (dsDNA) antibodies, and complement levels are used to identify patients with high disease activity 
and at risk for developing LN. The aim of the study was to determine the role of autoantibodies (ANA, Anti-
dsDNA) and complement (C3 and C4) in active and inactive LN patients. A total of 56 LN patients were enrolled 
in this study, 18 of which were diagnosed as having active LN, 18 with inactive LN and 20 healthy controls. 
The serums of each study groups were measured using indirect immunofluorescence assay (IIF) for ANA and 
anti-dsDNA and immunonephelometry for C3 and C4. Statistical analyses were performed using SPSS 
software, version 22.0 and values were expressed as mean ± standard deviation (SD). The results were 
analysed by One-Way ANOVA, independent t-test and chi-square test. ANA was detected in all LN patients 
with p-value <0.001. Anti-dsDNA antibodies were found in less than one-third of both LN patients (22.22%). 
Active LN patients presented a higher frequency of anti-dsDNA as compared to inactive LN patients (27.78% 
vs.16.67%). However, no significant difference was found in anti-dsDNA and C4 for both LN groups. 
Meanwhile, C3 levels were decreased in active LN patients as compared to inactive LN patients (active LN; 
0.76 g/l (0.44 g/l), inactive LN; 1.04 g/l (0.22 g/l) p=0.010). To conclude, ANA and C3 may have a great potential 
as diagnostics factor for LN. 
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Abstract 
Microsporidia infections in human have been reported from all over the world, mostly involved 
immunocompromised patients. Enterocytozoon bieneusi (E. bieneusi) is one of the most common 
microsporidian species infecting HIV/AIDS patients. To date, routine diagnosis of microsporidiosis is limited to 
stool examination which unable to rule out systemic or disseminated infection. This study was conducted to 
detect circulating E. bieneusi DNA and proteins in blood specimen, which were not previously used for the 
diagnosis of disseminated microsporidiosis. Blood samples from HIV/AIDS-positive patients were collected 
from Sungai Buloh Hospital and Universiti Kebangsaan Malaysia Medical Centre (UKMMC). These samples 
were subjected to PCR assay using species-specific primer EBIEF1/EBIER1. The samples were sent for 
sequencing and phylogeny analysis was performed in MEGA 7 using neighbor-joining algorithms. Out of 100 
patients, seven were confirmed positive for E. bieneusi by PCR. A fragment of 607 bp was successfully 
amplified. A gel-free shotgun proteomics analysis using Orbitrap Fusion (Thermo Fischer Scientific) was 
performed towards 7 positive serum samples to detect the circulating proteins of E. bieneusi. The analysis 
identified a few significant E. bieneusi proteins i.e. uncharacterized protein (B7XJ00), DNA topoisomerase 2 
(B7XIW3), and actin (B7XHF2) which above protein scores cut-off level. Bioinformatic tools were used to 
analyse the protein sequences. Identification of circulating E. bieneusi DNA and proteins in blood samples 
may aid in early diagnosis, and can increase the awareness among the clinician that the disseminated cases 
of E. bieneusi did occur in our setting. 
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Abstract 
S. Typhi is a causative agent of typhoid fever in human. Several outer membrane proteins (OMPs) of the S. 
Typhi have been functionally characterized, but their involvement in pathogenicity and virulence are not fully 
known. The aim of this study was to investigate the function of TolC, outer membrane channel protein of S. 
Typhi, in the invasion of human cells and particularly in relation to the expression of the type III secretion 
system-1 (TTSS-1) that is needed for Salmonella invasion. Deletion of tolC resulted in a lower transcription of 
the Salmonella pathogenicity island-1 genes invF, sipA, sipC, and sipD, showing that all genes required for 
TTSS-1 biosynthesis are down-regulated in the tolC mutant. Consequently, the invasion experiments 
performed with the tolC mutant demonstrated that it was significantly less competent to invade HT-29 epithelial 
and THP-1 macrophages cells than its parental strain. Invasion and SPI-1 expression were restored and 
increased as compared to their wild-type parent by complementation of the tolC mutant with the wild-type allele 
of the tolC gene. These data suggest that TolC mediates the entry of S. Typhi into host cells. These results 
explain that the tolC mutants are attenuated and have reduced expression of TTSS-1 effectors that involved 
in pathogenicity. Recognition of common pathways that regulate the expression of the tolC and the type III 
secretion system-1 will give convincing evidence for its role in invasion of host cells.  
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Abstract 
Nowadays quality of water is at risk due to increasing disposals of toxic chemicals from agricultural, industrial, 
domestic wastewater, mine runoff and atmospheric pollution. The common metals found to pollute water 
include lead and zinc. Some metals like zinc is essential trace metal to living organisms, but become toxic at 
higher concentrations.  Lead has no known biological function but it is toxic especially to aquatic organisms. 
Protozoa communities including free-living amoebae could provide valuable information on the health status 
of aquatic ecosystem since they are abundant and widely distributed in the ecosystem. Being single-celled 
eukaryotic organisms and have relatively short generation times and react rapidly to the changing of the 
environmental conditions to suggest these microbes are better indicator organisms for toxicity analysis of lead 
and zinc. A proteomic approach was employed to analyse the toxicity of both metals on Acanthamoeba sp, an 
environmental isolate, in vitro. The amoeba was exposed to the IC50 concentration of both metals in 24-well 
plates for 72 h at 30oC before 2DE was carried out. Protein spots on 2D gels were captured using ImageMaster 
2D Platinum 6.0 for analysis and identification the protein spots in control and treated gels. Proteins spots 
observed on the gels of heavy metals-treated amoeba are categorised as over exposed, under exposed and 
newly synthesized proteins as responses of the amoebae to avoid the metal toxicity. These proteins therefore, 
have potential as biomarkers for lead and zinc toxicity in amoeba. 
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Abstract 
Leptospirosis is the most widely spread zoonotic disease worldwide. It is also one of the Neglected Tropical 
Diseases (NTD). World Health Organization (WHO) estimates the annual incidence is 10 per 100 000 per year 
in the humid tropics with case fatality rate of 5-30%. Currently, commercially available ELISA assays are based 
on antibody detection of general WHO serovars. This study aims to identify novel immunogenic proteins for 
Leptospira spp. Subsequently, these would be used as candidates for novel pathogen biomarker and could 
potentially be developed into ELISA based diagnostic assays. Two ORFeome phage display libraries of the 
entire Leptospira spp. genomes from Malaysian local strains and WHO Leptospira spp. reference strains were 
constructed. Subsequently, 18 immunogenic oligopeptides were selected from these libraries using pooled 
sera from leptospirosis patients. The immunogenic character of these oligopeptides was validated using 
oligopeptide phage, analyzed by titration ELISA using sera from leptospirosis patients and control sera. Six 
immunogenic oligopeptides were validated. Currently, these potential biomarkers are being cloned for 
recombinant protein production for further confirmation. In conclusion, we identified six candidates of novel 
immunogenic proteins of Leptospira spp. and these will be validated using a panel of positive and negative 
sera for prospective applications in diagnostics of leptospirosis. 
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Abstract 
Enteric fever is a systemic infection of humans caused by 4 Salmonella serovars, namely S. Typhi, S. Paratyphi 
A, S. Paratyphi B, and S. Paratyphi C. The inefficient detection method for these serovars due to its large 
diversity urges more serious attempts to find a rapid differential diagnostics method of the disease. In this 
study, a multiplex PCR-Line Probe Assay (mPCR-LiPA), a combination of PCR and reverse hybridization 
blotting technique that permits molecular detection of multiple DNA targets was developed and evaluated for 
the diagnosis of enteric fever. Reference strains ATCC7251, ATCC9150, ATCC8759, and ATCC9068 served 
as positive control to validate the mPCR-LiPA, and agarose gel electrophoresis (AGE) as the comparative 
method. The limit-of-detection (LoD) of the number of PCR cycle and the amount of genomic DNA needed for 
both platform was evaluated. The analytical specificity of the mPCR-LiPA was screened using 153 pure clinical 
isolates from INFORMM Biobank. There were no cross-reactions between the probes. The LoD for mPCR-
LiPA was 15 PCR cycles and 1 × 10-5 ng/µL genomic DNA, thus demonstrating higher sensitivity than AGE 
which requires 20 PCR cycles and 1 × 10-3 ng/µL genomic DNA. All 83 strains of S. Typhi, 23 strains of S. 
Paratyphi A, 7 strains of S. Paratyphi B, and 1 strain of S. paratyphi C were tested positive, 29 strains of other 
Salmonella serovars and 10 strains of non-Salmonella bacteria were tested negative. In conclusion, a highly 
sensitive and specific mPCR-LiPA was developed and ready for further clinical trials. 
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Abstract 
Osteoarthritis is a disease of high economic burden and there is still no definitive method to diagnose early 
osteoarthritis. Biomarkers had proven to be useful in disease diagnosis. The objective of this study is to identify 
potential biomarkers from synovial fluid in early osteoarthritis. Twenty adult New Zealand white rabbits (n=20) 
were divided into two groups, Control group (n=5) and experimental group (n=15) which is subdivided into 
Week 4 (n=5), Week 8 (n=5), and Week 12 (n=5) groups. Rabbits from experimental group were induced using 
monoiodoacetate into right stifle joint. At the end of Week 4, Week 8 and Week 12 post induction, the rabbits 
were euthanized. Synovial fluid from the right stifle joint was collected for proteomic analysis via two 
dimensional gel electrophoresis and MALDI TOF/TOF. The right stifle joint were harvested and subjected to 
micro-CT and histology analysis as gold standard to stage osteoarthritis. Statistical analysis from micro-CT 
data was performed using ANOVA and the histology slides will be qualitatively graded via OARSI Cartilage 
Histopathology Grading/Staging System. Eleven proteins (ceruloplasmin, fibrinogen, serotransferrin, serum 
albumin precursor, serpin peptidase inhibitor, α-1-antiproteinase F precursor, haptoglobin precursor, 
complement 3a, apolipoprotein-IV precursor, immunoglobulin lambda chain C region, immunoglobulin gamma 
heavy chain) had significantly different expression (>2.0 fold) between synovial fluid obtained from control 
group and experimental groups. Changes in parameters of subchondral bone micro-architecture and articular 
cartilage demonstrated early onset of osteoarthritis and showed subtle variations across these time-points. 
The development of a panel of biomarkers could be useful in diagnosing early osteoarthritis.  
Keywords: osteoarthritis; biomarkers; proteomics; subchondral bone; articular cartilage 
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Abstract 
Peninsular Malaysia is populated by the Malays (majority), Chinese, Indians and Orang Asli (OA) – Semang, 
Senoi and Proto Malays (~0.5%). The objective is to demonstrate the ancestral lineage of OA populations in 
Peninsular Malaysia using Y-STR haplotype data. This information may be useful in understanding the human 
dispersal in mainland and island of Southeast Asia, besides for forensic application. We have analysed 17 Y-
STRs loci for 90 randomly unrelated OA males from selected settlements in Peninsular Malaysia using the 
AmpFlSTR Yfiler™ kit (Applied Biosystems™). The samples consist of 54 Semang (16 Kensiu, 13 Lanoh, 25 
Bateq); 30 Senoi (21 Semai, 9 Che Wong) and 6 Proto-Malay (6 Orang Kanaq). A total of 52 different 
haplotypes were identiﬁed and 34 were individually unique. The discrimination capacity of OA calculated was 
0.61333, which may suggest there were potentially only few common paternal ancestors. The PD, PIC, p-
value and pairwise Rst analysis was calculated to show the genetic structure of the OA subgroups with the 
Malays and other world populations (from YHRD website). Y-STR data showed Lanoh and Kensiu (Semang) 
are very strongly related. Based on the MDS plot, the Orang Asli are genetically closer to the Negritos from 
Central African (Biaka Pygmy), South African (Xhosa); Australia Aborigines; Indian and Austronesian 
populations rather than to China and Taiwan populations. This study presents data for a very precious relict 
group, whom are the earliest inhabitants of Peninsular Malaysia. These OA groups are now very scanty and 
not showing any population growth for the past 10 years. 
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Abstract 
Bladder cancer (BC) is the most expensive cancer to manage due to the high risk of recurrence and 
progression that requires life-long routine invasive monitoring. The development of non-invasive biomarkers 
of recurrence and progression can thus increase survival, decrease treatment costs and improve patient 
quality of life. However, to date, no biomarker(s) are routinely used in the clinical management of BC patients, 
especially in predicting risk of progression and recurrence. CTAG1B was previously found to be highly 
expressed in advanced BCs, albeit in Caucasian cohorts. Despite its potential as a target for cancer 
immunotherapy, the effect of expression modulation on cellular phenotypes is poorly understood. In this 
study, the pattern of CTAG1B expression in a cohort of Malaysian BC paraffin-embedded tissues was 
determined using immunohistochemistry. In addition, CTAG1B was overexpressed in EJ28, a minimally-
expressing cell line through the transfection of CTAG1B-pcDNA3.1(-). At 72h post-transfection, the over-
expressing transfected cells were subjected to cell-cycle and proliferation analyses. CTAG1B was 
expressed in a greater subset of advanced stage and grade BC tissues obtained from Malaysian patients. 
CTAG1B was successfully overexpressed in the transfected cells. The CTAG1B-overexpressing cells had a 
significantly higher proliferation rate at 72-96h post-transfection (p-value <0.05). The findings from this study 
indicate that CTAG1B overexpression has a protumourigenic effect in BC. Further functional studies are 
needed to clarify the potentially oncogenic role of CTAG1B and determine the potential utility as a biomarker 
in a subset of BCs. 
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Abstract 
Infection by high risk human papillomavirus (HPV) and integration of HPV genome into host chromosome is a 
key event in neoplastic progression of cervical lesions. The viral oncoproteins E6 and E7 affect gene 
expressions involved in cell cycle, p53 pathway and retinoblastoma gene. Gene expression is mainly controlled 
through transcription regulation, which is mediated through transcription factors, E2F. E2F family is mainly 
involved in the G1/S transition in cell cycle. Increasing expression of these genes is linked to carcinogenesis. 
The study aimed to profile E2F genes expression in HPV-related precancerous cervical intraepithelial 
neoplasia (CIN) lesions and cancer lesions, using formalin fixed paraffin embedded (FFPE) tissues. Total RNA 
was extracted from 12 FFPE samples, consisting of 3 normal cervical tissues as control, 3 low grade CIN (CIN 
1), 3 high grade CIN (CIN 2/3) and 3 squamous cell carcinoma (SCC). The extracted RNA was hybridized to 
human transcriptome array (HTA) 2.0 Affymetrix. Gene expression analysis was evaluated using Affymetrix 
transcriptome analysis console software. Normal tissue was used as control and analysed against CIN1, CIN 
2/3 and SCC. The results showed a differential expression of E2F genes, whereby it was most up-regulated 
in SCC. Only E2F1 gene showed a significant difference, p<0.05, with -1.09-fold for CIN 1 vs normal, 1.21-fold 
for CIN 2/3 vs normal and 1.82-fold for SCC vs normal. The hypothesis is HPV oncoproteins inactivate pRb 
gene, leading to activation of E2F genes which mediate cell cycle proliferation and p53-dependent/independent 
apoptosis. E2F1 plays an important role in the regulation of genes involved in cervical carcinogenesis. 
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Abstract 
Basidiomycetes, especially mushrooms have been regarded as one of the famous delicacies among Asian 
country and well known for their health promoting benefits. Due to their promising medicinal values and rich in 
bioactive compounds, it has extensively gained the attention of medical researchers and aestheticians to 
explore the efficacy of mushroom extract towards the biomarker MMP-1 synthesis in aging process. This work 
is going to demonstrate the biological activities of polysaccharides of three edible mushrooms after undergone 
hot water extraction and purification including antioxidant (1,1-diphenyl-2-picrylhydrazyl (DPPH) radical 
scavenging and Ferric Reducing Antioxidant Power (FRAP) assay), antibacterial and toxicity test (Brine shrimp 
lethality test). Additionally, understanding the correlation of collagen and MMP-1 biosynthesis were done on 
human dermal fibroblast cells in conjunction with the determination of wound healing. Of all extracts, Pleurotus 
sajor caju contains highest antioxidant capacities which showed IC50 at 1.8771± 0.0120 mg/ml. Studies using 
human dermal fibroblast (HDF) cells showed that the extract has relatively low cytotoxicity effect and it even 
stimulated cell proliferation. Tramella fuciformis showed the highest increased in procollagen (PICP) 
stimulation using ELISA test kit and this will be further studied using gene expression level using Real Time 
PCR method. Studies using the MMP-1 will also be done by same method as procollagen test. In conclusion, 
the data indicated in this work show the crude polysaccharides of these mushrooms might potentially be 
deployed as functional element in dermatological industry. 
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Abstract 
HIF-1α signaling is the crucial pathway for cancer cells in keeping its oncogenic drive and progression. In 
general, stabilize HIF-1α binds to hypoxia-response element (HRE) in the promoter region of target gene to 
start transcription. In addition to enhance its binding ability to the DNA of target gene, HIF-1α recruits co-
activators such as CBP and p300. High expression of stabilize HIF-1α parallels to elevated voltage-gated 
sodium channels (VGSCs) expression in various types of aggressive human cancers. However, the role of 
HIF-1α/CBP/p300 in the regulation of VGSCs particularly the isoform Nav1.5 which is highly expressed in 
aggressive breast cancer cells has yet to be explored. Thus, this study was designed to investigate the role of 
HIF-1α/CBP/p300 in the regulation of Nav1.5 in aggressive breast cancer. HIF-1α was silenced in MDA-MB-
231 cells using siRNA and the mRNA expression of CBP, p300 and Nav1.5 expression was measured using 
real time-PCR. Metastasis of the cells was investigated using transwell migration assay. Results indicate that 
only the expression of CBP and Nav1.5 was significantly down-regulated when HIF-1α was silenced, followed 
by 40% reduction in metastasis - represented by reduced number of migrated cells. As a conclusion, our study 
revealed the role of HIF-1α/CBP in regulating the expression of Nav1.5 in breast cancer in which interruption 
of the HIF-1α/CBP lead to suppression of metastasis of breast cancer cells. Ultimately, information gain from 
HIF-1α/CBP/Nav1.5 could be useful as potential biomarker target for breast cancer metastasis. 
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Abstract 
Diagnosis of leptospirosis based on clinical presentations is challenging since they mimic other acute febrile 
illnesses. In acute phase infection (<10 days), Leptospira bacteria and antigen circulate in a patient’s peripheral 
blood. This study was aimed at developing a lateral flow rapid antigen detection dipstick test to complement 
the existing commercial antibody test for detection of acute leptospirosis. Several kinds of rabbit antiserum 
with high titers (≥ 1:128000) were raised against leptospiral recombinant proteins with reported diagnostic 
value (LipL32, LipL41, OmpL1 and LigA), as well as against a leptospiral lysate cocktail. Colloidal gold 
nanoparticle was used to conjugate IgG fraction of each antiserum and used for development of a lateral flow 
dipstick test. The results showed that the use of anti-leptospiral lysate (LL) IgG as both capture and gold-
conjugated antibody was the best assay format. The test showed good sensitivity of ~105 cells, high specificity 
with clinically important pathogen panel, and broad reactivity with common Leptospira spp. serovars in 
Malaysia. Evaluation with a panel of patient serum from acute leptospirosis (n=54) and control serum (n=39) 
demonstrated diagnostic sensitivity and specificity of 57.4% and 87.2%, respectively. When the results of the 
antigen detection dipstick and a commercial antibody detection kit were combined, the sensitivity and 
specificity for detection of acute leptospirosis was approximately 70% and 84% respectively. In addition, an 
antigen detection dipstick test for human urine was developed. Further development and evaluation of the 
rapid test prototypes are needed to enable their potential application for patient diagnosis. 
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Abstract 
Foodborne disease is a major public health problem in both developed and developing countries. Rapid and 
accurate detection and identification of microbial pathogens in food is an essential component of food safety 
tool.  The conventional microbiological approach is time-consuming, labour intensive and involves multiple 
steps and reagents costs. Hence, there is an increasing interest in the improvement of analytical methods in 
terms of speed, specificity and sensitivity and ease of operation. We have developed an amino-modified 
aptasensor using CNT-deposited ITO substrates for the detection of Salmonella species. Covalent coupling 
immobilization of aptamers was carried out on carboxy-rich multiwalled carbon nanotubes. The morphology of 
the aptamer-CNT substrate was characterized by table top scanning electron microscopy. The sensor 
conductivity behaviour and resistance values were checked by cyclic voltammetry and electrochemical 
impedance spectroscopy. The increased resistance values after exposing to the Salmonella samples indicated 
a covalent approach of bonding between the Salmonella and the anti-Salmonella aptamer. The linearity 
analysis showed the developed aptasensor was stable and maintains linearity with the increase of scan rate. 
Sensitivity testing revealed the limit of detection for S. enteritidis was 55.0 cfu/ml.  This study shows the 
potential use of aptasensor-based carbon nanotubes for rapid and effective detection of the S. enteritidis 
through an electrochemical approach. 
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Abstract 
A major hurdle in the development of bacterial diagnostics is the availability of an antigen in the target group 
of interest (Goi), which is ubiquitously expressed and conserved in all members.  When considering diagnostic 
devices, the capture reagents must ideally recognise all members of the Goi, with minimal cross-reactivity to 
other bacteria in order to maximise the sensitivity and specificity of the device.  In order to overcome this hurdle 
an in house biomarker discovery tool (IDRIS) has been developed.  IDRIS allows the rapid integration and 
processing of complete genomic sequence data to identify conserved epitopes - stretches of amino acids 
present on the surface of a given Goi.  IDRIS allows the user to ascertain if the epitope is common, for example, 
to a given species or genus of bacteria and critically allows the user to validate if the epitope occurs in other 
non-target bacteria in order to negate any cross-reactivity which may occur. IDRIS was used to identify unique 
species-specific epitopes in a Clostridium difficile surface associated protein. Monoclonal antibodies generated 
against these epitopes were found to recognise all Clostridium difficile species tested, with no cross-reactivity 
to closely related bacteria.  Purification of the native protein target and probing antibody-target binding by SPR 
revealed one antibody (Ab521) bound with a KD of 36.5 nM. IDRIS has been shown to be a useful tool to guide 
the production of antibodies suitable for diagnostic tests and has now been applied to other bacterial targets 
including Group B Streptococcus. 
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Abstract 
Amoebiasis, caused by Entamoeba histolytica is a public health problem in many developing countries, 
causing up to 100 000 fatal cases annually. The biggest challenge in the management of amoebiasis is its 
laboratory diagnosis. The available commercial antigen detection assays for intestinal infection vary in their 
sensitivities and specificities. Therefore, this study aimed at developing a test that can rapidly detect the 
parasite antigens in stool samples. Pyruvate phosphate dikinase (PPDK), one of the excretory-secretory 
proteins of E. histolytica (EhESA), has been shown to be of diagnostic importance. Thus polyclonal antibodies 
against rPPDK and EhESA were produced; and a rapid dipstick test developed using anti-rPPDK PAb lined 
on the dipstick as the capture reagent and anti-EhESA PAb conjugated to colloidal gold as the detector reagent. 
The performances of the dipstick, commercial Techlab E. histolytica II ELISA and real-time PCR were 
compared using 70 stool samples from patients infected with Entamoeba species (n=45) and other intestinal 
pathogens (n=25). When compared to real-time PCR, the diagnostic sensitivity of the dipstick for detection of 
E. histolytica was 65.4% (n=17/26); while the diagnostic specificity when tested with stool samples containing 
other intestinal pathogens was 92% (23/25). In contrast, Techlab E. histolytica II ELISA detected 19.2% (5/26) 
of the E. histolytica-positive samples as compared to real-time PCR. Therefore the lateral flow dipstick test 
produced in this study enabled rapid detection of E. histolytica, and showed good potential to be further 
developed into a diagnostic tool for intestinal amoebiasis. 
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Abstract 
PanLF Rapid is a rapid diagnostic test that can detect infections caused by lymphatic filarial parasites. The 
test is being used by the Malaysian Ministry of Health in the lymphatic filariasis elimination programme. It is 
based on the detection of recombinant proteins BmR1 and BmSXP. The availability of recombinant monoclonal 
antibodies to the recombinant proteins would be very useful for various applications. In this study a human 
lymphatic filariasis scFv library was constructed using phage display technology. In total, six unique 
monoclonal antibodies (2F, 5B, 3A, 4F, 6D and E3) to BmSXP were successfully isolated. These clones 
represented the IgHV5KV1, IgHV2KV3, IgHV3KV1, IgHV3LV3, IgHV5LV8 and IgHV5LV2 V-gene family. 
Cross-reactivity, antibody concentration and assessment of the binding performance of the monoclonal 
antibodies were determined by ELISA.  Out of six clones, two potential recombinant monoclonal antibodies 
(5B and 3A) were successfully identified, produced and tested in two applications. The first application was for 
making affinity column whereby single and mixture antibody columns were produced; and the results showed 
better performance with the latter. The second application was for preparation of colloidal gold conjugate, 
whereby monoclonal antibody 5B was successfully conjugated with gold nanoparticles, and the results showed 
positive reaction when tested with dipsticks lined with BmSXP and with the commercial PanLF Rapid cassette 
test. Thus this study has produced a novel lymphatic filariasis scFv library that can be used to screen target 
against filarial antigens. In addition, the isolated monoclonal antibodies were successfully utilized in two 
applications.     
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Abstract 
Despite the continuous global battle against tuberculosis (TB), this deadliest disease had ailed a staggering 
number of 10.4 million people in estimation and claimed 1.8 million lives in year 2015 alone. It emerged next 
in line to HIV/ AIDS which has been known as the deadliest disease worldwide. Heat shock protein 16.3 had 
been identified as immunodominant antigen present in latent TB infected individuals. Thus, it serves as a 
promising diagnostic biomarker and therapeutic target for latent TB infection. This study highlights on in silico 
optimisation of two novel single domain antibodies, namely E3 and F1, from phage display library with 
specificity against HSP16.3. The models of antigen and dAbs were first predicted using comparative modelling. 
The dAbs were then docked against the predicted epitopes of HSP16.3. The docking complexes were refined 
using molecular dynamics (MD) simulations. Computational alanine scanning and per residue free energy 
decompositions were performed in order to identify the hot spot residues of dAbs. The effects of mutations on 
targeted hot spots were investigated using MM-GB/PBSA calculation. An improved binding free energy in 
mutated protein complex over the wild type is regarded as successful optimisation. The best candidate for E3 
mutant had exhibited 68.8% improvement in binding free energy whereas 44.2% improvement was observed 
for F1 mutant. The findings provide guidelines for designing dAbs with affinity enhancement against HSP16.3 
for future testing at in vitro level. 
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Abstract 
Tuberculosis (TB) is caused by Mycobacterium tuberculosis (MTB) with 1.5 million of deaths annually. Thus, 
early diagnosis of TB is important for efficient management. In an earlier study, a light chain variable domain 
antibody clone D11 showed high relative binding to MTB lipid diacylated sulfoglycolipids (Ac2SGL), presented 
on transmembrane glycoproteins cluster of differential 1 class b (CD1b), which is important marker for TB 
infected patient. The aim of the study was to predict the binding conformation of the D11 with Ac2SGL-CD1b 
protein and optimise its binding. The conformations of D11 and Ac2SGL-CD1b were modelled with MODELLER, 
docked using ZDOCK along with RosettaDock and further refined using molecular dynamics simulation to 
study the interactions. The study of the affinity changes upon mutating hot-spot residues was performed using 
mCSM-AB webserver and the binding free energy of the complex was calculated with MMPBSA/MMGBSA 
approximation. Results indicated that Tyr32 on CDR1 of D11 has hydrogen bonding with Ac2SGL, while CDR2 
and CDR3 formed significant hydrophobic interactions with the methyl branches of Ac2SGL (-65.76 kcal/mol 
van der Waal force). This showed hydrophobic interaction is favourable in the immunogenic interaction and 
important for recognition. The screening single residue mutation screening on Ser28Arg showed an 
improvement in binding with difference of 15.5 kcal/mol energy whereas Tyr32Trp improved slightly of four 
kcal/mol. The changes of serine to arginine showed improvement in vdW interactions, which support stability 
of domain antibody D11 on CD1b during interaction with Ac2SGL. This study provided some insights into D11 
optimisation for future in-vitro testing.  
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Abstract 
Entamoeba histolytica causes amoebiasis, which leads to amoebic dysentery and amoebic liver abscess, of 
which is fatal if untreated. The membrane proteins of E. histolytica are key molecules in the development of 
the disease and are crucial to the discovery of biomarkers for drug therapy, vaccine development and 
diagnostic markers. In this study, two commercial membrane proteins extraction methods, ProteoExtract® 
Native Membrane Protein Extraction Kit (Calbiochem) and ProteoPrep® Membrane Extraction Kit (Sigma), and 
a conventional method were compared.  The amount of proteins yielded for Calbiochem extracts were 
significantly higher than Sigma and conventional method.  A total number of 171 proteins were identified using 
a combination of the three extraction methods by LC-MALDI-TOF/TOF; in which 56, 30 and 127 proteins were 
identified from Calbiochem, Sigma and conventional method, respectively. Furthermore, 35, 7 and 95 proteins 
were unique to Calbiochem, Sigma and conventional method. However, only 10 proteins were found to be 
common among the three methods. Functional classification of protein classes using PantherDB software 
revealed that the proteins are involved as oxidoreductase (23.9%), cell adhesion molecule (0.9%), membrane 
traffic protein (4.4%), receptor (3.5%), signalling molecule (1.8%) and transfer/carrier protein (0.9%). Overall, 
the Calbiochem kit gave the highest yield of membrane protein extract, while, the conventional method gave 
the best hits of protein identification. In conclusion, the methods compared in this study were complementary 
to each other based on mass spectrometry analyses and its combination improved membrane proteome 
coverage.  
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Abstract 
Entamoeba histolytica is a causative agent for amoebiasis, a disease of significant mortality in human in 
endemic areas, mainly in developing countries. To date there is no vaccine that prevents the infection of this 
parasite. Antigenic protein plays an important role in inducing immune response by triggering B-cells and T-
cells, which may be potential biomarker in vaccine development. To date, there is no study on the antigenic 
membrane proteins of virulent and avirulent variants of E. histolytica. Thus, we compared two different variants 
of E. histolytica membrane proteins known as virulent and avirulent variants by western blot, then followed by 
MALDI-TOF/TOF and database search analyses. We identified eight antigenic protein bands from the virulent 
variant, i.e., 250kDa, 150kDa, 100kDa, 60kDa, 50kDa, 30kDa, 28kDa and 25kDa, and eight antigenic protein 
bands from the avirulent variant, i.e., 280kDa, 250kDa, 150kDa, 74kDa, 45kDa, 35kDa, 25kDa and 20kDa. 
From the MALDI-TOF/TOF analysis, four well-annotated proteins, one uncharacterized protein and five 
putative proteins were identified from the virulent variant. Whereas, two well-annotated proteins and seven 
putative proteins were identified from the avirulent variant. Furthermore, Calreticulin, putative protein was 
identified in both variants. Thus, this potential protein could be explored as a vaccine candidate in the future 
study. 
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Abstract 
Entamoeba histolytica is an enteric protozoan parasite that causes amoebiasis in humans as well as non-
human primates. The invasive trophozoites of E. histolytica can inhabit in the host tissues and provoke 
diseases such as intestinal colitis and induce liver abscess formation. Membrane proteins of E. histolytica play 
a significant role in the expression of the virulence factor, as well as colonization and dissemination in their 
host. To deepen the understanding on the molecular mechanisms of the disease, we compared the membrane 
proteins from virulent and avirulent variants trophozoites of E. histolytica by a quantitative proteomics approach 
using isobaric tag labelling (iTRAQ), analysed with liquid chromatography (nano-LC) and MALDI-TOF/TOF to 
identify the differentially expressed proteins. Our analysis resulted in identification of 127 proteins in total. 
Differentially expressed proteins (fold change >2) were confidently quantified (P < 0.05) and we found 5 
proteins were significantly up-regulated while 6 proteins were down-regulated, respectively. Significant 
differentially expressed proteins were further investigated by assessing their integration and prediction of 
protein-protein interactions network via STRING database (http://string-db.org). STRING predicted 14 
associations among differentially expressed proteins in functional enrichment, whereby 3 proteins were 
involved in amoebiasis, 2 proteins were associated with phagosome and 3 proteins were closely associated 
with protein processing in endoplasmic reticulum (enrichment P value: 0.011). The identification of differentially 
expressed proteins in this study may contribute to better understanding on the mechanism of E. histolytica 
virulence.  
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Abstract 
Discovery on DNA-templated silver nanocluster (DNA-AgNCs) has seen as an alternative to the conventional 
fluorescent probes (i.e. organic fluorophores and quantum dots). This is because DNA-AgNCs offer low cost 
of synthesis and good biocompatibility. Currently, DNA-AgNCs has shown its effectiveness in bioimaging and 
biosensing. The designs of these DNA-AgNCs can be as simple as a single DNA chimeric conjugate, or can 
be more complex with two or more individual DNA strands needed. Hitherto, the impact of DNA sequence 
formulation on the sensing performance of AgNCs remains ambiguous. In this work, we formulate three 
different designs of DNA-AgNCs and study their sensing performance towards adenosine. We systematically 
position AgNCs nucleation sequences and adenosine aptamer at different location of a single chimeric DNA 
template. We name these chimeric conjugates as Apta5, Apta3 and AptaM, with the last letter implies the 
position of AgNCs nucleation sequence at 5’-end, 3’-end and in the middle of DNA template. Among these 
designs, only Apta5 gives selective result against adenosine, with linear range of detection from 1 to 2500 µM. 
We deduced that the selectivity and emission behaviour are highly dependent on the relative position of AgNCs 
nucleation sequences and aptamer, as well as the sequences used to encapsulate AgNCs. 
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Abstract 
Antibody immobilisation is the key factor in the development of highly sensitive and reproducible antibody-
based assay in diagnostic platform. The complexity of pinning antibodies is important in interfering the antigen 
binding as the antibody may have undergone structural changes upon immobilisation on solid phase. 
Consequently, the result of the diagnostic assay may be vary based on different strategy of immobilisation 
used. In this study, we sought to discover a new candidate of antibody binding protein – the human neonatal 
Fc receptor, for application of antibody immobilisation in diagnostic assay. Protein expression was carried out 
to produce the active form of human neonatal Fc receptor. The recombinant protein formed was tested on its 
efficiency in immobilising rabbit IgG against hepatitis B virus surface antigen. Study was extended further to 
develop a sandwich assay for detection of hepatitis B virus surface antigen. The result was compared to the 
conventional immobilisation approach through physical adsorption. The findings demonstrated that human 
neonatal Fc receptor was efficient in capturing antibody and generated higher signals compare to physical 
adsorption method.  
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Abstract 
Notch signaling pathway is implicated in angiogenesis. Clear Cell Renal Cell Carcinoma (CCRCC) is the most 
common type of kidney cancer which have abnormally high abundance of blood vessels. Current treatment for 
CCRCC are available however some patients may acquire resistance to current treatment. Fringe is a regulator 
of Notch Signalling however very little is known about the roles of Fringe in tumour angiogenesis. The aim of 
this project is to study the role of Fringe in tumour angiogenesis. Fringe gene knockdown was performed on 
Ea hy926 endothelial cell line using lentiviral transduction. These cells were then subjected to MTT assay and 
scratch assay to determine if Fringe can affect cell proliferation and cell migration. Fringe knockdown resulted 
in decreased proliferation and migration compared to Ea hy926 empty vector control (EV). Down regulation of 
Notch-related genes HEYL and HEY2 were found in Fringe knockdown when compared to Ea hy926 EV. In 
addition, Ve-cadherin and Thrombospondin-1 were downregulated in Ea hy926 shFringe cells, suggesting that 
Fringe plays a role in angiogenesis. The p21 gene was also downregulated which indicate that Fringe may be 
involved in cell senescence. This project is expected to shed light on the role of Fringe in tumour angiogenesis 
which may provide a novel strategy for cancer treatment. Future work includes co culture assay with renal 
cancer cell line to determine the effect of fringe in tumour angiogenesis. 
 
 
 
 
Keywords: Clear cell renal cell carcinoma; ea hy926; HEYL; HEY2; p21 
 
 
 
 
 
 
 
 
 
MOLECULAR DIAGNOSTICS & BIOMARKER DISCOVERY
3 - 4 May 2017 • Equatorial Hotel Penang,  Malaysia
MDBD 2017    -  75  -
OP45: Endogenous bioactive dynorphin 3-14 as a biomarker in chronic rhinosinusitis and its 
immunomodulatory effects 
 
*1,2Fazalul Rahiman, Siti Sarah; 3Morgan, Michael; 4Gray, Paul; 1Shaw, Paul N and 1Cabot, Peter J.  
 1School of Pharmacy, The University of Queensland, Qld, Australia 
2School of Pharmaceutical Sciences, Universiti Sains Malaysia, Penang, Malaysia 
3Institute for Molecular Bioscience, The University of Queensland, Qld, Australia 
4School of Medicine, The University of Queensland, Qld, Australia 
* s.fazalulrahiman@uq.edu.au  
 
Abstract 
Upon its release in rodent inflamed tissues, dynorphin 1-17 (DYN 1-17) is rapidly biotransformed into a range 
of fragments, with dynorphin 3-14 (DYN 3-14) being the most stable and prevalent fragment. DYN 1-17 has 
been shown previously to regulate the inflammatory response following tissue injury; biotransformation 
fragments of DYN 1-17 may also be involved in mediating these effects. This study aims to investigate the 
presence of DYN 3-14 following biotransformation of DYN 1-17 in human chronic rhinosinusitis (CRS) tissue 
and to determine its effects on the LPS-activated toll-like receptor 4 (TLR4) signalling pathway. DYN 1-17 was 
incubated with human inflamed nasal tissue explants and its biotransformation examined using liquid-
chromatography mass spectrometry. The translocation of nuclear factor-kappaB/p65 (NF-κB/p65) and the 
release of pro-inflammatory cytokines interleukin-1beta (IL-1β) and tumor necrosis factor-alpha (TNF-α) were 
assessed in differentiated THP-1 cells. DYN 3-14 was identified as one of the major fragments produced 
following the metabolism of DYN 1-17 with human inflamed nasal tissues. Furthermore, DYN 3-14 (10 nM) 
inhibited (35%) of LPS-induced NF-κB/p65 nuclear translocation and modulated both IL-1β and TNF-α, 
inhibiting IL-1β and paradoxically augmenting TNF-α release. LPS-induced HEK-Blue™−hTLR4 cells were 
treated with DYN 3-14; DYN 3-14 (10 μM) inhibited TLR4 activation with approximately 300-fold lower potency 
than the potent TLR4 antagonist LPS-RS. These findings indicate that DYN 3-14 is a potential TLR4 antagonist, 
affecting cellular signalling in response to LPS and cytokine release, and thereby suggesting that this 
endogenous opioid peptide may be a useful biomarker for CRS and other inflammatory-related disease.  
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Abstract 
Breast cancer is remaining the second highly notorious killer among women in the age of 40-59. Nepenthes 
gracilis (N.G) is a carnivorous plant and well known for their digestive enzymes. The pitcher fluid of N.G. (N.G-
pf) was collect and subjected to pH and protease inhibitors assays. The proteolytic activity test of N.G-pf 
showed a pH optimum at 3.0 and high aspartic protease activity compared to cysteine, metalloproteinase and 
serine protease. Besides, the crude N.G-pf was fractionated and cell detachment effect on selected breast 
cancer cell lines was determined. Cells were detached by the crude and fractionated N.G-pf but the effect was 
not significantly strong when compared with that of trypsin-EDTA. Nonetheless, the crude and fractionated 
N.G-pf has shown anti-proliferation effects on MDA-MB231 at a concentration 5 times lower than standard 
National Cancer Institute (NCI) criteria for cytotoxicity (IC50 < 30 µg/ml). Cell proliferation of MCF-10A (non-
cancer origin breast cell line was affected by crude N.G-pf, but this was not observed when sub-fractions of 
N.G-pf was applied. Epidermal growth factor receptor (EGFR) highly effects on breast cancer’s cell growth. 
The MDA-MB231 cells were treated with EGFR inhibitor (ICI 180 782), N.G-pf fractions and with the 
combination of EGFR-N.G-pf fractions. The cells treated with N.G-pf fraction and N.G-pf-EGFR inhibitor 
combination group successfully inhibited the growth up to 65 %. The EGFR inhibitor alone treated cells does 
not kills the MDA-MB231. This elucidate that, the N.G-pf fractions might involve in ER-α36-EGFR complex 
signaling pathway to inhibit the proliferation of MDA-MB231 cells.        
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Abstract 
Over centuries plants have been a rich source of natural therapeutic agents for the treatment of various types 
of cancer including breast cancer. Ximenia americana roots are widely used in many African countries as a 
traditional medicine to treat different types of cancer including breast cancer. However, the anti-cancer 
properties of Ximenia americana roots have not been investigated yet. This study aims to investigate the anti-
proliferative effect of water, 50%ethanol and protein crude extracts of X. americana roots on MCF7 and MDA-
MB-231 breast cancer cell lines and to assess the morphological changes induced by the active extract on 
these cell lines. Water, 50% ethanol extracts were prepared using maceration technique and protein extract 
was prepared using Tris-HCl (ph 7) buffer. The three extracts were screened for their anti-cancer activity using 
MTT assay. The morphological changes that induced by the active extract were assessed using hematoxylin 
and eosin staining and inverted light microscope. The results showed that, the crude protein extract exhibited 
dose and time-dependent anti-proliferative effect in MCF7 and MDA-MB-231 with the IC50 values of 1.57± 
0.107 and 2.33 ± 0.161 µg/ml, respectively. Extract-treated MCF7 and MDA-MB-231 cell lines showed some 
apoptotic features when observed under light microscope. Thus, the Ximenia americana roots have cytotoxic 
proteins that could be further investigated as anti-breast cancer therapy.  Further studies are ongoing to 
fractionate and identify the bioactive protein (s) that present in Ximenia americana roots and to investigate the 
therapeutic potentials.    
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Abstract 
Obesity is a potential risk factor contributing to the development of type 2 diabetes. Meanwhile, diabetes is 
one of the most prevalent chronic diseases, affecting 6.4% of the world’s adult population. MicroRNAs 
(miRNAs) are short (-22 nucleotides) regulatory RNAs involved in many fundamental biological processes. 
They are involved in post-transcriptional regulation of gene expression. Dysregulated expression of 
microRNAs has been associated with a variety of diseases, including obesity and diabetes. The aim of this 
study is to identify microRNAs that are differentially expressed in obese, diabetic and control C57BL/6 mice by 
using small RNA sequencing. Total RNAs were extracted from the serum of the target groups of animal. Next, 
the small RNAs were sequenced using the TruSeq small RNA Library Prep Kit in a MiSeq Illumina sequencer. 
A total of 52 up-regulated and 54 down-regulated miRNAs were identified based on the comparison of the log2 
fold change of obese and diabetic (with normal mice as control; FC ≥ 2). The obese groups showed 22 up-
regulated and 25 down-regulated microRNAs. Meanwhile, in the diabetic group, 32 microRNAs were up-
regulated and 29 were down-regulated. These findings will help better understand the mechanism of metabolic 
disorders and may influence future approaches for the diagnosis and treatment of obesity and diabetes. 
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Abstract 
Pancreatic cancer has the highest mortality rate of all major cancers due to its aggressive biology and lack of 
effective treatment. Gemcitabine is approved to be the first line anticancer drug for the treatment of pancreatic 
cancer. However, its efficacy may be reduced due to acquired resistance. Orthosiphon stamineus (O.s) is a 
medicinal herb which is used as a folk medicine in South-East Asia. Currently, there is no data available on 
the in vivo toxicity effect of gemcitabine and O.s when used in combination. This study aims to evaluate the 
toxicity effect of O.s either alone or in combination treatment with gemcitabine in athymic nude mice in order 
to select the safest dose for further anticancer studies. O.s (200 or 400mg/kg/day) alone and/or gemcitabine 
(10mg/kg/3days) were administered through oral gavage and interperitoneal injection respectively over a 
period of fourteen days. The mice in the control group were given distilled water. Different parameters including 
blood serum biochemistry, hematology, myeloid-erythroid ratio, incident of lethality, and histopathology 
analysis of liver, kidney, and spleen tissues were studied. Combination treatment of O.s and gemcitabine at 
the tested doses and treatment duration did not cause any sign of toxicity and damage to the organs in nude 
mice when compared to control group. The data obtained from this study will help to select the best dose for 
future pre-clinical studies. On-going work is being carried out to investigate the effect of O.s and gemcitabine 
in pancreatic xenograft tumor model. 
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Abstract 
Nasopharyngeal carcinoma (NPC) is one of the most common cancers in Malaysia. Majority of the cases were 
diagnosed at late stage, which complicate the treatment and disease outcome. The inaccessible location and 
inconvenient biopsy procedures of NPC make it difficult to detect early. MicroRNAs (miRNAs) was found to 
present in blood circulation in stable state and change with pathological state, including malignancy. Therefore, 
this study is aimed to assess the potential of circulating miRNAs as non-invasive biomarker for early detection 
of NPC. The total RNA was extracted from plasma of six NPC patients and five age- and gender-matched 
control subjects. The miRNA extracts were subjected to profiling using qPCR-array platform. The profiling data 
were processed and analysed statistically using ExpressionSuite software for normalisation and differential 
expression. The preliminary result found that twelve miRNAs were differentially expressed (p<0.05) in NPC 
patients as compared to control subjects, where nine miRNAs were up-regulated and three miRNAs were 
down-regulated. To the best of our knowledge, only hsa-miR-191 was previously reported to be detected in 
plasma and serum NPC, while the other elevens miRNAs were novel finding in this study. However, validation 
using qPCR must be performed to confirm the expression of dysregulated miRNAs in this study. As a 
conclusion, this study has found a list of miRNAs that were significantly dysregulated in NPC patients as 
compared to control subjects and the result need to be further validated to confirm the expression of those 
miRNAs.  
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Abstract  
Sensitive, specific, rapid, inexpensive and easy-to-use nucleic acid tests for use at the point-of-need are critical 
for the emerging field of personalised medicine for which companion diagnostics are essential, as well as for 
application in low resource settings. Here we report on the development of a point-of-care nucleic acid lateral 
flow test for the direct detection of isothermally amplified DNA. The recombinase polymerase amplification 
method is modified slightly to use tailed primers, resulting in an amplicon with a duplex flanked by two single 
stranded DNA tails. This tailed amplicon facilitates detection via hybridisation to a surface immobilised 
oligonucleotide capture probe and a gold nanoparticle labelled reporter probe. A detection limit of 1 x 10-11 M 
(190 amol), equivalent to 8.67 x 105 copies of DNA was achieved, with the entire assay, both amplification and 
detection, being completed in less than 15 minutes at a constant temperature of 37ºC. The use of the tailed 
primers obviates the need for hapten labelling and consequent use of capture and reporter antibodies, whilst 
also avoiding the need for any post-amplification processing for the generation of single stranded DNA, thus 
presenting an assay that can facilely find application at the point of need. 
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Abstract  
Aeromonas taxonomy keeps expanding and the genus is currently composed of 27 species. A. dhakensis (A. 
aquoriorum) often indistinguishable from A. hydrophila, is emerging as a pathogen of clinical importance in 
severe soft tissue degloving infections as an occupational and recreational hazard, and bloodstream infections 
in immunocompromised individuals. However, correct identification remains problematic due to the phenotypic 
and genotypic heterogeneity of the species. The aim of this study was to develop a rapid, simple and reliable 
genotypic tool to differentiate Aeromonas at the species level based on a PCR-RFLP approach and microfluidic 
capillary electrophoresis targeting rpoD housekeeping gene.  A pair of degenerated universal primers was 
designed to amplify the rpoD gene. Next in silico restriction analysis of targeted gene allowed the identification 
of a single restriction endonuclease (RE) AluI which enabled distinct differentiation of the 25 species, except 
for A. sanarelli and A. taiwanensis in which required an additional RE HpyCH4IV. This method was first tested 
with 60 clinical and environmental Aeromonas isolates and the discriminatory power was validated using type 
(Figure 1). Using an Agilent Bioanalyzer, the developed PCR-RFLP assay unambiguously identified the tested 
isolates encompassing 12 Aeromonas species - A. hydrophila, A. dhakensis, A. veronii, A. caviae, A. 
enteropelogens, A. salmonicida, A. jandei, A. media, A. allosaccharophila, A. taiwanensis and A. sanerellii.  
The results of the tested samples were further substantiated by RFLP patterns of the 12 selected type 
strains.We believe this new method offers a rapid and accurate technique for molecular identification of 
Aeromonas species.                                                             
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Abstract 
Colorectal cancer (CRC) is the most and second most common cancer in male and female in Malaysia. 
Epidermal growth factor receptor (EGFR) is a promising target for antibody therapies against metastatic CRC 
(mCRC), but the therapies are only confined to RAS wild type tumour. Several studies have demonstrated the 
potent biomarkers for CRC, but little has been associated with KRAS mutation. Autophagy is a self-destructive 
mechanism that destroys the damaged cells by directing cellular components for lysosomal degradation. Here 
we aim to evaluate the potential of autophagy as biomarkers for advanced CRC in association with KRAS 
mutation. Normal (CCD114 and CCD841), wild-type KRAS (HT29 and SW48), and mutated KRAS (HCT116 
and SW480) CRC cell lines were used in this study. Four autophagy markers (LC3A, LC3B, LC3C, and p62) 
were optimised, and LC3B and p62 were selected for further studies. Western blot analysis showed that LC3B 
and p62 were over-expressed in KRAS-mutated cell lines regardless of cellular stress. KRAS-targeting siRNA 
treatment of cell lines resulted in marked reduction of autophagy effector expression, similar to those treated 
with autophagy inhibitor LY294002. After 72-hour exposure of chemo-therapeutic drugs Cisplatin and 5-
fluorouracil at respective inhibitory concentration (IC)50, both LC3B and p62 expressions were significantly 
reduced. Similarly, gamma-irradiated CRC cell lines exhibited reduced levels of both autophagy effectors. 
These data suggest the therapeutic potential of autophagy for CRC treatment. We conclude that LC3B and 
p62 can be potentially developed into biomarkers for KRAS-associated CRC. These findings will be validated 
using patient formalin-fixed tissues, and correlated with treatment response and overall survival data.  
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Abstract 
Development of nanotechnology, nanoparticles based product and its application is generating interest of 
many researchers due to its promising biological achievement. However, it is well known that inorganic 
nanomaterials are good antimicrobial agents, metal nanoparticles as copper assume special importance due 
to its low cost and easy availability .In this study the green synthesis method as eco-friendly approach is used 
to produce biologically copper  oxide nanoparticlesfrom Ficus Carica leaf extract .The synthesized 
nanoparticles was characterized through the UV-Vis Spectrophotometer as it found to be 437 nm 
,Transmission electron microscopy (TEM) that  investigated  particle sizes in the range 51-62 nm and typical 
XRD patterns of the formed CuO Nps  with high phase purity were obtained , a chi¬tosan stabilizer as naturally 
occurring polymers was added to the prepared copper nanoparticles in different amounts .FTIR spectroscopy 
analysis was performed to copperoxide nanoparticle ,chitosan , copperoxide chitosan composite to confirm 
that CuO nanoparticle was mixed with polymer . The antibacterial efficacy of chitosan ,copper nanoparticles 
alone and polymer/metal composites( Co oxide-chitosan nanoparticle) was studied against 22 bacterial 
pathogen  like methicillin-resistant  S. aureus  as gram positive bacteria , Escherichia coli o157 as gram 
negative bacteria that showed  great antibacterial activity.The effect of the prepared Chitosan-CuO composite 
on ultrastructure of bacterial cells were evaluated by scanning electron microscopy (SEM), it was found that 
the antibacterial activity of Cu-chitosan nanoparticle composite is more greater than antibacterial activity of 
copper nanoparticles  and  chitosan alone that indicate the addition of  chi¬tosan stabilizer enhance at great 
extent the antimicrobial activity of CuO Nps. 
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Abstract 
Immunology has evolved dramatically with the rapid development in science and technology. Various 
strategies involving different immune components have been considered to be incorporated in both diagnostics 
and therapies. Recently, T cell receptor (TCR)-like antibody has drawn the attention of researchers worldwide, 
targeting various diseases such as cancer, viral infections and auto immune diseases. TCR-like antibody is a 
unique approach whereby the antibody is able to mimic the role of T cell in providing internal 
immunosurveillance and simultaneously executes its function as antibody to efficiently eliminate diseases, 
incorporating the advantages of both humoral and cellular immunity. Besides that, TCR-like antibody can also 
be utilized to diagnose diseases since certain pathogens are capable of immunoediting which affects antigen 
recognition and ultimately the MHC pathway. Tuberculosis is a disease caused by Mycobacterium 
Tuberculosis and is indicated as one of the top ten causes of death worldwide by World Health Organization 
(WHO). The available diagnostic tests such as tuberculin skin and immunological tests are found to be more 
efficient in diagnosing active TB infection rather than latent phase and most patients fail to comply with the 
lengthy treatment given resulting in poor recovery. In this study, TCR-like antibody is hypothesized to gain 
maximum benefits in terms of diagnostics and therapeutics. A high-throughput method for producing MHC-
peptide complex via UV peptide exchange is generated. As the experiment models, MHC Class 1 molecule 
HLA-A2, HLA-A11 and HLA-A24 were used. The antibodies with the binding ability to the target peptide-MHC 
are generated by panning against the antibody phage display library. 
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Abstract 
The gold standard for diagnosis of leptospirosis is by the detection of antibody towards Leptospira spp. by 
using micro-agglutination test (MAT). However early diagnosis might be missed due to fact that antibody mostly 
become detectable after tenth day of illness. Polymerase chain reaction (PCR) has been reported as a useful 
tool for early diagnosis of acute leptospirosis thereby can reduce mortality and morbidity. In this study, a 
multiplex PCR (mPCR) was successfully developed and evaluated for detection of two regions of gene 
encoding for 16s rRNA of Leptospira spp. The assay was tested with 37 Leptospira spp., 12 other bacterial 
species and 4 fungal species.  Preliminary data showed positive results for almost all Leptospira spp.  while 
all of other bacterial and fungal species were identified as  negative results. . The analytical sensitivity of the 
assay was 1 cfu/ml. Therefore. our in-house mPCR has a potential to be used as rapid and early tool for 
diagnosing acute leptospirosis.  
 
 
 
Keywords: mPCR; acute leptospirosis; 16S rRNA 
 
 
 
 
 
 
* i i r. .
MOLECULAR DIAGNOSTICS & BIOMARKER DISCOVERY
3 - 4 May 2017 • Equatorial Hotel Penang,  Malaysia
MDBD 2017    -  88  -
 
PP11: A randomized study on isolation of Salmonella enterica serovar Typhi from gallbladder 
patients with hepatobiliary diseases in HUSM 
 
1*Ghazali, Asmak and 1Mustaffa, Khairul Mohd Fadzli 
 
1Institute for Research in Molecular Medicine (INFORMM), Universiti Sains Malaysia, Health Campus, 
16150, Kubang Kerian, Kelantan, Malaysia. 
*asmak0504@gmail.com 
 
 
Abstract 
Typhoid fever is caused by Salmonella enterica serovar Typi (S. Typhi) becomes a public health concern in 
developing and under developing countries with poor hygiene practice. It is estimated that number of typhoid 
fever episodes are 13.5 million new cases reported yearly. 1-5% of typhoid patients harbors S. Typhi for years 
as asymptomatic carriers and forms a crucial reservoir for the further spread of disease. Studies have shown 
that S. Typhi can be isolated from gallbladder, liver, spleen and bone narrow. By forming biofilm around 
gallstones in gallbladder, the bacteria can survive in human’s high bile salt environment. To date, 
cholecystectomy (removal of gallbladder) remains the best alternative option for typhoid carriers with 
gallstones.  However, the patient still remains becoming a reservoir due to dissemination of the bacteria in 
other organs. Randomized study has been performed to isolate S. Typhi from cholecystectomic gallbladder 
patient with hepatobiliary disease using culture technique, Typhoid-Carrier PCR kit and the Typhidot-C have 
been used for S. Typhi confirmatory test from the samples. Five culture techniques have been evaluated and 
optimized; direct incubation (technique 1), upper layer collection (technique 2), vortex (technique 3), upper 
layer and pellet isolation (technique 4) and bile dilution (technique 5) before proceed with PCR and Typhidot-
C test. Out of 80 samples, 78 samples showed negative detection of S. Typhi but two samples showed 
presence of suspected salmonella species in XLD plate but negative for PCR. As a conclusion, this study 
unsuccessfully isolates S. Typhi from patient with hepatobiliary disease. Therefore, there is a need to refine 
inclusion criteria such as experienced typhoid fever before embarking in this study. 
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Abstract 
Biomarker detection is the measurement of a particular substance in an organism whose presence is highly 
associated to certain conditions, especially diseases. However, most traditional biomarker detections rely on 
ELISA, which is costly, time consuming and labour-intensive. In contrast, cysteamine-stabilised gold 
nanoparticles (cys-AuNPs) are newly introduced nanomaterials that act as signal probes to enable rapid 
colorimetric-based detection due to their interparticle-distance dependent optical properties, ease of 
preparation and fast response. We aim to exploit the electrostatic interaction between positively charged cys-
AuNPs and negatively charged DNA aptamer (antibody-like DNA strand) in fabricating an aptasensor. 
Introduction of DNA aptamer electrostatically attracts nearby cys-AuNPs to close proximity, resulting in 
aggregation that changes the colloidal appearance from red to grey. We hypothesised that presence of 
targeted biomarker induces conformational changes on the aptamer and influences the subsequent cys-
AuNPs aggregation, providing a mean of detection. Using thrombin as model, we discovered that our 
aptasensor exhibits bimodal behaviour when different aptamers were applied. Both 15- and 29-mer thrombin-
specific aptamers were employed as capture probes individually. However, incubating thrombin with the former 
aptamer enhanced cys-AuNPs aggregation whereas with the latter aptamer reduced particles aggregation. 
The extent of enhancement or reduction was dependent on thrombin concentration with distinct sensitivity 
ranges for each aptamer. Despite early stage hitherto, we envision that once established, our aptasensor holds 
great potential to enable tuneable detection range and generalize for various biomarkers. 
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Abstract 
Soluble proteins, including cytokines, chemokines and growth factors, are small proteins that mediate and 
regulate immunity, inflammation, and hemopoiesis. These proteins are involved in the pathogenesis of many 
diseases. Their concentration in biological fluids and tissues suggests activation of pathways involved in an 
inflammatory response or disease development. They could serve as a tool for screening, diagnosis 
classification between stages of disease or surveillance for therapy. Enzyme-linked immunosorbent assays 
(ELISA) and bioassay have been used as a gold standard in cytokine level measurements in clinical practice. 
However, these methods allow only single cytokine detection at a time and ineffective for screening purposes. 
Multiplexing technology allows measurement of multiple soluble proteins simultaneously allowing rapid, cost 
effective and marked efficiency in analyzing small volumes of specimens. In this study, we explored the profiles 
of key inflammatory cytokines, chemokines and other soluble proteins derived from colorectal carcinoma 
(CRC, n=20), colorectal polyps (polyps, n=20) and healthy volunteers (control, n=20) using multiplexed bead-
based immunoassays. We aimed to evaluate if the levels of these soluble proteins can classify these groups 
of populations and explore the possible application of the soluble proteins as biomarkers in early stage 
screening and/or surveillance. We observed significant high IL-4, FasL and TGF-β1 levels but lower levels for 
RANTES in polyps patients as compared to controls. Significant high IL-8, VEGF, MIP-1β, Eotaxin and G-CSF 
observed in CRC when compared to controls. Between CRC and polyps patients, significantly higher levels of 
Eotaxin and G-CSF but lower levels for TGF-β1 were detected in sera of CRC patients. Our findings may hold 
promise for the further development of serum screening assays which potentially useful in diagnosis as well 
as a target for therapy. Furthermore, this soluble protein profiles may be useful for the surveillance and 
evaluation of cancer vaccines in clinical trials. 
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Abstract 
Polymerase chain reaction (PCR) based detection has been extensively used to detect and identify pathogenic 
fungi. Asymmetric PCR preferentially amplifies one DNA strand in a double-stranded DNA template and for 
use in DNA hybridization studies. Linear-After-The-Exponential-PCR (LATE-PCR) is an advanced asymmetric 
PCR method using primers at different concentrations, with innovative primer design to assure high efficiency 
and specificity. In the present study, we optimised LATE-PCR parameters to amplify and produce single 
stranded DNA of major fungal pathogens including Candida spp. and Aspergillus spp. The conserved fungal 
internal transcribed spacer (ITS) region was used to design limiting primer (ITS 4) and excess primer (ITS 1) 
for the LATE-PCR. The number of PCR cycles, primer annealing temperature, concentrations of genomic 
DNA, limiting and excess primers, MgCl2 and Taq polymerase were optimized. Gel electrophoresis of LATE-
PCR product showed a smaller band size compared to conventional PCR product indicating the presence of 
single stranded DNA. The single stranded product was hybridised with digoxigenin labeled complementary 
probe and detected using anti-digoxigenin antibody forming a conjugate by dot blotting. The conjugate then 
undergoes enzyme-catalysed colour reaction with phosphate substrate and tetrazolium salt producing the blue 
precipitate. LATE-PCR products of both Candida spp. and Aspergillus spp. successfully hybridized to 
respective oligonucleotide probes with no cross reactivity observed between each fungal genus probe and 
non-target LATE-PCR products. In conclusion, this advancement of PCR may be utilised for a rapid, 
membrane-based detection assay for detecting clinically important fungal pathogens. 
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PP15: Potential impact of BRCA1-3’UTR- TG or TT variant (rs8176318G/T) in the Breast cancer 
populations of Saudi Arabia. 
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Abstract 
The Breast Cancer 1, early onset gene (BRCA1) encodes a tumor suppressor protein that functions as a 
negative regulator of tumor growth. Genetic mutation of breast cancer 1 (BRCA1) is one of the most notable 
factors responsible for a proportion of breast cancer cases. A germline, variant in the BRCA1 3’UTR 
(rs8176318C/T) was previously shown to predict breast and ovarian cancer risk in women from high-risk 
families, as well as increased risk of triple negative breast cancer. Thus, investigations of the underlying 
mechanisms that regulate BRCA1 gene expression provide further insight into possible targets for breast 
cancer therapy. The aim of this study was to determine the frequency of T/T variant of BRCA1 3’UTR in breast 
cancer cases and its association with breast cancer progression. The study was conducted on 100 cases and 
100 sex matched controls. DNA extraction was done for the FFPE specimens using NucleoSpin® DNA 
FFPE kit and for blood using DNAeasy kit from Qiagen.  It was observed that patients with Breast cancer 
possessed significantly higher frequency of T/T variant of BRCA1 3’UTR gene (58%) than healthy controls 
(30%). Independent evaluation of the T/T variant of BRCA1-3’UTR revealed significant variation in baseline 
frequency by ethnicity, with a documented minor allele frequency in different populations of approximately 
0.28. Similarly, a significant difference (p=0.0013) was observed in genotype distribution among cases and 
healthy controls. It was concluded that BRCA1 3’UTR variant (rs8176318C/T) is significantly associated with 
increased risk of Breast cancer among the population of Saudi Arabia.   
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PP16: Identification of Salmonella enterica serovar Typhi virulence factors through bioinformatics 
analysis and yeast morphology assay 
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Abstract 
Typhoid fever is a symptomatic bacterial infection caused by Salmonella enterica serovar Typhi (S. Typhi) that 
usually occurs due to poor sanitation and poor hygiene. The identification of novel virulence factors (VF) of S. 
Typhi will allow for better understanding of the pathogenesis of typhoid infection and potentially help disease 
management. In this study, we used Saccharomyces cerevisiae as a model organism to identify S.Typhi VFs 
that cause morphological changes in yeast. The selection of VFs from the S. Typhi proteome in the available 
databases online (e.g. NCBI and UniProt) was carried out based on the VFs’ ontology, function, subcellular 
location and biological process (e.g. adhesion, colonization, toxicity, motility, biofilm formation). The potential 
VFs were then cross-referenced to more specific databases for VFs such as VFDB (http://www.mgc.ac.cn/VFs) 
and PATRIC (http://patricbrc.org). These VF databases were established to provide current knowledge on 
various bacterial pathogens to accelerate and increase the accuracy of in silico prediction of VFs. A list of 
potential VFs are curated using extensive bioinformatics analysis and literature review. Beginning with the full 
proteome of S.Typhi CT18 of 4718 proteins and we selected 192 potential VFs for expression in yeast. 190 
genes are successfully clone into plasmid bearing green fluorescent protein (GFP) using homologous cloning 
in high-throughput format. This is followed by expression of the VFs in yeast. The morphological changes 
cause by the VFs and the protein localization in yeast are observed. 
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PP17: Identification of Salmonella enterica serovar Typhi virulence factors using a yeast growth 
inhibition screen 
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Abstract 
The study of virulence factors (VFs) is crucial for the understanding of bacterial pathogenesis. When VFs are 
expressed in yeast Saccharomyces cerevisiae, they have been observed to be detrimental to yeast cells (e.g. 
causing growth inhibition). In this sense, yeast can act as a sensitive indicator to identify VFs. There are still 
many unknown VFs and for those already reported, their roles in pathogenesis are not completely understood. 
This study aims to identify Salmonella enterica serovar Typhi VFs by expressing them in S. cerevisiae. First, 
putative VFs were identified by bioinformatics analysis using online databases such as UniProt, VFDB and 
PATRIC. We selected 192 potential VFs from the full proteome of S. Typhi CT18 which contain 4718 proteins. 
The VFs were selected based on their gene ontology (GO) which covers function, biological process and 
subcellular location. Then, the selected VF genes were cloned and expressed in yeast in a 96-well plate format. 
Yeast growth was monitored quantitatively by measuring the optical density of the culture and qualitatively by 
checking the cell’s viability on dilution assay. Of the 192 VFs selected, 176 VFs were successfully cloned and 
expressed in yeast, 24 VFs were found to inhibit the growth of yeast. These VFs will be subjected to further 
characterization studies. 
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PP18: A preliminary report on proteomic-mediated response in mud crabs  
taken from Setiu Wetland lagoon, Terengganu. 
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Abstract 
Setiu Wetland lagoon Terengganu is a center for various water related-activities such as agriculture, fish 
farming and boating activities that contribute to toxic pollutants in its water that affect the organisms inhabit the 
surrounding areas. Scylla spp (known as wild mud crabs) are abundant at that area and important for 
commercial purposes. Poor water quality affects the health and biology of the crabs that cause changes in 
their proteins synthesis as part of defense mechanisms under stress conditions. To confirm this, tissues of 
gills, hepatopancrease and claws of mud crabs were subjected for proteomic analysis by 1D and 2D 
electrophoresis. Proteins of mud crabs were extracted from crab’s tissues by using homogenize buffer, pH 7.8. 
For 1DE, 20 ug of protein samples were resolved on 10 % SDS gel. For 2DE, 200 ug of proteins samples were 
loaded on the strip for IEF. One high intensive band (~115 kDa) was detected from all tissues of mud crabs 
taken at all sampling locations. Interestingly, although 5 protein bands (~73, ~64, ~55, ~24, and ~19 kDa) were 
observed in all tissues at B and C sampling locations, these proteins were not expressed in hepatopancrease 
at A location. Protein separation in 2DE resulted 57 protein spots from gills, 32 protein spots from claws, and 
55 protein spots from hepatopancrease of mud crabs. All these protein spots are observed at pH in the range 
of 3-9. Proteins expressed in various tissues of mud crabs observed in this preliminary study have potential as 
biomarkers for water quality at Setiu Wetland lagoon. 
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PP19: The identification of Leptospira interrogans virulent factors with a yeast growth inhibition 
screen 
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Abstract 
Virulence factors are pathogen-produced macromolecules that are capable to cause diseases. It can be 
effector proteins produced by pathogenic bacteria to help in invasion and evasion as well as enable the bacteria 
to replicate and spread in the host by affecting the host defense system. Leptospira interogans is an 
aerobic,Gram-negative spirochetes bacteria that is responsible for Leptospirosis, a fatal disease that can 
cause meningtis, kidney and liver failure. However, the knowledge about invasion mechanisms of L. 
interrogans remains inadequate. To identify the virulent factors of L. interrogans, we developed a high-
throughput cloning system that can be applied to a 96-well plate format. A total of 278 potential virulence genes 
were selected and 230 were able to be cloned into a yeast expression plasmid. We are currently performing a 
yeast growth inhibition assay. 
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PP20: Establishment of a novel sirtuin inhibitor as an adjuvant therapeutic agent in colorectal cancer 
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Abstract 
Colorectal cancer (CRC) is the world’s third most common cancer in men and the second most common in 
women. 5-Fluorouracil (5-FU) is the first line therapy for CRC. However, patients may acquire resistance to 5-
FU, thus affecting treatment outcome and patient survival. Sirtuins (SIRTs) are highly conserved NAD+ 
dependent class III histone deacetylases (HDAC) that play a role in cancer. There are seven SIRT (1-7) in 
mammals. SIRT1 has been found to be upregulated in CRC. Although SIRT2 was studied to a lesser extent 
compared to SIRT1, the former was found to deacetylate p53 tumour suppressor gene that suppresses cell 
proliferation and tumour growth. We hypothesise that suppressing both SIRT1 and SIRT2 with our novel 
inhibitor may inhibit CRC cell viability through apoptosis. This project aims to study the role of our novel sirtuin 
inhibitor BZD9L1 in mediating chemosensitivity of CRC to 5-FU in vitro. The effects of treatments on HCT116 
and HT29 colorectal cancer cell proliferation were determined using Cyquant. Clonogenic assay and scratch 
assay were performed to assess cell survival and cell migration respectively, post treatment. Combination 
treatment of BZD9L1 and 5-FU resulted in synergistic reduction in cell viability and the ability to form colonies 
compared to single treatment of either one in HCT116 cells, but not in HT29 cells. Combination or stand-alone 
treatment does not affect HCT116 cells ability to migrate and this could be due to concentration of SIRT1/2 
inhibitor used in the treatment. The concentration used in this experiment is capable of increasing 
chemosensitivity of HCT116 cells towards 5-FU but it may not be enough to supress cell migration. Thus, 
understanding the molecular mechanisms affected by of these treatments in colorectal cancer is vital. Current 
work includes real-time PCR, senescence and immunoblotting to observe the downstream effect of these 
treatments. 
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Abstract 
The serological investigation remains the primary approach to achieving satisfactory results in STDs 
identification. However, the accuracy of the native antigen used in the current diagnostic kits has proven to be 
insufficient globally, so significant efforts have consistently been made to find alternative reagents as capture 
antigens/antibody. Consequently, multi-epitope peptides are promising diagnostic markers, with the potential 
for improving the accuracy of diagnostic kits. This research aims to perform a systematic review to assess the 
diagnostic accuracy of all reported recombinant antigens and multiple point-of-care rapid assay platforms for 
HIV detection according to standard methods and summarise test performance using meta-analysis to identify 
promising antigen for development of multiepitope peptide for detection of HIV/AIDS antigen and antibodies. 
Further to develop a diagnostic platform to detect HIV/AIDS antibodies using multiepitope peptides (MEP). 
The MEP is designed to include eight epitopic regions of 8 selected antigens fused to form a 330 amino acid 
peptide. Rapid dot-blot flow through assay was developed with MEP as antigen component at 320ng/ml 
antigen concentration and protein-A gold conjugate for detection of the antigen-antibody complex. On analysis 
of 53 known samples, 23 seropositive and 33 seronegative,  HIV MEP flow through assay showed 87% 
sensitivity and 90.7% specificity over 47.8% sensitivity and 100% specificity of commercial MERIL Quadro HIV 
1-2 Ab flow through assay. 100% reproducibility was achieved on analysis of 10 blinded reactive and five 
blinded non-reactive samples with three different batches. (With further optimisation, MEP based assays will 
be a promising antigen component in efficient HIV/AIDS diagnosis 
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PP22: Triple negative breast cancer: A review of molecular classification and potential target 
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Abstract 
Breast cancer is the second leading cause of death among women worldwide. Triple negative breast cancer 
(TNBC) is defined by the immunohistochemical absence of estrogen (ER), progesterone (PR), human 
epidermal growth factor receptor 2 (HER2) expressions and erb-b2 receptor tyrosine kinase 2 (ERBB2) gene 
overexpression. Besides that, TNBC is also characterized by the poor prognosis and lack of therapeutic target 
as compared to hormone receptor positive and HER2 type breast cancers. TNBC comprises of about 15% of 
all breast cancer cases and has molecular features related to BRCA1 germline mutation carriers. The 
challenge for TNBC treatment is that they are unresponsive to either trastuzumab or hormone therapy. 
Therefore, to determine the presence or absence of a certain biomarker in TNBC could help to predict which 
therapy is the most suitable for targeted TNBC treatment. The aim of this review is to focus on the TNBC 
molecular features and new therapeutic options such as the use of EGFR antagonists, PI3K/Akt pathway, 
ARF1 regulation, PMCA2 downregulation, PARP inhibitors, VEGF and anti-angiogenics as potential therapy 
for TNBC. This approach will have great impact on development of new treatment tumor biology, to identify 
suitable biomarkers and customization of prognostics and therapies in TNBC patients. 
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Abstract 
Defective or inefficient apoptosis has become the hallmark of cancer cell. Extensive studies on molecular 
pathway reveal that targeting the apoptosis pathways in cancer can be used in many therapeutic treatments. 
In order to avoid apoptosis, cancer cells usually target several molecular mechanisms to become resistant to 
any apoptotic molecules. In this review, an understanding of the underlying mechanism of apoptosis pathways 
is provided to unravel novel cancer drug targets in treatment of various types of cancer. Recently, the use of 
natural herbs in treatment of cancer provides an alternative method to treat cancer patients without major side 
effects. A new unsung medicinal plant Goniothalamus, is known to have an apoptosis-inducing compound 
Goniothalamin. The biological property of curcumin has also been thoroughly studied and has been reported 
to induce apoptosis in many cancer cell lines. Thus, this review focuses on providing an overview of apoptotic 
molecular pathways in cancer and elucidates some of the apoptosis-inducing compounds in natural plants. 
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Abstract 
Acinetobacter baumanii is an opportunistic pathogen. There are many different species of Acinetobacter that 
can cause disease, but A. baumanii accounts for about 80 percent of reported Acinetobacter infections. It can 
cause diseases such as pneumonia and meningitis. It has become an increasingly important human pathogen 
because of the increase in the number of infections caused by this organism and the emergence of multidrug-
resistant (MDR) strains. There is a need for identification of novel drug targets against this pathogen. In this 
study, we extensively analysed all available 964 hypothetical proteins (HPs) among A. baumanii. We 
performed extensive functional analysis of these HPs with the help of bioinformatics tools and assigned 
functions to 930 HPs. We classified 559 HPs were binding proteins, 330 HPs were lipid binding proteins, 11 
HPs were enzymes, 17 HPs were receptor, 4 HPs were transporter, 9 HPs were nuclear receptor and 34 HPs 
were not functionally annotated by any of these tools. This functional classification will help to identify novel 
drug targets and also may help in the comprehensive understanding of pathogenesis, drug resistance, and 
adaptability to host for treatment of the diseases. 
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PP25: Functional annotation of conserved hypothetical proteins from Salmonella typhi 
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Abstract 
Salmonella typhi belong to Gram-negative enteric bacillus belong to the family Enterobacteriaceae. Infection 
of S. typhi leads to the development of typhoid, or enteric fever. This disease is characterized by the sudden 
onset of a sustained and systemic fever, severe headache, nausea, and loss of appetite. Typhoid fever affects 
roughly 17 million people annually around the globe. Due to emergence antibiotic resistance among various 
strains, the treatment of typhoid became a major public concern. There is immediate need of identification of 
novel drug targets against this pathogen. Our aim of the study is to combine a number of bioinformatics tools 
for function prediction of previously not assigned proteins in the genome of Salmonella typhi. The hypothetical 
proteins available in the genome were extensively analyzed. Amino acid sequences of all 770 hypothetical 
proteins were analysed and we successfully assigned a function to 559 hypothetical proteins. Out of 559 
hypothetical proteins were functionally annotated, 118 proteins belong to enzyme, 36 proteins belong to 
transport protein, 30 proteins belong to structural protein, 6 proteins belong to Ion channel, 24 proteins belong 
to bacteriophage related proteins, 17 protein belong to cellular process regulator protein, 92 protein belong to 
miscellaneous function, 196 protein belong to Domain of Unknown Function (DUF) and 211 proteins were not 
able to functionally annotated by any bioinformatics tools. The outcome of this work will be helpful for a better 
understanding of the mechanism of pathogenesis and in finding novel drug targets for Salmonella typhi. 
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Abstract 
Klebsiella pneumoniae, a Gram-negative prominent nosocomial pathogen, is responsible for a variety of 
diseases in humans among immunocompromised patients. It is mainly responsible for septicemia, pneumonia, 
respiratory and urinary tract infections. As more Klebsiella pneumoniae strains are becoming highly resistant 
to various antibiotics, treatment of this bacterium has been rendered more difficult. This situation poses a threat 
to public health. Hence, identification of novel drug targets is necessary.  Approximately 20% of the genome 
of K. pneumoniae HS11286 encodes hypothetical proteins. Hypothetical proteins are proteins with an unknown 
function where their sequences and structures are largely non-similar with other known proteins. Through 
computational tools, deciphering the functions of hypothetical proteins of this pathogen may give insight to 
possible novel potential drug targets. The present study was designed to functionally classify hypothetical 
proteins by using various bioinformatics tools available in Klebsiella pneumoniae HS11286. We have 
successfully characterized 731 out of 973 proteins. We classified 239 proteins as enzymes, 68 proteins as 
binding proteins, 41 proteins as transport proteins, 18 proteins as factor, regulators, 16 proteins as lipid binding 
proteins, 14 as bacteriophage related proteins, 13 proteins as cell cycle related, 10 proteins as signalling 
proteins, 4 proteins as ion channels, 2 proteins as nuclear receptor, 2 proteins as monoclonal, 1 protein as 
receptor, while 204 proteins predicted Domain of Unknown Function (DUF) and the rest of proteins were not 
functionally annotated by any of the tools. This computational functional classification of hypothetical proteins 
will help to identify potential novel drug targets among the classified drug targets. 
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Abstract 
In this study we report the effect of glucose oxidase (GOx) concentration on the performance of the indium 
tin oxide (ITO) glass electrode modified with iron oxide nanoparticles (IONPs) and nafion for glucose 
detection. IONPs were synthesized using precipitation technique and surface functionalized using citric acid 
(CA) to provide hydrophilic surface and functional group for glucose oxidase (GOx) enzyme immobilization. 
The effect of GOx enzyme concentration (1mg/ml to 10 mg/ml) to the electrocatalytic performance of the 
modified electrode for glucose biosensor detection was studied. Increasing the concentration of GOx 
increases the electrocatalytic performance of the bioelectrode. This is because more enzymes would 
produce more hydrogen peroxide (H2O2) at the same concentration of glucose under the same condition. 
From the transmission electron microscopy (TEM) images analysis, the size of IONPs obtained was ~19 nm 
and the X-ray diffraction (XRD) spectra showed the presence of spinel cubic lattice of maghemite (γ-Fe2O3). 
The bioelectrode designated as Nafion/Gox/IONPs-CA/ITO shows good electrochemical performance for 
glucose detection with high sensitivity of 90.44 μAmM-1cm-2 for a linear range of 1.0-12.0 mM glucose 
concentration. 
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Abstract 
Xanthophyllomyces dendrorhous produces astaxanthin as its principle carotenoid, which was recently used in 
nutraceutical industries especially in cosmetic and pharmaceutical aspects because of its strong antioxidant 
properties. Mutagenesis by using chemical mutagen, 1-methyl-3-nitro-1-nitrosoguanidine, was carried out to 
obtain a hyperproducing strain, M34, as the astaxanthin production in wild type strain of X. dendrorhous is low. 
Wild type strain and mutant M34 were compared for carotenoid production and mRNA expression level of idi, 
crtE, crtYB, crtI, crtR, crtS carotenogenic genes to correlate carotenoid production with the transcript levels of 
these genes. The changes in the sequence of these genes were also studied to further elucidate the 
mutagenesis that lead to an increase in carotenogenesis in the mutant.  At the end of stationary phase, total 
carotenoid yield of M34 was two folds higher than the wild type. For mRNA expression, both crtE and crtS 
genes showed higher expression, which are 1.3 and 3.8 folds respectively when compared to wild type. 
Besides, all six carotenogenic genes exhibited nucleotide changes, with crtI and crtS with just one nucleotide 
change after the mutation while crtR had the most changes of 18 nucleotides compared to wild type. This study 
will help in understanding the role of the carotenogenic genes in further improvement of carotenoid production. 
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Abstract 
Molecular approaches, such as PCR and real-time PCR, have shown to be sensitive and specific methods in 
the early phase of leptospirosis; however, the needs of the sophisticated and expensive machine for both 
methods hinders its application in low-resource settings thus delays the proper treatment. As a rapid, simple 
and cost-effective detection method, loop-mediated isothermal amplification (LAMP) assay offers a better 
anticipation for early detection of leptospirosis. In this study, LipL32 gene, which is the specific marker to 
pathogenic Leptospira interrogans, was used as a target region for LAMP. The ability of the LipL32-LAMP 
assay to accelerate detection (100 copies/µl of synthetic plasmid) was optimized using four key components; 
reaction temperature, primers set design, Mg ion concentration and enzyme concentration. The reactions were 
incubated in tabletop thermo-block and evaluated manually by the presence of fluorescent green by naked 
eye every 5 minutes and time to results (TTR) were recorded accordingly. Results showed from three primers 
set of LipL32 (LipL32-1, LipL32-2 and LipL32-3) incubated in three different temperatures 60oC, 63oC and 
65oC, the primers set LipL32- 2 showed TTR of 20 minutes when incubated at 63oC. Therefore, LipL32-2 
primers set and 63oC incubation temperature was chosen to be used throughout the experiment. The TTR for 
LipL32-2 assay was 15 minutes when 10 mM of Mg ions incorporated into the reaction. The TTR for LipL32-2 
assay was then accelerated to 10 minutes when 1.6X of Bst3.0 DNA polymerase were incorporated. Thus, the 
best performance of the LipL32 assay within 10 minutes to positive results would offer a sensitive and specific 
rapid detection assay for leptospirosis.  
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PP30: Melioidosis: diagnostic value of IFAT IgM and IFAT IgG in comparison with qPCR 
 
*1M. Imad. A. Mustafa Mahmud; 1Arumugam Janaki; 1S. H. How; 1A. R. Jamalludinand and 2Ahmad Kasfi 
1Kulliyyah of Medicine, International Islamic University of Malaysia (IIUM), Malaysia. 
2Hospital Sultanah Nur Zahirah 
* imad@iium.edu.my  
 
Abstract 
The annual incidence of the melioidosis in Malaysia is about 6.1 per 100,000 populations and the disease 
carries a high mortality of about 50%, most patients being diabetic with late presentation, Culture & sensitivity 
is a standard diagnostic method which takes at least 3 days to confirm the diagnosis while molecular testing 
by PCR is not routinely performed. In this comparative study 30 blood culture confirmed cases of melioidosis 
were followed up by IFAT and qPCR on peripheral blood samples collected on the day of confirmed diagnosis 
by conventional culture. The qPCR assay was previously developed in our laboratory in Basic Medical 
Sciences Department, Faculty of Medicine, International Islamic University Malaysia. The assay targeted the 
type III secretion system gene cluster of Burkulderia pseudomallei (Genbank accession number AF074878). 
Of 30 patients with positive blood culture for B. pseudomallei only 20 (66.7%) tested positive by qPCR on 1st 
day of obtaining the confirmed culture results i.e. ≥2 days after admission and empirical antibiotic treatment, 
while 72.5% tested positive by IFAT IgM and 60% tested positive for IFAT IgG using the cut off values of ≥20 
and ≥80 respectively as determined previously by us based on ROC curve analysis. Two control groups were 
included in this study, patients with other infections and patients without apparent infections. In conclusion, it 
seems that the combined results from these 2 diagnostic tests might be of more diagnostic value than each 
alone. 
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PP31: Synthesis and characterization of gold nanoflowers as label in lateral flow dipstick 
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Abstract   
Lateral flow dipstick offers several advantages such as low-cost, rapid test, on site applications and simple to 
use for detection of various types of analytes. Spherical shaped gold nanoparticles (AuNPs) are commonly 
used as label in a dipstick because of its conjugation properties, easy to synthesis and visibility by naked eyes. 
However, AuNPs based dipstick show less sensitivity due to lower surface Plasmon resonance (SPR) peak 
compared to other dipsticks labels. In this work, flowers shaped or multi-branched gold nanoparticles (gold 
nanoflowers, AuNFs) were synthesized and characterized for labelling in dipstick to enhance its sensitivity. 
The AuNFs were synthesized using hydroquinone as mild reducing agent added to boiling gold salt solution. 
The solution then turned from yellow to blue after several minutes. This AuNFs were characterized using UV-
Vis spectrometer, zeta-sizer and transmission electron microscope (TEM) microscopy. AuNFs show higher 
SPR peak at 701 nm due to its shape compared to sphere AuNPs. The size of AuNFs was 75 nm measured 
by zeta-sizer. Morphology of AuNFs was observed using TEM and flower-like shape with 10 to 15 projectiles 
was observed. AuNFs were successfully synthesized and characterized to be used as improved label in 
dipstick application.  
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PP32: Optimization of Indirect Competitive ELISA for the Development of Immunosensor to detect 
Aflatoxin B1 in peanut sample 
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Abstract 
Aflatoxin B1 is a carcinogenic secondary toxic metabolite which leads to health effects through consumption of 
contaminated food. ELISA is an immunochemical method, which offers selective, sensitive, rapid and 
inexpensive technique to detect molecule in a matrix with simple sample preparation. In this study, multi-level 
factorial design was used to examine the effects of pH, incubation time and temperature towards the assay 
performance. Checkerboard titration was done to determine the specificity of the primary antibody, anti-AFB1 
towards the binding site of the coating conjugate, AFB1-BSA. Skimmed milk was found to be the optimal 
blocking agent. Reducing the concentrations of both coating conjugate and antibody resulted in better 
sensitivity. AFB1-BSA at 0.25 µg/mL with 1/5000 (v/v) of anti-AFB1 antibody was chosen as the optimum 
concentrations for coating and antibody dilution which resulted in highest sensitivity with IC50 value of 0.0183 
ng/mL. The assay performed well in buffer of pH 7 with 0.5 h incubation time at 25⁰C. A non-linear calibration 
curve using AFB1 standard with linear working range of 0.001 to 10 ng/mL and R2 value of 0.9875 was 
obtained. The developed assay was successfully used to detect aflatoxin B1 in peanut sample with minimal 
matrix effect.  
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Abstract 
Bismuth oxide nanoparticles (Bi2O3 NPs) recently had drawn tremendous attention in medical 
imaging, X-ray radiosensitizing and biomolecular detection due to its high atomic number (Z = 83) 
which directly possess high X-ray attenuation coefficient. However, exploration of this compound is 
hampered owing to challenges in synthesizing control for in-vivo stability. The aim of this preliminary 
study is to determine the cytotoxicity effect of Bi2O3 synthesized at different temperatures via 
hydrothermal method in-vitro. The Bi2O3 NPs synthesized at 60, 90 and 120 °C were each 
characterized using scanning electron microscope (SEM). Bi2O3 NPs cytotoxicity was evaluated using 
cell viability assay (MTT assay) upon 24 hours exposure to human hepatic cell line (WRL 68). MTT 
assay showed increase in cell viability as the synthetization temperature of each Bi2O3 NPs increase. 
The data suggest the response of WRL 68 to Bi2O3 NPs have a significant relationship with its 
synthesization temperatures, hence give a better understanding in Bi2O3 NPs synthesizing control to 
enhance its biocompatibility. 
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Abstract 
Hypothyroidism is one of Autoimmune Thyroid Diseases (AITD) condition became a concerning for society. 
This disease is asymptomatic and should be aware especially for pregnant women because it will lead to 
decline in the infant's condition or born with mental or physical disabilities. The number of births is less healthy 
due to the worsening of the manifestation of symptoms in pregnant women who suffer from hypothyroidism, 
not in spite of the delay in determining the early detection and precise handling. Thyroid Peroxidase (TPO) 
antibody titer can be detected early before Triiodothyronine (T3) and Thyroxine (T4) hormone level alteration, 
and could be used for monitoring successful treatment. This work proposed to develop a reverse flow 
immunochromatography based detection using autoantibody of thyroid peroxidase as test line part. This test 
is conducted by using 20 μL sera and required 20-30 minutes test duration. This methods promise to have 
more specificity and sensitivity over commercial kits available and also not laborious. This   works is started 
with preparation of recombinant human autoantibody of thyroid peroxidase from patients, then it was produce 
in E. coli BL-21 cells and purify before apply in cassette kits. Meanwhile, it was also prepared for the control 
lines which use goat anti mouse IgG to support test result interpretation. This platform also have promise to 
prevent hypothyroidism in pregnant women. 
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Abstract 
Cervical cancer is an aggressive and a deadly cancer. Patients suffering from a recurrence and advance 
cancer built resistance to conventional treatment modalities namely chemo- and radiotherapy. Hence, novel 
treatment strategies are required to treat these patients. The anti-apoptotic proteins are expressed in many 
tumours and hence have become attractive targets for cancer therapy. The interest to target them increased 
with development of BH3-mimetics, which specifically target these proteins. BH3-mimetic ABT-263, which 
inhibits BCL-2, BCL-XL and BCL-w, demonstrated impressive single agent activity in most haematological 
tumours and small cell lung carcinoma (SCLC) but exhibited disappointing outcome as a single agent in most 
solid tumours. It has become clear that sensitivity to ABT-263 rely on expression of another anti-apoptotic 
protein, MCL-1. Thus, chemotherapeutic agents or targeted therapies that can repress or neutralize MCL-1 
are predicted to synergize with ABT-263. Here we report that combination of MCL-1 selective inhibitor A-
1210477 (AbbVie) and ABT-263 (Navitoclax, AbbVie) exhibited synergistic effects on cervical cancer cell lines 
SiHa, C33A, CaSki and HeLa. Furthermore, drug potentiation studies revealed that A-1210477 potentiated 
SiHa and CaSki to ABT-263 by 5- and 11-fold respectively. The potentiation in the opposite direction showed 
that ABT-263 was able to potentiate SiHa and CaSki to A-1210477 by 8-fold. Together these findings show 
that combination of ABT-263 and A-1210477 could be a potential treatment strategy for cervical cancer. Future 
studies, which involve testing this combination in 3D spheroids and xenograft models, are necessary to fully 
unleash the prospect of this combination to combat cervical cancer.  
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PP36: Serotyping dengue virus with silver nanocluster DNA switch 
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Abstract 
Dengue is regarded as a prevalent mosquito-borne viral disease in tropical and subtropical countries1. There 
are four dengue serotypes (1-4). Infection of one serotype could confer to life-long immunity against that 
serotype but not to other three serotypes. Secondary infection is reported to associate to life-threatening 
diseases such as dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS). Hence, determination 
of dengue serotype is crucial for epidemiological and pathological studies to find out current and past 
infections2. DNA detection of dengue virus has the advantage of high limit of detection in sample. To serotype 
dengue virus in sample, DNA switch was constructed. DNA switch composed of two sets of DNA probes where 
main probe A (MP-A) anneals with dengue priming strand (DPS) serotype 1 and 2, while MP-B anneals with 
DPS serotype 3 and 4. Each of the DPS that annealed to the same main probe generate different colour of 
silver nanocluster to serotype dengue virus. In the presence of specific dengue target, specific DPS could be 
toehold out and isolated via streptavidin-biotin affinity interaction. Isolated DPS binds with common primer to 
initiate polymerization and nicking process to generate silver nanocluster strands. Incubation of silver 
nanocluster strands with silver nitrate and reduction with sodium borohydride generates fluorescent under UV. 
Dengue virus serotype is able to be determined via the colour of fluorescent emitted by silver nanoclusters. 
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PP37: Cassettes hybridization for vector assembly (CHyVAs): An alternative approach towards in 
vitro antibody affinity maturation 
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Abstract 
Vector assembly is a method in molecular synthetic biology that assemble DNA parts into a functional vector 
system. Most of the vector assembly approaches stipulate the starting materials have to be in single stranded 
form and endonucleases are usually employed to digest double stranded DNA into single stranded. Here, we 
proposed a new and efficient vector assembly method – cassettes hybridization for vector assembly (CHyVAs) 
– that uses stable double stranded DNA and hybridization between homologous overlapping regions on each 
DNA cassette to construct a new vector. This method was successfully applied to generate functional vectors 
with desired protein and antibiotics inserts. Therefore, we envisage the application of CHyVAs as an alternative 
method to achieve antibody affinity maturation. In conclusion, CHyVAs provides a simple yet feasible 
alternative to chain shuffling and construction of mini-libraries for selection of affinity matured antibodies.  
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PP38: Identification of potential clones recognized anti-Strongyloides antibodies by cDNA library 
immunoscreening 
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Abstract 
Strongyloidiasis is a parasitic disease caused by the nematode Strongyloides stercoralis. In human, this 
parasite can cause long-term infection or can disseminate to other organs in an immunosuppressed individual, 
the latter commonly result in a fatal outcome. Most patients are asymptomatic or present with non-specific 
gastrointestinal complaints. There is no gold standard method to rule out the infection and serology is 
commonly used for laboratory diagnosis. The available commercial tests are based on native parasite antigen 
extract which have problems of cross-reactivity with other helminthic infections. A recombinant antigen-based 
test is a good alternative for improved diagnostic specificity and standardized test quality, thus the present 
study was conducted to achieve this goal. In this study, potential infection biomarkers against strongyloidiasis 
were identified by immunoscreening a S. stercoralis phage cDNA library using two secondary antibodies, i.e 
anti-human IgG-HRP and anti-human IgG4-HRP. Three consecutive phases of immunoscreenings were 
performed using individual pre-adsorbed patients and control serum samples, and this resulted in selection of 
20 cDNA clones from each IgG- and IgG4-phage immunoblots. Finally, two cDNA clones, namely Ss3a and 
SsIa, were selected as having high potential diagnostic value. Both clones were reactive with all serum 
samples (n=14) from patients with confirmed infection based on parasitological and/or DNA detection of 
Strongyloides larvae in their stool samples. The diagnostic specificities of the clones were also high i.e. 90% 
and 87% (n=24) for Ss1a and Ss3a respectively. Subsequently, inserts of these clones were cloned and 
recombinant proteins produced for use in the development of improved serodiagnosis for strongyloidiasis.  
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PP39: Multiplex real-time polymerase chain reaction assay for detection of helminthes and protozoan 
parasites in stools of eight aborigine communities in Malaysian Peninsular 
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Abstract 
Parasitic infections remain endemic among the aborigines in Malaysia. The routine diagnostic method for stool 
examination using microscopy is not sensitive and time consuming, especially when concentration and staining 
techniques are performed.  In this study, a multiplex real-time PCR was used to simultaneously detect 
Entamoeba histolytica, Giardia lamblia, Ancylostoma duodenale, Ascaris lumbricoides, Strongyloides 
stercoralis and Trichuris trichuria. A total of 130 stool samples from aborigine communities of Termiar, Jakun, 
Semai, Semalai, Mahmeri, Jahut, Temuan and Orang Asli ethnics from Perak, Selangor, Johor and Pahang 
were analysed. DNA extraction was performed using QIAMP DNA Stool Mini Kit. Two-tube multiplex real-time 
PCR assays were performed to detect DNA of the six parasites, and the results were compared with 
microscopic examination. The results showed that the real-time PCR detected parasite DNA from all samples 
(n=130), 125(96%) were positive for both helminthes and protozoa, all contained two to four species of 
helminthes and 125(96%) contained one to two species of protozoans. Meanwhile microscopic examinations 
were positive for only 89 (68.5%) samples. This study showed that the prevalence of parasitic infections among 
the aborigines was still very high. The rate of detection by the real-time PCR was 1.5 times higher than by 
microscopic examination. In addition, the real-time PCR allowed multiple species detection in a single run, 
thus shortening the time to obtain results. In conclusion the multiplex real-time PCR provides a more accurate 
prevalence data on the parasitic infections among the aborigines.    
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PP40: Biopanning of antibody phage clones using ‘Ping Pong’ panning 
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Abstract 
Phage display is known as the most robust tool for isolating specific high affinity binding molecules against a 
variety of targets. The display technology is essential for diagnostic and therapeutic applications, typically the 
antibody discovery and generation. Biopanning is described as the affinity selection method for the screening 
of phage displayed combinatorial antibody libraries in search for the target-specific ligands. Despite the fact 
that phage displayed antibody libraries has proven promising in the identification of target-specific molecules, 
the problems associated with recombinant antigens are affecting the selection efficiency. Recombinant 
antigens are often designed, validated and expressed via various expression systems as targets for antibody 
selection.  Although antibody phage selection is often conducted with purified antigen, some antigens are 
difficult to be expressed and requires laborious downstream purification. Hence, crude antigen can be used as 
targets without undergoing purification procedures. Crude proteins or antigens are presented as the native 
mixture of expressed biomolecules, however in a most complex state whereby the endogenous proteins are 
expressed alongside with the antigen. The affinity selection methodology can be customized and optimized to 
cater with antibody phage selection against crude antigen. A proposed idea for affinity selection against crude 
ubiquitin is conducted by ‘fishing’ the ubiquitin by anti-ubiquitin phage while negative selection of ligands 
against endogenous proteins in one go. It is demonstrated that the idea could be feasible to select antibody 
phage against crude antigen with enrichment of positive phages.  
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Antibody Selection  
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Abstract 
Zika Virus (ZIKV) is an arthropod-borne virus which contained single stranded positive sense strand of RNA. 
The outbreak of Zika Virus are a serious threat to public health by causing fever, rashes, headache, dizziness 
and neurological complication, such as Guillian-Barre syndrome and microencephaly. The polyprotein of Zika 
Virus constitute 3 structural proteins (Envelop, E; Membrane precursor, PrM; capsid protein) and 7 non-
structural protein (NS1, NS2A, NS2B, NS3, NS4A, NS4B and NS5). NS proteins are co-translated on the 
endoplasmic reticulum (ER) membranes to form replication competent complex. Thus, anti-NS can be useful 
in diagnostic or therapeutic purpose. To produce NS protein, sequence of NS protein were chosen, 
synthesized and cloned into pRSET-BH6, expressed in BL21 (DE3) with the helper plasmid, pRARE3 at 25 
°C, 160 rpm for overnight. The main challenge in producing NS protein was the formation of inclusion bodies 
during protein expression. Thus, 8M urea buffer was used after lysing the cell with lysis buffer and lysozyme. 
Besides, optimization were done on expression hosts, additives and urea concentration. The protein band 
were confirmed with SDS PAGE and western blot. In conclusion, selected non-structural protein were 
successfully expressed and extracted out for purification. 
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PP42: Making sense of the mess; pre-panning process for improved antibody enrichment in phage 
display 
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Abstract 
Antigen B is a major protein component of Echinococcus granulosis metacestode that causes human cystic 
echinococcosis which now becomes common in many regions of the world. Development of antibodies against 
Antigen B is important for therapeutic and diagnostic applications. The antibody selection was done using 
phage scFv library. Biopanning with the library was carried out to enrich anti-Antigen B antibodies. A major 
complication with biopanning processes is the enrichment of non-specific binders. Therefore, optimization of 
the panning process was done to improve antibody enrichment. We adopted a pre-incubation step utilizing 
immunotubes coated with the interfering proteins to isolate non-specific from target specific clones. Phage 
library preparation was pre-incubated before binding with the immobilized Antigen B on microtiter plate. 
Blocking with 5% PTM was used for biopanning and polyclonal ELISA analysis. The introduction of pre-panning 
clean-up of the library was able to reduce the background during panning. Polyclonal antibody ELISA analysis 
shows improve in background reduction with an increase in enrichment output. In conclusion, the additional 
step of background subtraction using the pre-panning clean-up was able to yield good polyclonal antibody 
enrichment. 
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strip assay for the rapid detection 
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Abstract 
Gold nanoparticles (AuNPs) conjugates have been used in a variety of biological applications, including in 
basic research and clinical diagnostic. Preparation of stable AuNPs conjugates is a simple process involves 
passive adsorption causes by electrostatic and hydrophobic interaction between AuNPs surface and 
antibodies. This process is optimally achieved at a pH near the isoelectric point (pI) of the antibody being 
conjugated. This study focuses on the stable conjugation efficiency of the antibody with different size AuNPs 
and concentration of antibody adsorbed to the AuNPs. Different size of AuNPs (10 nm, 20 nm, 30 nm and 40 
nm) were prepared using the seeding- growth method to conjugate antibody for immunochromatographic strip 
assay for rapid detection. The concentration of antibody adsorbed to the AuNPs is a critical parameter in the 
preparation of AuNPs conjugates. If the concentration of antibody adsorbed to the gold surface is very small, 
aggregation takes place upon addition of electrolytes present in a standard buffer. Determination of the optimal 
gold-antibody concentration was achieved using the challenge method with 10% NaCl solution. The minimum 
concentration of antibody that did not exhibit a colour change from red to purple or grey revealed the most 
suitable amount for conjugation. The conjugation stability was investigated by UV-Vis NIR spectroscopy and 
particles size analysis. Based on optimized conjugation conditions, the use of 40nm AuNPs exhibited superior 
performance for the detection of immunochromatographic strip assay relative to other sizes of AuNPs.  
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PP44: Contamination of Leptospira spp. in flood affected areas in Kelantan 
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Abstract 
Leptospirosis is a common yet neglected zoonotic disease mainly caused by pathogenic Leptospira species 
(spp.). Leptospirosis causes mild to life-threatening complications in animals and human. Outbreaks of 
leptospirosis around the world have been associated to heavy rainfall and flooding. These extreme weather 
events increased the risk of leptospirosis to those who live within Leptospira-contaminated environments and 
also the magnitude of outbreaks. We aimed to investigate the presence of Leptospira spp. in environmental 
samples collected from areas affected by flood in Kelantan occurred in January 2017. An amount of 52 water 
and soil samples were collected from three districts which were Tumpat, Pasir Mas and Kota Bharu. The 
samples were cultured and enriched in liquid EMJH, a selective media for Leptospira spp. followed by dark-
field microscope (DFM) observation to determine positive morphology for Leptospira. Only positive samples 
under DFM were preceded for detection of pathogenic Leptospira, performed using PCR targeting LipL32 
gene, a known conserved virulence factor among pathogenic Leptospira. Our findings revealed 35 positive 
samples for Leptospira under DFM: 19 (54%) from Tumpat, 10 (29%) from Pasir Mas and 6 (17%) from Kota 
Bharu. Four samples (11%): 3 from Tumpat and 1 from Pasir Mas were detected as pathogenic Leptospira. 
Therefore, this study confirms that Leptospira-contaminated environments are associated with flood. 
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PP45: A Nanocluster Beacon to detect FOXP3 sequence 
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Abstract 
DNA-templated silver nanocluster is a new class of fluorescence probe that has been reported and favourable 
in many diagnostic application owing to their special properties like small size, photostability and water 
solubility. By using the advantages of AgNCs, we adapted the AgNCs to isolate regulatory T cells (Tregs). 
These Tregs are responsible for immune modulation and its impairment may lead to imbalance of the immune 
system, resulting in autoimmune diseases. Isolating Tregs enables a better characterisation of Tregs, but it 
has been a great challenge due to the fact that the FOXP3 distinct marker is located intracellularly. Therefore, 
internalisation of probe into the cells without killing the cells were needed. Hereby, we introduced an optimised 
method for detection of FOXP3 target with hybridising silver nanocluster probe to its target. The successful 
hybridisation of three-way junction with AgNC, G-rich and FOXP3 target have generated a shift in fluorescence 
spectra with an increased fluorescence intensity. The AgNC design was also used to hybridise FOXP3 mRNA 
using total RNA isolates. Similarly, hybridisation to FOXP3 positive RNA generated a shift in fluorescence 
spectra and an increase in fluorescence intensity. This silver nanocluster system enables a successful 
detection of FOXP3 target sequence with a shift in excitation and emission wavelengths of AgNC, which allows 
a rapid and easy detection of DNA and RNA. 
 
 
 
 
Keywords: Silver nanocluster; Fluorescence shift; DNA Hybridisation 
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Life Science is part of Chemopharm, we offer 
a vast product, solutions and services for 
laboratories, analytical testing, healthcare, 
clinical testing, research and education for 
research and testing in studies relating to living 
organisms and their life structure in botany, 
microbiology and genetics – the functional 
genomics, proteomics and food safety. Please 
do not hesitate to contact us regarding any 
question you may have. Thank you
Chemopharm Sdn Bhd – HQ
No 20, Jalan SS2/66, 47300 Petaling Jaya, 
Selangor      
T : +603-7872 6000  |  F : +603-7872 6044
W : www.chemopharm.com.my
 
Visit us at  
Google Virtual Tour : goo.gl/53zvMd
Google+ : goo.gl/5VrSWY
Youtube : goo.gl/mxHYB6 
Straits Scientific (M) Sdn Bhd also known as 
“3S” was established in 1985 specializing 
in providing quality laboratory and research 
products in Malaysia. With more than 20 years 
of experiences in diagnostics/ research industry, 
it has developed itself as a partner, trusted in 
laboratory testing by most of the hospitals and 
laboratories throughout the nation. To cater the 
needs of healthcare/ Research, Straits Scientific 
has three divisions (Diagnostic division, Medical 
division and Scientific division) aiming to provide 
excellent support to its customers.
Contacts
Straits Scientific (M) Sdn Bhd
(Company No. 148818-K)
10-A, Jalan Nirwana 37, Taman Nirwana, 68000 
Ampang, Selangor.
Tel: 03-9284 7170 / 9284 7173
Fax: 03-9285 4417
Email: straits@3s.com.my 
Website: www.3s.com.my
PLT Scientific Sdn Bhd is a pioneer in scientific 
glassware technology in Malaysia since 1989, 
bearing the name FAVORIT® which now 
personified scientific glassware in the Malaysian 
market. Both the standard interchangeable and 
the volumetric glassware we manufacture, and 
in combination with DURAN®, PLT can supply 
the complete spectrum of scientific glassware. 
PLT Scientific is a leading supplier of scientific 
equipment offering products ranging from 
state-of-the-art analytical instruments to basic 
laboratory glassware, with an ambition to 
be a total solution provider of products and 
services, a ‘one-stop’ centre for your scientific 
endeavours. 
Point of Contact: 
Azzy Iyzati 
Sales Application Specialist 
012-6884495 / +603-80682368 (ext 72) azzy@
pltscientific.com
Nano Life Quest Sdn Bhd
NLQ, one of the fastest growing scientific 
products distribution companies established 
in 2005 with GDPMD certified. We offer a 
total solution for the molecular diagnostics, 
life Sciences, agri-biotechnology, medical & 
pharmaceutical market segments in Malaysia 
as well as the region of the South East Asia.
Phone: +603-5525 2608
info@nanolifequest.com, www.NanoLifeQuest.
com
MATRIOUX brings technology expertise 
and delivers reliable solutions on research 
strategy, laboratory setup and diagnostics 
work.  We distribute consumables, reagents 
and instruments for molecular, cell culture and 
western blot related research and diagnostic.  In 
addition, we also provide customized research 
and consulting services.  
Contact: 
Email: info@matrioux.com Tel : +603-80802070 
Fax : +603-80752070
Neoscience is one of the leading distributors 
of premium plastic consumables, molecular 
biology products, laboratory supplies, and 
scientific instruments for the sectors of 
Biotechnology, Clinical Diagnostics, Molecular 
Biology, Genomics and Tissue Culture. We 
ensure customer satisfactions by providing 
excellent quality products at a competitive price 
with a timely delivery and services.
Contact Details
Neoscience Sdn Bhd
Unit C705, Level 7, Block C, Kelana Square,
17, Jalan SS7/26, Kelana Jaya,
47301 Petaling Jaya, Selangor, Malaysia.
Tel: +603 7610 0388
Fax: +603 7610 0389
Email: info@neoscience.com.my
Company Website
http://www.neoscience.com.my/
Genomax Technologies is founded in 2003 by 
a team of enterprising professional with years 
of experience in life science research products. 
Our mission is to provide life science research 
communities, biotechnology & pharmaceutical 
companies, CROs and hospitals in Malaysia, 
Thailand and Singapore with innovative 
products and services.
 
Address: 
A3-7-28, Block A3, Pusat Dagang Setia Jaya, 
Leisure Commerce Square, No 9, Jln PJS 8/9, 
Petaling Jaya, 46150 Selangor
Email: info@genomax.com.my
Website: www.genomax.com.my
Tel: (603) 7496 7886
Fax: (603) 2169 6168
Reszon Diagnostics International Sdn. Bhd.
 
Specialized in developing and manufacturing 
innovative IVD kits for infectious disease 
diagnosis and drug of abuse screening. 
Manufactured in ISO13485-certified facility, our 
diagnostic kits are widely used and recognized 
in various countries and research institutions 
worldwide as well as by local Public Health 
authority and WHO representatives to promote 
disease elimination program.
Contact us at 
03-80251603, Email: info@reszonics.com, 
Website: www.reszonics.com.
Bio-Diagnostics Sdn Bhd was incorporated in 
January 1986. Our main business fields are 
life science research, biotechnology, clinical 
diagnostics, bench top devices and laboratory 
consumables of the industry. Having been 
in business for 31 years, we have establish 
good and reputable contacts with all relevant 
government departments, research institutions, 
colleges and universities in Malaysia.
 
Contact details:
Bio-Diagnostics Sdn Bhd
15 Jalan SS 5A/11, Kelana Jaya,
47301 Petaling Jaya, Selangor
Tel: +603-7877 2611
Fax: +603-7877 2610
Email: info@bio-diagnostics.com.my
Website: www.bio-diagnostics.com.my
Next Gene Scientific is a fast growing Life 
Science Solution provider which offers below 
products & services:
• Genomics Services (Oligonucleotides, 
 Probe, Gene & Peptide Synthesis, 
 Sequencing Service, NGS, Cloning, 
 Bioinformatic Analysis Software)
• Primary Cells and Cell Isolation
• Cell Cultures and Microbiology Media
• Restriction Enzymes and Antibiotics
• A-Z Chemicals
• Lab Instruments and Consumables
 
Next Gene Scientific Sdn Bhd 
No.7, 2nd Floor, Jalan Puteri 1/7, Bandar Puteri, 
47100 Puchong, Selangor, Malaysia.
Tel: +603-8051 5106 
Fax: +603-8051 5107 
www.nextgene.my
MyTACG Bioscience Enterprise provides 
complete and versatile solutions from sample 
preparations to sequencing (Sanger, Next 
Generation & Pac Bio) to life science research 
community.  We work with worldwide renowned 
and reputable manufacturers, sequencing 
facilities and service providers to offer a 
ONE-STOP ALL-PLATFORMS solution to 
researchers.
Add:  No 54-2, First Floor Front Portion, Jalan 
Radin Anum 1, Bandar Baru Sri Petaling, 57000 
Kuala Lumpur, Malaysia.
Mobile: +60 16 905 2819
Tel: +60 3 9054 3265
Fax:+60 3 8736 6787
E-mail: info.mytacg@gmail.com (Enquiry)
           yhchin.mytacg@gmail.com (Direct)
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